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Abstract I (English) 
Neutrophil granulocytes are the largest group of white blood cells and play a significant role 
in the innate immune system. With the discovery of a vast number of thus far unknown 
functions, neutrophil granulocytes became a focus in biomedical research. One of the most 
remarkable findings are neutrophil extracellular traps (NETs), fibril networks of decondensed 
chromatin with attached antimicrobial proteins that can be released as a response to various 
stimuli in order to defend pathogens. The process of NET formation (NETosis) is 
evolutionarily highly conserved and involved in many pathological conditions. A detailed 
analysis of NETosis can, therefore, contribute to a better understanding of such diseases and 
therapeutic strategies. 
So far, the biophysical forces driving the morphological alternations that underlie chromatin 
decondensation and subsequent NET release are poorly understood. This issue is addressed 
in the first manuscript of this thesis. The results of this study show that NETosis occurs in 
three distinct phases of which only the first depends on enzymatic activity and energy 
consumption. The second phase is primarily driven by material properties and entropic 
swelling of chromatin. Therefore, the start of chromatin decondensation with nuclear 
envelope breakdown (onset of phase 2) represents a point of no return in NETosis. Complete 
chromatin decondensation is followed by NET release through rupture of the plasma 
membrane at a predetermined breaking point (phase 3). This biophysical characterization 
facilitates our understanding of the precise mechanisms of NETosis and highlights the extent 
by which complex biological processes can be driven by material properties. 
In vitro NETosis studies are being conducted by an ever-increasing number of groups. They 
use highly diverse amounts of serum and serum albumin in their culture media. This is 
problematic, as these supplements interfere with NETosis depending on their concentration, 
used stimulus and neutrophil donor species (human vs. mouse). Details are analyzed in the 
second manuscript, which contributes to the comparability of research conditions.  
Furthermore, ultraviolet-visible (UV-Vis) light can massively alter cell functions. The third 
manuscript investigates the effect of UVA and blue light on NETosis. Light activates a 
neutrophil elastase (NE)- and myeloperoxidase (MPO)-dependent pathway of ‘suicidal’ 
NETosis, which requires the riboflavin-mediated generation of reactive oxygen species 
(ROS). External factors, therefore, have a crucial impact on NET formation, which has to be 
considered for in vitro studies. Additionally, light-induced NETosis may be of particular 
interest in the pathogeneses of light-sensitive disorders (“photodermatoses”) including 
autoimmune diseases such as lupus erythematosus. 
Together, these studies provide detailed insight into the mechanisms of NET formation and 
their regulation.  
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Abstract II (German) 
Neutrophile Granulozyten sind die größte Population weißer Blutzellen und ein essentieller 
Bestandteil des angeborenen Immunsystems. Durch die Entdeckung einer Vielzahl neuer 
Funktionen sind neutrophile Granulozyten in den Fokus der biomedizinischen Forschung 
gerückt. Die Bildung neutrophiler extrazellulärer Traps (NETosis), einem Netzwerk aus 
dekondensiertem Chromatin dekoriert mit antimikrobiellen Substanzen, welches zur Abwehr 
von Pathogenen freigegeben werden kann, ist eine der eindrucksvollsten Funktionen. 
Interessanterweise ist dieser Prozess evolutionär konserviert und involviert in 
verschiedenste Pathologien. Daher kann eine detaillierte Analyse dieses Prozesses zu einem 
tieferen Verständnis der damit assoziierten Erkrankungen und zur Entwicklung möglicher 
therapeutischer Strategien beitragen. 
Bisher sind die biophysikalischen Kräfte hinter den massiven morphologischen 
Veränderungen, welche die vollständige Chromatindekondensation und Freigabe der NETs 
ermöglichen, nur wenig verstanden. Die Beantwortung dieser Frage steht im Fokus des 
ersten Manuskriptes dieser Arbeit. Die Bildung von NETs kann in drei Phasen unterteilt 
werden. Davon ist jedoch nur die erste abhängig von enzymatischen Prozessen und 
Energieverbrauch. Die zweite Phase hingegen wird von den Materialeigenschaften der Zelle, 
insbesondere dem entropischen Schwellen des Chromatins, bestimmt. Der Beginn der 
Dekondensation geht hierbei mit der Ruptur der Kernhülle Hand in Hand und repräsentiert 
einen „point of no return“. Nachdem das Chromatin vollständig dekondensiert ist, bricht die 
Plasmamembran an einer vorbestimmten Position (Phase 3). Diese biophysikalische 
Charakterisierung erleichtert unser Verständnis der der NETose zugrundeliegenden 
Mechanismen maßgeblich. Sie hebt auch hervor, in welchem Ausmaß Materialeigenschaften 
einer Zelle komplexe Vorgänge steuern können. 
In vitro Studien der NETose werden von einer stetig steigenden Zahl von Forschungsgruppen 
durchgeführt. Sie verwenden die unterschiedlichsten Serum- und Serumalbuminzusätze in 
ihren Kulturmedien. Allerdings beeinflussen Serumzusätze die NETose abhängig von ihrer 
Konzentration, dem verwendeten Stimulus und der Neutrophilenspezies (human vs. murin). 
Diese Mechanismen werden detailliert im zweiten Manuskript analysiert, was zu einer 
verbesserten Vergleichbarkeit von experimentellen Konditionen beitragen kann.  
Auch Licht aus dem ultravioletten und sichtbaren Bereich kann Zellfunktionen massiv 
beeinflussen. Der Effekt von UVA und blauem Licht auf Neutrophile wurde im dritten 
Manuskript untersucht. Licht aktiviert die „suizidale“ NETose über einen Neutrophilen 
Elastase (NE)- und Myeloperoxidase (MPO)-abhängigen Weg, der die Bildung von reaktiven 
Sauerstoffspezies (ROS) über Riboflavin voraussetzt. Demnach können externe Faktoren die 
NETose massiv beeinflussen, was von großer Bedeutung für in vitro Untersuchungen ist. 
Darüberhinaus ist es denkbar, dass lichtinduzierte NETose in der Pathogenese von 
Erkrankungen mit erhöhter Photosensibilität, beispielsweise Autoimmunerkrankungen wie 
des Lupus erythematodes, beteiligt ist.   
Die Ergebnisse dieser Arbeit erlauben einen detaillierten Einblick in die Mechanismen der 
NETose sowie in deren Regulierung.  
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Motivation and outline 
In the past decades, the idea of neutrophils changed from purely short-lived, mature killing 
cells to highly sophisticated modulators of immune responses. This development has been 
accelerated by the discovery of new neutrophil functions such as the release of neutrophil 
extracellular traps (NETs) and the regulation and modulation of innate and adaptive 
immunity and of multiple neutrophil phenotypes behind these tasks. Hence, the detailed 
molecular analysis of these new functions in physiological and pathological conditions is the 
focus of ongoing research. However, only a small number of studies have considered and 
explored the underlying biophysical mechanisms, which can substantially augment the 
understanding of their complex sequences and driving forces.  
During the formation of neutrophil extracellular traps, neutrophils can release a fibril 
network of decondensed chromatin in combination with antimicrobial peptides and other 
mediators to disarm and subsequently attack pathogens. The generation of NETs, apart from 
phagocytosis and degranulation, thus represents a newly discovered defense strategy. While 
studying NET release (NETosis) in detail, it became increasingly clear that the deregulation of 
NETosis is deeply implicated in a variety of diseases including chronic and acute 
inflammation as well as cancer and autoimmune diseases. Additionally, several groups 
reported the formation of extracellular traps (ETs) among different cell types, species, and 
organisms such as earthworms and plants. ET formation is, therefore, a highly conserved, 
fascinating phenomenon. During NETosis, the neutrophil cell body undergoes profound 
changes as the cell decondenses its chromatin and dissolves its inner membranes in 
response to a stimulus. This process leads to a unique mixture of cytoplasmic and granular 
content along with the decondensed chromatin. In only a few hours, this mixture leaves the 
cell through the cell membrane in a yet not fully understood manner.  
 
How the cell can perform such extensive cell alterations, as well as the underlying 
biophysical mechanisms, remains unknown. The first and largest part of this thesis focuses 
in-depth on the biophysical and biological characterization of NETosis (Manuscript I). 
 
The second part of this thesis targets the influence of two external factors on NETosis: serum 
and serum albumin in cell culture media (Manuscript II) and the effect of UVA and blue light 
on in vitro NET formation (Manuscript III). The latter is of particular interest regarding the 
involvement of light sensitivity in autoimmune disorders and may serve as a starting point to 
understand the contribution of neutrophils to these still largely enigmatic mechanisms. 
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CHAPTER 1 - Scientific background  
1.1 Neutrophils in the human immune system   
1.1.1 Functions of neutrophils   
To protect itself from intruders, the human body employs a complex system of surface 
barriers, antimicrobial substances, biochemical cascades, and highly specialized cells: the 
immune system. Dysregulation of this finely tuned network leads to uncontrolled 
inflammation with severe tissue damage and is implicated in a variety of severe diseases. 
Therefore, a detailed understanding of single components of this complex system is essential 
to ameliorate defective regulation and the host’s defense against pathogens. 
Classically, the immune system is divided into an innate and an adaptive defense, which 
builds a finely regulated, closely linked system to protect the organism from pathogens and 
allow the body to return to physiological conditions. The innate immune system represents 
the first line defense against pathogens and is characterized by a broad and fast response 
with the overall goal to stop invading pathogens directly and to activate the adaptive 
immune response. It comprises physical, chemical and biological barriers, the complement 
system and multiple cells such as professional phagocytes (neutrophils, macrophages, 
dendritic cells and mast cells), eosinophils/basophils, innate lymphoid cells as well as natural 
killer cells (NK cells). In contrast, the adaptive immune response is characterized by a rather 
slow antigen-specific answer and is responsible for the development of long-term protection 
against reinfection in the form of memory cells. This precise response is regulated by T cells 
(T helper cells, T killer cells, ɶɷdĐĞůůƐ͕ƌĞŐƵůĂƚŽƌǇdĐĞůůƐ and natural killer T cells) and B cells, 
which are located in the secondary lymphoid organs such as lymph nodes, spleen and 
mucosal lymphoid follicles. Here, T cells are mainly responsible for the antigen-specific cell-
mediated response, while B cells mediate the humoral immune response through 
production of antibodies. Thereby, the presentation of antigens by innate immune cells, so-
called antigen-presenting cells (APCs), to lymphocytes in the lymph nodes bridges innate and 
adaptive immunity [1]. 
During the last decades, this strict division into two distinct branches has been challenged. 
More and more researchers report new closely related or overlapping immune functions, 
thus highlighting considerable flexibility of the immune system. For instance, innate immune 
cells like NK cells and macrophages can be altered by histone modifications or DNA 
methylation and thereby obtain short-time immunological memory, referred to as “trained 
immunity” [2, 3].  
Neutrophils are classically assigned to the innate immune system. After their production in 
the bone marrow, they enter the blood circulation and patrol for infection to exert their 
primary function, the fast elimination of invading pathogens. For this purpose, they are 
equipped with an arsenal of innate defense strategies: phagocytosis, degranulation, and the 
recently discovered NETosis, extensively discussed in paragraph 1.1.5 and 1.2. The classical 
innate functions, phagocytosis and degranulation have already been addressed in many 
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detailed studies and have led to a profound understanding of neutrophils as a short-lived, 
terminally differentiated “unsophisticated thugs” [4]. During the last two decades, however, 
this one-sided and narrow view has been challenged, not insignificantly, as a consequence of 
the invention of new technics such as CRISPR/Cas9, super-resolution microscopy, next-
generation sequencing or intravital imaging [4]. Thus, so far unexplored functions like the 
formation of NETs [5] shifted into the focus of neutrophil research. 
Furthermore, the dogma of neutrophils as exclusively short-lived cells has been questioned, 
as they are able to perform more sophisticated functions than initially anticipated. A recent 
study confirmed a half-life time of around 19 h [6], which can be increased after cell 
activation in the context of inflammation by cytokines or bacterial products [7]. In a selective 
study, even lifetimes of 5.4 days were reported [8], however, this finding is a matter of 
ongoing debate [9].  
Additionally, in contrast to long-lasting opinions, neutrophils do not get fully terminally 
differentiated and inactive. Upon stimulation, neutrophils can modulate gene expression 
profiles towards transcriptional regulators as well as proteins for cell survival, proliferation 
and T cell activation to modulate the immune response actively [10-12]. 
Among the remarkable discovery of NETosis, whose underlying mechanisms are the main 
focus of this thesis, neutrophils are able to closely communicate with cells of the innate and 
adaptive immune system and build a ‘social network’ to regulate and modulate the immune 
response [13, 14]. These functions are presumably carried out by phenotypically different 
neutrophils (see also paragraph 1.1.3) [15, 16]. Even direct modulation of T and B cell 
functions at the site of infection and within lymphatic organs has been reported [17-19]. 
Neutrophils can express major histocompatibility complexes (MHC) as well as co-stimulating 
molecules by translocation or de novo synthesis in response to various stimuli [20-23] 
characterizing neutrophils as APCs. In response to severe infection, they can infiltrate into 
the lymph nodes [19], most likely guided by C-C motif chemokine receptor 7 (CCR7) 
expression [24], and present antigens to cluster of differentiation 4 positive (CD4+) T cells 
[25]. Neutrophils can also transport viral antigens to bone marrow or lung and directly 
influence memory CD8+ T cell-priming [26-28]. Even a modulation of B cell function by 
cytokine production [29] or by so-called B cell helper neutrophils has been described. The 
latter can alter immunoglobulin class switch, somatic hypermutation as well as antibody 
generation in the marginal zone of the spleen [30]. In addition, neutrophils can affect the 
function of innate immune cells such as monocytes, dendritic cells (DCs) or NK cells [31-34]. 
However, a major part of these studies has been carried out in mice.  Therefore, their role in 
humans requires further investigation [15]. 
Altogether, these findings indicate that neutrophils are complex cells performing multiple 
innate and adaptive functions to kill pathogens and modulate immune responses. As a 
consequence, the role of neutrophils in pathophysiological conditions has also been 
reconsidered. They appear to have an underestimated immense role in severe and chronic 
inflammation [35, 36], autoimmune diseases [37] and cancer [38, 39]. 
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1.1.2 Architecture and development of neutrophil granulocytes 
Around 1011 neutrophils are produced in humans per day [40], which makes them the 
largest population among white blood cells (50-70%). Together with eosinophils and 
basophils, they belong to the polymorphonuclear granulocytes, aptly named by Paul Ehrlich 
after the lobulated structure of their nucleus (in detail discussed in paragraph 1.1.4) [41].   
The exact morphology of these cells measuring 10-15 µm was elucidated in detail by 
electron microscopy [42, 43] (Fig. 1). Aside from their unique nuclear structure, the 
neutrophilic cytoplasm is characterized by several types of granules, which differ in size and 
content. Four major types of granules have been described, however, more subtypes are 
under consideration [44]: azurophilic granules (AGs), specific granules (SGs), gelatinase 
granules (GGs) and secretory granules/vesicles (SVs). All of them have distinct functions 
according to their content of dissolved and membrane-bound molecules (Fig. 1, see also 
paragraph 1.1.5). The different types of granules are formed during distinct stages of 
maturation in the bone marrow (granulopoiesis) [45]. This process lasts in total around two 
weeks [46] and is tightly regulated by growth factors and cytokines. Granulopoiesis takes 
place in three phases: 1) lineage determination starting from hematopoietic stem cells 
(HSCs) (stem cell pool), 2) the mitotic phase (proliferating cells) and 3) the post-mitotic 
phase (terminally differentiated cells) [16, 45]. The exact sequence of lineage determination 
is currently under discussion. It most likely proceeds directly from HSCs to granulocyte-
monocyte progenitor cells [47-49]. In the proliferating phase, first myeloblasts and then 
promyelocytes are formed. The latter already contain AGs. These cells further proliferate to 
myelocytes containing SGs [46]. In the post-mitotic phase, the cells start to lose their round 
nucleus and develop from metamyelocytes over band cells holding GGs, to fully mature 
neutrophils with multilobulated nuclei and the full arsenal of granules [45]. The origin of 
each type of granule was confirmed by correlation of the granular proteome with the 
corresponding transcriptome [50]. The exact content of granules can differ slightly even 
within the same granule type according to the time of generation [51-53].  
The onset of differentiation is closely controlled in the HSC niche of the bone marrow by 
HSC-surrounding cells [45]. Here, HSCs are maintained in the bone marrow mainly by the 
interaction of the CXC chemokine receptor 4 (CXCR4) with the CXC chemokine ligand 12 
(CXCL12) [54]. Granulocyte-colony stimulating factor (G-CSF) represents one of the main 
inductors of granulopoiesis. In response to G-CSF, HSCs redistribute within the HSC niche 
[55], and transcription factors are regulated toward the granulocytic lineage. Furthermore, 
G-CSF controls neutrophil release into the blood by downregulation of the CXCR4-CXCL12-
interaction [56, 57] and induction of the CXCR2-CXCL1-interaction with endothelial cells [58]. 
CXCR2 and CXCR4 are, therefore, functional antagonists in the regulation of neutrophil 
release from the bone marrow [59]. Additionally, the upregulation of the interleukin (IL) 23-
IL17-axis in the tissue increases G-CSF and chemokine release from endothelial cells to 
recruit neutrophils [60-62]. Enhanced granulopoiesis, also referred to as emergency 
granulopoiesis, occurs in response to pathogen recognition [63, 64] in order to sufficiently 
defend intruders. Persistently elevated granulopoiesis, however, can lead to chronic 
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inflammation [35]. Downregulation of granulopoiesis can be mediated by phagocytosis of 
aging apoptotic neutrophils by suppression of the IL23-IL17-axis and therefore decrease in 
G-CSF production, as described in mice [65].  
Interestingly, under physiological conditions, neutrophils are also regularly found in spleen, 
liver, and lung. Whether these cells are mature neutrophils, or continuously recruited to 




Figure 1: Architecture of human neutrophil granulocytes. Neutrophils display two prominent morphological 
characteristics: lobulated nuclei and neutrophil granules. Neutrophil granules have a unique composition of 
free (normal writing) and membrane-bound (italic writing) proteins. Granular types: azurophilic granules (AGs), 
secretory and gelatinase granules (SGs, GGs) and secretory vesicles (SVs). MPO: myeloperoxidase, NE: 
neutrophil elastase, NSP4: neutrophil serine protease 4, SLPI: secretory leukocyte protease inhibitor, CD: 
cluster of differentiation, Mac-1: macrophage-1 antigen, fMLPR: N-formyl-methionyl-leucyl-phenylalanine 
receptor, TNFR1: tumor necrosis factor receptor 1, VAMP2: vesicle-associated membrane protein 2, MMP-25: 
matrix metalloproteinase-25, CR1/3: complement receptor 1/3, CXCR2: CXC chemokine receptor 2.          
Neubert et al., in preparation. 
1.1.3 Heterogeneity of neutrophil granulocytes 
The concept of neutrophil heterogeneity was already proposed in 1984 [67]. With the 
description of new neutrophil functions, this topic moved back into focus. It is an ongoing 
debate whether these phenotypes represent functionally distinct subtypes or only 
phenotypes modified by the surrounding tissue, age and host situation. This discussion is 
addressed in recent reviews [15, 16, 45], but goes beyond the scope of this thesis. 
Nonetheless, the phenotypes/subtypes differ in neutrophil function and are important to be 
considered in neutrophil dysregulation (e.g., NETosis). Therefore, they will be summarized 
shortly in this paragraph. 
Clearly different phenotypes have been assigned to priming, aging, and exhaustion. Priming 
leads to enhanced neutrophil defense (e.g., higher respiratory burst) and can be induced by 
activating chemotactic stimuli [35, 68]. For instance, cells are primed for NETosis in 
hyperglycemia [69] and systemic lupus erythematosus (SLE) [70]. In contrast, aging is a 
programmed change in phenotype, which occurs daily in a circadian fashion as shown in 
mice [71]. These cells are CXCR4 positive to easily migrate back to the bone marrow [72]. 
They share surface markers for adhesion and cell-to-cell-cross-talk with primed neutrophils 
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and act pro-inflammatory [71, 73]. Continuous stimulation can lead to exhaustion or 
paralysis of neutrophils, characterized by a massive decrease in granules as reported during 
sepsis [74]. A similar phenotype can occur in systemic inflammation or infections with 
resistant bacteria [75]. Interestingly, neutrophil function also changes with the host’s age. 
Cells from aged hosts show an increasing deficiency in bioenergetics as well as altered 
recruitment with enhanced tissue damage and impaired defense mechanisms, such as 
NETosis [76-80]. 
Additionally, a few tissue- and disease-specific neutrophil phenotypes/subtypes have been 
reported [15]. Tissue-specific neutrophils include B cell helper neutrophils in the spleen [30], 
lymph node neutrophils [24, 81] and pro-angiogenic neutrophils [82]. Disease-specific 
subtypes/phenotypes have been reported particularly in inflammation, autoimmunity and 
cancer [83]. One prominent example are low-density neutrophils (LDNs), which show a 
strikingly low amount of granules. This phenotype was first described in SLE as well as 
rheumatic diseases [84] and verified in multiple diseases including cancer, sepsis, psoriasis, 
acquired immune deficiency syndrome and malaria [15]. Two different types exist among 
LDNs. First, pro-inflammatory LDNs, which were described especially in autoimmune 
diseases. These cells are prone to undergo NETosis and share multiple markers with 
activated or exhausted neutrophils [84-87]. Second, an immunosuppressive LDN-type is 
frequently observed in cancer. This type is difficult to separate from granulocytic myeloid-
derived suppressor cells (G-MDSCs), which represent one of the most important types of 
tumor-associated neutrophils [88-91]. 
1.1.4 The neutrophil nucleus – structure and function 
The neutrophil nucleus has unique properties, which allow the cell to rapidly migrate to its 
target, tightly squeeze through the endothelium [92-94] or even undergo the massive 
alterations during NETosis. It has a remarkable lobulated shape, which develops during 
granulopoiesis. Under physiological conditions, each cell has 3 to 4 lobuli connected by thin 
strands of nucleoplasm with little internal chromatin (Fig. 2 (1)). The number of these lobuli 
can vary depending on activation or in the context of diseases [95-99]. 
Within the lobuli, the chromatin is distinguishable in a compact heterochromatin region in 
the periphery and a large inter-chromatin compartment (DNA-free) in the center of the 
nucleus (Fig. 2 (2)). The large inter-chromatin regions arguably contribute to the high 
flexibility of the nucleus [100]. These layers are separated by euchromatin, the active 
nuclear compartment in neutrophils [100]. Within the chromatin, 147 base pairs [101] are 
tightly packed by histone octamers from H2-H4 (Fig. 2 (3)) into nucleosomes [102, 103]. 
Thereby, histone H1 functions as a linker to further compact the DNA in the nucleosome 
[104]. The exact topology of the neutrophil nucleus was only recently described by Zhu et al. 
with respect to its alterations during differentiation [105]. Modification of histones including 
methylation, ubiquitinylation, acetylation, citrullination or phosphorylation can regulate 
chromatin functions, such as transcription and chromatin de- and condensation [106, 107].  
The cell’s chromatin is protected by the nuclear envelope consisting of the inner (INM) and 
outer (ONM) nuclear membrane separated by the perinuclear space (PNS) and stabilized by 
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the underlying lamina. Nuclear pore complexes (NPCs) interrupt the membrane and function 
as transport systems between the extracellular space and the cytoplasm [108, 109]. The 
nuclear lamina represents a complex protein system consisting of intermediate filaments 
type V (Lamin A, B1, B2, and C) [110, 111], which are anchored in the INM by several 
membrane proteins [112] (Fig. 2 (2)). The lamina is connected to the heterochromatin by the 
lamina-associated domains [113] and via the linker of nucleoskeleton and cytoskeleton 
(LINC) complex to the cytoskeleton [114, 115]. It can adapt to the cell’s requirements [116] 
and has been considered to contribute to nuclear shaping, mechanotransduction and overall 
cell mechanics [117]. Interestingly, neutrophils contain relatively low amounts of nuclear 
envelope proteins, which are down-regulated during granulopoiesis [118]. Mature 
neutrophils lack proteins of the LINC complex [119] as well as lamin A/C and contain only 
low remaining lamin B [118]. These alterations may constitute the mechanistic basis for the 
morphological plasticity of the neutrophil nucleus. For instance, lamin A/C-deficiency 
significantly softens the nucleus and increases its deformability [120-122].  
In contrast, lamin B receptor (LBR) expression increases during maturation as shown in HL-
60 cells (human leukemia cell line) and mouse models [105, 123]. LBR is a transmembrane 
protein that binds to chromatin, lamins (especially Lamin B) and heterochromatin binding 
protein 1 (HP1) as reviewed elsewhere [124-126]. Interestingly, loss of LBR leads to impaired 
lobulation and decreased migration in neutrophils of LBR-deficient patients [127, 128]. The 
exact contribution of LBR to neutrophil function especially in vivo, however, is a matter of 
ongoing debate [94, 125, 129].  
 
Figure 2: The neutrophil nucleus. 1) Overview of a human neutrophil. 2) Typical structure of the nuclear 
envelope. INM/ONM: inner and outer nuclear membrane, PNS: perinuclear space, NPC: nuclear pore complex, 
LBR:  lamin B receptors, HP1: heterochromatin protein 1. 3) Nucleosome structure. H 1-4: histone 1-4.   
Neubert et al., in preparation. 
The role of the cytoskeleton in the development of the lobulated nucleus is still under 
consideration as well. While actin is presumably not involved, a contribution of tubulin has 
been discussed, and a decrease of vimentin may favor a multi-lobulated nuclear shape [97, 
119, 123, 130, 131]. Overall, neutrophils form an astonishingly flexible nucleus, although 
parts of the exact underlying mechanisms still remain unresolved [105, 119].  
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Remarkable are also the morphological differences between murine and human neutrophils. 
The nuclear lobes of human neutrophils are frequently connected with thin strands, while 
murine cells rather feature a “twisted ring-shape” [99]. Additionally, the latter show higher 
lamin B expression and appear less fragile than human cells [99]. In general, the morphology 
varies considerably among different species, possibly due to different tissue densities [92], 
which needs to be considered for their comparison within experimental data.  
1.1.5 Defense strategies of neutrophils - degranulation and phagocytosis 
To attack intruders, neutrophils have to be recruited and guided to the place of infection. 
This process has to be tightly regulated since uncontrolled neutrophil activation can lead to 
massive tissue damage as discussed in paragraph 1.2.5 for NETosis. The complex 
mechanisms of neutrophil recruitment are reviewed in detail by Kolaczkowska and Kubes 
[66]. 
In the classical scenario of diapedesis, neutrophils have to migrate through the intact 
endothelium into the tissue to reach the site of infection [132]. Therefore, the cells have to 
show particularly high flexibility and compensate the mechanical forces due to the shear 
stress of the blood flow as well as pressure of the surrounding cells. This process is tightly 
regulated and involves characteristic changes of the nuclear morphology and its interplay 
with the cytoskeleton as recently extensively reviewed [94, 133]. The unique morphology of 
neutrophils also allows them to reach a remarkable migration speed of 19 +/-6 µm/min in 
vitro [134].  
Neutrophil infiltration from the vasculature into the tissue is mainly induced by mast cells 
and macrophages as well as pathogens and their products recognized by receptors for 
pathogen-associated molecular patterns (PAMPs) [135]. To guide neutrophils to the site of 
infection, the endothelium, in the first step, expresses E- and P-selectin in proximity to the 
stimulus and neutrophils bind by glycosylated ligands such as P-selectin glycoprotein ligand 1 
(PSGL1) [136] enabling them to adjustably tether and roll along the endothelium [137]. 
Under high shear stress, even thin membrane extensions can be built, so-called ‘slings’, 
which wrap around a neutrophil and guide the rolling cell on the endothelial lining [138]. 
Further stimulation of neutrophils by e.g., chemokines attached to the endothelium [139], 
leads to activation of integrins on the cell’s surface (inside-out-signaling). The main integrins 
involved are ɴ2-integrins (lymphocyte function-associated antigen 1 (LFA-1), macrophage-1 
antigen (Mac-1)) and ɴ1-integrins (very late antigen-4 (VLA-4)). These integrins mediate the 
cell’s binding to intercellular or vascular cell adhesion molecule-1/2 (ICAM-1/2, VCAM-1) 
expressed by the endothelium [140]. Subsequently, neutrophils reduce rolling speed, crawl 
and flatten the cell body until they attach firmly and start to migrate para- and 
transcellularly through the endothelium [141]. Thereafter, cells are guided to the site of 
infection by chemotactic gradients (e.g., chemokines, leukotrienes, complement factors or 
bacterial products) [66, 142]. In addition to this classical way, alternative recruiting pathways 
of neutrophils into specific tissues such as liver, brain or spleen were reported [14, 66]. For 
instance, neutrophils can be recruited CD44-hyaluronan-dependently into the liver [143]. 
Interestingly, within the tissue, neutrophils are even able to guide themselves over large 
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distances in complex cell cluster movements. This process, also referred to as neutrophil 
swarming, can be mediated by leukotriene B4 [144].  
 
Having arrived at the target, neutrophils attack pathogens by different strategies including 
degranulation, phagocytosis and NETosis (Fig. 3). One of the most important tools to exert 
these functions is the directed release of different granules. As already alluded to 
paragraph 1.1.2, neutrophils contain at least four different types of granules (AGs, SGs, GGs, 
VSs) with unique compositions of dissolved and membrane-bound molecules [145-147] 
(Fig. 1 and below). The granules discharge their contents in a precisely defined sequence in 
response to multiple signals and thresholds (reviewed in [148]). In general, they are released 
inversely to their generation and with increasing content of antimicrobial substances (SVs Æ 
GGs Æ SGs Æ AGs). The precise regulation of degranulation is complex (Fig. 3 (1)). The 
current knowledge including the underlying signaling cascades was only recently 
summarized by Yin et al. [148]. 
SVs [149, 150] contain a large fraction of membrane-bound proteins including receptors 
(e.g., fMLPR, CR1/3, ϭϲď ;&ɶZ///ďͿ͕ CXCR2), MMP-25, membrane fusion proteins (e.g., 
VAMP2), integrins (Mac-1) as well as membrane-bound nicotinamide adenine dinucleotide 
phosphate (NADPH) oxidase components (gp91phox/NOX2, p22phox) (Fig. 1; for abbreviations 
see figure legend). Furthermore, they contain a surprisingly high amount of cytoplasmic 
proteins [149], most likely originating from an endocytotic formation of these vesicles [146]. 
Importantly, SVs are already mobilized during rolling [151] by the induced modest calcium 
increase and simultaneous activation by chemokines [152, 153]. Thereby, integrins [154] and 
receptors [155] are transported to the cell’s surface, which modulate neutrophil activation 
as well as firm adhesion to the endothelium.  
Specific (lactoferrin positive) and gelatinase (gelatinase positive) granules (SGs, GGs) have 
similar functions and overlapping contents [45, 50]. They contain moderate amounts of 
antimicrobials (SG > GGs) and several membrane-bound receptors and integrins (e.g., 
fMLPR, TNFR1, Mac-1) to guide neutrophils to the site of infection and initiate the 
antimicrobial defense [148]. Degranulation of SGs and GGs occurs in response to stronger 
calcium signals (calcium flickers [156]) induced by the increasing chemotactic signal and 
subsequent G protein-coupled receptor activation (GPCR) [157]. Thereby, the majority of 
these granules is released onto the cell surface and only a few granules (mainly SGs) into the 
phagosome during phagocytosis (Fig. 3 (2)) [158].  
AGs contain a large number of antimicrobial effectors such as myeloperoxidase (MPO), 
serine proteases (neutrophil elastase (NE), proteinase 3, cathepsin G (CG) and neutrophil 
serine protease 4 (NSP4)), bactericidal/permeability-increasing protein, defensins and 
lysosomal proteins. Hence, the main function of AGs is the effective killing of pathogens. To 
carry out this function, AGs can be secreted onto the cell surface (membrane-targeting, 
actin-dependent [159]) or into the phagosome (phagosome-targeting, tubulin-dependent 
[160]) [161-163]. Their degranulation is triggered by an additive calcium signal induced by 
combinations of GPCR, phagocytic receptor [164] and complement receptor [165] activation 
[148, 164, 166]. 
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Figure 3: Defense strategies of neutrophil granulocytes. Neutrophils can attack pathogens by three main 
mechanisms. 1) The release of antimicrobial substances by degranulation. 2) Phagocytosis of bacteria. 3) 
Immobilization and attack of bacteria by the release of NETs. Neubert et al., in preparation. 
Phagocytosis is one of the most important defense strategies of neutrophils first described 
by Metchnikoff in 1905 [167] (Fig. 3 (2)). Neutrophils can engulf opsonized pathogens by 
pseudopod extension in so-called phagosomes after binding of immunoglobulin G (IgG) by 
phagocytic receptors (e.g., FcyRIIa and FcyRIIIb) or complement factors by complement 
receptors [168]. Importantly, neutrophil phagocytosis is closely connected to degranulation. 
Unlike macrophages, they do not perform the classical endosome-lysosome pathway, but 
fuse AGs and partly SGs, directly with the phagosome in a remarkably fast manner within 
seconds [169] (reviewed in detail by Nordenfelt and Tapper [168]). During this process, the 
degranulation of granules can occur already prior to and during phagosome formation at the 
plasma membrane [170]. In this way, neutrophils can directly attack pathogens by 
antimicrobial substances from the first contact on. This antimicrobial response is supported 
by the generation of reactive oxygen species (ROS) (oxidative burst), one of the key steps in 
phagocytosis [171]. For ROS generation, the protein complex NADPH oxidase first assembles 
at granular, plasma and phagosomal membranes triggered by soluble agonists such as 
phorbol 12-myristate 13-acetate (PMA) and fMLP [172, 173] or in the context of 
phagocytosis activation [174]. Upon activation, the membrane-bound components 
(gp91phox/NOX2, p22phox), which are mainly localized at the membranes of SGs, GGs and to a 
lower extent SVs [145, 146], associate with the cytosolic components (p47phox, p67phox, 
p40phox) as well as with the Ras-related C3 botulinum toxin substrate (Rac) [168] (Fig. 1 and 
Fig. 4). The assembly of NADPH oxidase enables the reduction of O2 to superoxide anions 
(O2.-) followed by subsequent formation of several ROS types, above all hydrogen peroxide 
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(H2O2). The formation of H2O2 is the basis for further ROS production. It can be used for 
instance by MPO to generate hypochlorous acid (HClO) or in Fenton reactions to create 
hydroxyl radicals (OH.) catalyzed by metal ions (e.g., Fe2+) [175].  
Furthermore, neutrophils are able to ‘choose’ a certain defense strategy [176]. For instance, 
NETosis is considered to be preferred over phagocytosis with increasing pathogen size as 
reported for fungi hyphae [177]. During this process, the decision for NETosis depends on 
multiple factors such as the accessibility of MPO and NE in granules [177], successful 
activation of phagocytosis via pathogen detection as shown for Dectin-1 [177] or 
cytoskeletal integrity [176, 177]. 
Beside the main defense pathways shown in Fig. 3, neutrophils can modulate the immune 
response by de novo synthesis of specific proteins or generation of microparticles [35]. 
Microparticles are membrane vesicles filled with heterogeneous content depending on the 
surrounding conditions and the activating stimulus. They can be released to carry out diverse 
functions in health and diseases [178]. These functions include contributions to reactions 
against opsonized particles [179, 180] or induction of pro-inflammatory [181] as well as anti-
inflammatory [182, 183] responses. 
Over time, activated neutrophils decrease their resistance against anti-apoptotic signaling 
[184] and, after successfully targeting the pathogen, they undergo apoptosis or, under 
certain circumstances, autophagy [185]. In this context, they can express ‘find-me’ or ‘eat-
me’ signals and are silently cleared by phagocytosis [35, 185, 186]. According to a model of 
Kennedy and DeLeo, this process can be dysregulated by certain pathogens or in a disease-
related context. Importantly, this dysregulation can induce a switch to pro-inflammatory cell 
death pathways such as pyroptosis, oncosis and NETosis [185, 187] accompanied by 
subsequent tissue damage and acute as well as chronic inflammation [35]. 
1.2 Neutrophil extracellular trap (NET) formation - NETosis 
1.2.1 Forms and pathways of NETosis  
In 1996 Takei et al. reported the “rapid killing of human neutrophils by the potent activator 
phorbol 12-myristate 13-acetate (PMA) accompanied by changes different from typical 
apoptosis or necrosis” [188]. However, this observation was initially barely acknowledged 
until Brinkmann et al. showed in 2004 that this mysterious cell death actually represents a 
third defense strategy of neutrophils besides phagocytosis and degranulation [189]. They 
reported that neutrophils could release a web-like structure of decondensed chromatin 
together with several attached antimicrobial proteins in response to gram-positive or -
negative bacteria, IL-8, lipopolysaccharides (LPS) or PMA. In these structures, the neutrophils 
immobilized and attacked gram-positive (Staphylococcus aureus) as well as gram-negative 
(Shigella flexneri) bacteria [189]. After fixation, these structures appeared as a web of 15-17 
nm long fibers with globular domains of ca. 25 nm visible in electron microscopy [189]. They 
termed these structures “neutrophil extracellular traps (NETs)” [189].  
In the following years, the research on NET formation, termed NETosis [190], exploded and it 
turned out that this phenomenon can occur in multiple forms in a physiological as well as 
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pathological context, as summarized in recent reviews [191-193]. Furthermore, it is well 
recognized that human and mouse neutrophils are not the only cells undergoing this 
fascinating process. The release of extracellular traps (ETs) was reported for various immune 
cells [194, 195] including monocytes and macrophages (METs) [196, 197], eosinophils (EETs) 
[198, 199] and mast cells [200]. Additionally, ETs similar to those observed in neutrophils, 
were documented in many species (e.g., dogs [201], cats [202], cows [203], sheep [204], 
carps [205], chicken [206], shrimps [207], oysters [208], social amoeba [209], earthworms 
[210] and root tip cells of plants [211]). Therefore, the formation of ETs is an evolutionarily 
highly conserved process. 
 
NET formation in neutrophils can occur in response to many different pathogens including 
bacteria [98, 212-214], viruses [215, 216], fungi [177, 214, 217, 218] and parasites [219-221] 
as well as activated platelets [212, 222], cytokines/chemokines [98, 189, 223, 224], mitogens 
such as PMA [98, 189, 213, 214, 217, 225], ionophores [212, 214], monosodium urate (MSU) 
or cholesterol crystals [213, 226, 227], and a variety of other substances [212] triggering 
highly diverse signaling cascades [192]. Frequently, the activity of the azurophilic proteins 
MPO and NE, as well as peptidylarginine deiminase (PAD) enzymes and ROS generation, are 
involved [98, 214, 217, 218, 224, 228]. Additionally, analogies with pyroptosis/ 
inflammasome formation [229, 230], autophagy [231, 232], necroptosis [233, 234] and, only 
recently, mitosis [235] were reported. In most scenarios, the activation is followed by 
subsequent chromatin decondensation, disintegration of nuclear and granular membranes 
and mixing of cytoplasmic content with the decondensed chromatin. Eventually, the cell 
releases the NET through the cell membrane into the extracellular space, leaving the cell to 
die [98]. This process is clearly distinct from apoptosis, necroptosis, and necrosis [98, 214], 
and was termed ‘suicidal’ NETosis. For mechanistic studies of ‘suicidal’ NETosis, the direct 
protein kinase C (PKC) activator PMA, ionophores or LPS are frequently used. These 
molecules are the main activators in the studies presented in CHAPTER 2, and their signaling 
pathways will be addressed in paragraph 1.2.2. 
In response to gram-positive bacteria, a different form of NET release was reported: ‘vital’ or 
‘non-lytic’ NETosis [236]. Here, the cells actively release chromatin within 10 minutes in the 
form of DNA-filled vesicles, possibly to allow a rapid attack of these highly invasive 
pathogens in vivo [237]. It was postulated that these cells are multitasking and even the 
same cell is able to perform NETosis while crawling at the same time [238]. Apart from 
nuclear DNA, mitochondrial DNA was found in these NETs [239]. However, the importance 
of these observations has not been clarified yet [237]. 
The relevance of the different forms of NETosis and respective pathways in vivo, as well as 
their contribution to the pathogenesis of diseases, is the subject of ongoing research. 
Several reviews discuss the relevance of, for instance, ‘vital’ vs. ‘suicidal’ NETosis [236], 
NETosis vs. necroptosis [240], NETosis vs. leucocyte hypercitrullination [241], NOX-
dependent NETosis vs. NOX-independent NETosis [193], aggregated NETs (aggNETs) [242] or 
the involvement of mitochondrial DNA [241].  
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The appearance of the released NET can be as diverse as the underlying pathway. Already in 
the first report of NETs, the presence of histones and granular proteins, most prominently 
NE, CG, and MPO, was reported [189]. In subsequent studies, the NET-attached proteome in 
response to PMA was added up to 24 or 29 proteins, respectively, including all four 
azurophilic serine proteases as well as several cytoplasmic proteins [243, 244]. In response 
to physiological stimuli, a NET-proteome including 28-80 variable proteins with a ‘core 
proteome’ of 33 proteins was confirmed [245, 246]. Bound to the NET, the antimicrobial 
histones [247, 248] and proteins are locally restricted and can contribute to a directed attack 
of the immobilized target [189, 244]. For instance, positively charged neutrophilic serine 
proteases, above all NE, have a high DNA-affinity and are proteolytically active within the 
NET [244, 249, 250]. Although the actual elimination of pathogens is still controversial, a 
contribution to pathogen-killing by NETs was confirmed in selective studies [251, 252] and 
their protective immune function demonstrated [253] for fungi [243, 254], bacteria [189, 
214, 251], viruses [215] and parasites [219]. NETosis appears to be especially needed to clear 
infections involving fungi hyphae, which are too large to be cleared by phagocytosis [192]. 
After release, the NET can cause significant tissue damage and destroy endothelial as well as 
epithelial cells [87, 255]. Therefore, NETs must be removed from the tissue. This process is 
mainly realized by deoxyribonuclease (DNase). DNase decomposes the DNA and inhibits NE 
activity. The remaining fragmented DNA and proteins are then, most likely, opsonized and 
subsequently cleared by macrophages in a presumably immunologically silent manner [256, 
257]. Inefficient clearance of NETs, as well as the dysregulation of NET formation, can 
contribute to the pathogenesis of several diseases. 
Pathogens can also employ different strategies to escape NETs. They can degrade NETs 
through DNases or modify the DNA structure as shown for Staphylococcus aureus [258, 259], 
Streptococcus pneumoniae [260] and Streptococcus pyogenes [261]. Furthermore, they can 
develop resistance against NETs mainly by virulence factors such as D-alanylation of 
lipoteichoic acids [262], or suppress NETosis by the release of proteases [263], exotoxins 
[264] and attenuation of neutrophil adhesion [265]. 
1.2.2 PMA-, LPS- and calcium ionophore-induced NETosis 
The PKC activator PMA is the most frequently used stimulus in mechanistic studies of 
‘suicidal’ NETosis, and its underlying signaling cascade is, therefore, the most widely studied 
one (Fig. 4). Interestingly, NETosis involves very similar signaling pathways in response to 
different pathogens or crystals [227]. The activation of PKC leads to ROS generation by the 
assembly of the NADPH oxidase [98] induced by Raf-MEK-ERK signaling [266]. The 
requirement for NADPH oxidase activity in NETosis was confirmed in neutrophils isolated 
from chronic granulomatous disease (CGD) patients, who suffer from a defect in this protein 
[98, 214]. The induced oxidative burst leads to H2O2 formation and subsequently triggers 
the activation and dissociation of NE, CG, and AZU from an azurophilic complex termed 
azurosome [228]. This process appears to depend on MPO, but the exact mechanism behind 
MPO involvement requires further investigation [217, 228]. After release from the 
azurosome, NE starts to degrade actin and at later stages promotes chromatin 
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decondensation together with MPO [228]. As a consequence, the cell undergoes the 
characteristic morphological changes of ‘suicidal’ NETosis. The necessity of MPO and NE was 
further confirmed in studies with neutrophils isolated from patients with MPO-deficiency 
[214, 217] or Papillon-Lefèvre syndrome. The latter lack the NE-activating protease 
dipeptidyl peptidase I (DPPI) [267] and therefore fail to generate NE. Downstream or parallel 
to NADPH oxidase activation, p38, MAPK and ERK phosphorylation [268], receptor-
interacting protein kinase 1 (RIPK1)-RIPK3-mixed lineage kinase domain-like protein (MLKL)-
signaling [234] or autophagy pathways [231] were proposed, but conflicting results 
necessitate further investigations [192, 193]. Apoptosis signaling, however, is not involved as 
suggested by caspase inhibition studies [214] and absence of DNA-fragmentation [98]. In 
contrast, activation of NETosis can even induce apoptosis inhibition [266, 269].  
Furthermore, the activity of peptidylarginine deiminase 4 (PAD4) was frequently implicated 
in NETosis, especially in chromatin decondensation. This deiminase converts arginine and 
methyl-arginine in a calcium-dependent fashion through deimination to citrulline, 
preferentially at the histone tail [270-273] (Fig. 5 (6)). PAD4 involvement appears to be 
heterogeneous and was shown for various stimuli and in multiple mouse models, often in 
autoimmune diseases [192]. However, its contribution to PMA-induced NETosis especially in 
human neutrophils is still controversial [214, 224].  
Only recently, crucial new players were described for PMA-induced NETosis. For instance, 
the chromatin-binding protein DEK seems to be required for successful NETosis and possibly 
contributes to chromatin decondensation [274]. Additionally, based on morphological 
similarities, a link between NETosis and mitosis was proposed [237]. This issue was 
addressed in a recent study by Amulic et al. [235]. They reported several parallels with 
mitosis including increased reactivity of the Ki-67 antibody and phosphorylation of 
retinoblastoma protein, lamin A/C and serine 10 of histone 3 (H3S10) as well as centrosome 
separation. In this context, NETosis appeared to depend on components of the cell-cycle 
machinery such as cyclin-dependent kinases 4 and 6 (CDK4/6). Interestingly, they did not 
observe S phase induction and emphasized the remarkable difference in temporal dynamics 
between both processes. Based on their results, they pictured NETosis as a “modified” or 
“hi-jacked” cell division [235].  
Calcium ionophore (CaI)-induced NETosis proceeds more rapidly and varies profoundly in the 
underlying signaling cascade compared to the PMA-induced process. Most strikingly, it does 
not require NADPH oxidase activation but mitochondrial ROS generation, and was therefore 
termed NOX-independent [275, 276]. The induction of this form of NETosis is mediated by 
the small-conductance calcium-activated potassium channel 3 (SK3) [275] and appears to be 
clearly independent of NE and MPO activation [214]. Furthermore, CaI-induced formation of 
NETs is accompanied by a fast transient increase in cytosolic calcium concentrations within 
the first minutes [277] and appears to depend strongly on extracellular calcium [276]. How 
the chromatin decondensation in response to CaI is regulated is not fully understood. Since 
the NET is exceptionally rich in citrullinated histone 3 (H3Cit) [214, 278, 279], a dependency 
on PAD4 activation was postulated, but the actual dependency on this enzyme, especially in 
human cells, is also for CaI an ongoing debate [214]. Remarkably, the cell membrane starts 
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to lose integrity already within the first 30 min and not with the final DNA release as 
reported for PMA induction [212]. This observation highlights the diversity of morphological 
changes during NETosis in response to different stimuli.  
 
 
Figure 4: Mechanism of PMA-induced NETosis. PMA, similar to crystals or microbes via receptors, directly 
activates protein kinase C (PKC) and subsequently promotes the assembly of nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidase via the mitogen-activated protein kinase/ERK kinase 
(MEK)/extracellular-signal-regulated kinase (ERK) pathway. Then, H2O2 generated by the induced oxidative 
burst triggers MPO-dependent dissociation of NE, cathepsin G (CG), and azurocidin (AZU) from the azurosome. 
Released from the granules, NE translocates to actin as well as to the nucleus and promotes chromatin 
decondensation, actin degradation and gasdermin D-cleavage. Chromatin decondensation is enhanced by MPO 
and histone citrullination (HCit) by peptidylarginine deiminase 4 (PAD4). Neubert et al., in preparation. 
LPS is used in mechanistic studies as a physiologically more relevant stimulus, often together 
with platelets [212]. The induction of ‘suicidal’ NETosis with LPS depends highly on the 
employed bacterial species [280], and the success and extent of activation vary profoundly 
[212, 225]. LPS-induced NETosis depends on Mac-1 [281] and toll-like receptor 4 (TLR4) 
activation [282] and involves NADPH oxidase as well as c-Jun N-terminal kinase (JNK) [282]. 
Furthermore, NE activity [283] and autophagic pathways [280] may be required.  
To defend against cytosolic LPS or intracellular infections with gram-negative bacteria 
(shown for Salmonella ȴsifA and Citrobacter rodentium), neutrophils can make use of an 
alternative pathway, caspase-11-driven NETosis (caspase-4 in humans), which shares key 
players with non-canonical pyroptosis. This pathway proceeds completely independent of 
NE, MPO, and PAD4, but depends on caspase-11 activation and subsequent cleavage of 
gasdermin D followed by pore formation on membranes [229]. Simultaneously, gasdermin D 
activation is involved in classical PMA-induced NETosis. Here, NE induces the cleavage of 
gasdermin D [230] (Fig. 4).  
1.2.3 Chromatin decondensation in NETosis 
As already alluded to, chromatin decondensation is an essential step in NETosis (Fig. 5). It is 
mainly initiated by histone alterations and chromatin modifications. The involved processes 
are highly diverse and depend largely on the used stimulus.  
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NE is possibly the most important player in the induction of chromatin decondensation and 
was extensively studied by Papayannopoulos et al. [218]. Upon stimulation, NE migrates into 
the nucleus, where it is detectable within the first hour and degrades histones H4 and H2B 
(Fig. 5 (4)) [218, 228]. The decomposition of these histones correlates with the onset of 
decondensation. NE also degrades the linker histone H1, as shown in vitro with isolated 
nuclei, possibly allowing the onset of core histone degradation [218]. After releasing NE 
from the azurosome, also MPO translocates to the nucleus [218]. Importantly, the 
contribution of MPO to chromatin decondensation is independent of its enzymatic activity 
and is most likely exerted through sterical interactions [218] (Fig. 5 (5)).  
The citrullination of histones by PAD enzymes decreases positive charges and weakens the 
electrostatic interactions with the negatively charged DNA. This mechanism is postulated 
most frequently for PAD4-induced decondensation during NETosis [279, 284]. Interestingly, 
deimination is tightly regulated by different PKC isoforms. For instance, W<ɲ ĚĞĐƌĞĂƐĞƐ 
deimination, while W<ɺŝƐrequired to induce citrullination in response to PMA or LPS [279] 
(Fig. 5 (6)). PAD4 was also postulated to restrict heterochromatin binding of HP1. HP1 
usually maintains the heterochromatin state by binding to methylated histone H3 
(H3K9me2/3) [285]. The citrullination of histone H3 at arginine 8 (H3cit8) during NETosis 
possibly impairs this binding, similar to a mechanism seen in fibroblasts [284]. However, 
since mature neutrophils have low levels of HP1 [99, 286], this requires further investigation 
(Fig. 5 (7)). 
Figure 5: Chromatin decondensation in NETosis. 1-3) Structure of the neutrophil nucleus. 4) Cleavage of 
histone (H) 1/2B/4 by NE. 5) Sterical interaction of MPO with chromatin. 6) Citrullination of arginines of core 
histone tails by PAD4. PKC isoforms differentially control the activity of PAD4. 7) Citrullination of arginine 8 at 
histone H3 (H3Cit8) by PAD4 possibly impairs binding of HP1 to dimethylated histone H3 at lysine 9 
(H3K9me2/3). 8) SerpinB1 and/or SLPI possibly regulate the activity of NE and/or PAD4. 9) Caspase-11-
mediated cleavage of histone H3. Neubert et al., in preparation. 
Overshooting decondensation can be regulated by serine protease inhibitors like SerpinB1 or 
secretory leukocyte protease inhibitor (SLPI) [287-289], which are frequently expressed in 
cytoplasm and granules of neutrophils [290, 291]. Both inhibitors translocate to the nucleus 
upon PMA activation, and their depletion significantly enhances NET formation as verified in 
deficient-mice [292, 293]. Furthermore, sterical effects of these molecules were postulated. 
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For instance, SerpinB1 was considered to restrict access of PAD4 to the histones tails and, 
therefore, subsequent histone citrullination [292] (Fig. 5 (8)). 
Caspase-11 is a newly described decondensation-inducing molecule that enters the nucleus 
through gasdermin D-induced pores and degrades histone H3 [229] (Fig. 5 (9)) (see also 
paragraph 1.2.2).  
1.2.4 Membrane modifications during NET formation 
After initiation of chromatin decondensation, the expanding NET has to overcome two 
restrictive barriers until it can reach the extracellular space: the nuclear and the plasma 
membrane. Although several studies address the signaling cascades underlying NETosis in 
detail, only little is known about the modification and remodeling of neutrophil membranes. 
This question is one of the main motivations for the first study presented in CHAPTER 2 
(manuscript I). The following paragraph will summarize the current knowledge on 
membrane modifications during NETosis including the recently found contribution of 
gasdermin D-driven pore formation (Fig. 6).  
The loss of the nuclear and plasma membranes was already reported by Fuchs et al. in early 
studies of PMA-induced NETosis [98]. According to electron microscopy images, inner and 
outer nuclear membranes (INM, ONM) dilate, followed by disintegration of the nuclear 
membrane in the form of vesicles 120 min after PMA stimulation. Simultaneously, granular 
membranes dissolve and NETs are released through rupture of the plasma membrane [98]. 
The formation of vesicles after 120 min was confirmed by Amulic et al. [235] (Fig. 6 (1)). 
Whether these vesicles form 
actively to allow chromatin 
distribution within the cell or 
are formed secondary to 
membrane rupture within the 
hydrophilic surrounding of the 
cytoplasm is unclear. 
Additionally, it is unknown 
how the supporting lamin layer 
behaves during NETosis. Only 
the phosphorylation of lamin 
A/C in PMA- or Candida 
albicans-induced NETosis was 
reported [235] (Fig. 6 (2)). 
Chen et al. and Sollberger et al. 
collectively reported the 
formation of pores induced by 
gasdermin D-cleavage during 
caspase-11/4-driven NETosis 
[229, 230]. The formation of 
membrane pores by cleaved 
Figure 6: Membrane modifications during NETosis. 1) Vesicle 
formation of the nuclear membrane. 2) Lamin phosphorylation. 3) 
Intracellular LPS and bacteria activate Caspase-11 (murine)/4 (human). 
4) Caspase-11/4 cleaves gasdermin D and induces pore formation. 
Pores in the nuclear envelope allow translocation of caspase-11 to the 
nucleus and subsequent chromatin decondensation. 5) NE, released 
from the azurosome, cleaves gasdermin D upon PMA/(CaI) activation. 
Likewise, pores in azurophilic granules further promote NE release. 6) 
Possible pore formation at the plasma membrane. ONM: outer 
nuclear membrane. INM: inner nuclear membrane. Neubert et al., in 
preparation. 
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gasdermin D to promote lytic cell death was studied by Liu et al. in pyroptosis [294]. Now, 
Chen et al. reported that upon infection, caspase-11 induces gasdermin D-cleavage to the 
p30 pore-forming fragment, which enriches at the nuclear membrane and allows the entry 
of caspase-11 into the nucleus [229] (Fig. 6 (3-4). In response to PMA or CaI, the cleavage of 
gasdermin D depended on NE activity (Fig. 6 (5)). Sollberger et al. correlated this observation 
with pore-formation in the plasma and granular membranes, but this observation requires 
further validation [230] (Fig. 6 (6)). 
Whether the cytoskeleton contributes to the breakdown of membranes in NETosis is largely 
unknown. A general involvement of the cytoskeleton in LPS-induced NETosis was proposed 
based on inhibition of tubulin and actin polymerization. The authors postulated that a 
functional cytoskeleton is required for NETosis and particularly actin for the final membrane 
rupture [281]. In contrast, actin degradation occurs after 30 min in response to Candida 
albicans and correlates with NE release from the azurosome. Actin-degradation by NE was 
likely required for further NETosis [228] (Fig. 6 (7)). Similarly, tubulin filaments dissolve from 
the microtubule organizing center (MTOC) within 30 min after PMA-stimulation. However, 
functional consequences of this observation are unclear [235]. 
1.2.5 NETosis in disease and autoimmunity 
The generation of NETs and its dysregulation were reported in several pathological 
conditions with growing evidence that NETs are “double-edged swords of innate immunity” 
[295] rather than only an additional defense strategy. Neutrophils isolated from patients 
with Papillon-Lefèvre syndrome or MPO-deficiency fail to form NETs. Yet, these patients do 
not suffer from severe immune-deficiency [267, 296]. This calls into question whether 
NETosis truly is an indispensable defense mechanism, and thus challenges the concept of 
deficient NETosis in diseases. However, this does not necessarily mean that NETosis is 
irrelevant in defense of acute microbial infections. 
Several recent reviews [192, 193, 297] highlight the broad implications of NETosis in several 
widespread infectious and noninfectious diseases such as cancer [298-301], diabetes and 
impaired wound healing [69], lung diseases [246, 302], preeclampsia [303], sepsis [304] and 
cardiovascular diseases including atherosclerosis, thrombosis and myocardial infarction 
[227, 305, 306]. Indeed, NETs are discussed as a biomarker for disease progression for 
instance of cardiovascular events [307, 308] or acute myocardial infarction [309]. 
Of note, NET formation is not necessarily negatively associated with disease progression. In 
gout, NETs can form aggregates, so-called aggNETs, which enclose MSU crystals, thus 
preventing further tissue damage and promoting an anti-inflammatory response [226]. 
However, aggNETs can also lead to obstructions as shown in pancreatitis [310]. 
 
The growing understanding of NETosis opened new perspectives on the role of neutrophils 
in autoimmune disorders [37, 311, 312] such as rheumatoid arthritis [313, 314], SLE [86, 
315], psoriasis [316, 317] or anti-neutrophil cytoplasmic antibody (ANCAs)-rich small-vessel 
vasculitis (SVV) [318]. Here, the immune system acts against the host itself and induces 
tissue damage. The exact development of autoantigens and subsequent break of immune 
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tolerance in these disorders is only partly understood. Possible scenarios include ‘molecular 
mimicry’, where foreign and self-peptides share structural similarities [319], as well as 
agglomeration of cell debris. Inefficient clearance of this debris by phagocytosis and 
complement activation can further enhance the reaction [311, 320, 321]. Thereby, especially 
antigens against nuclear content including histones and ribonucleic proteins as well as 
citrullinated structures were described. The development of these antigens, however, is only 
partly understood. Obviously, NETs are putative inducers of these antibodies [189]. 
Importantly, the implication of NETs in autoimmunity could also be a starting point to 
explain the connection between infections and the break of immune tolerance [311]. 
Not surprisingly, the presence of autoantigens against NET components such as citrullinated 
proteins, serine proteases, MPO or histones was detected in several autoimmune disorders 
[245, 318, 322, 323]. In line, neutrophils from patients with psoriasis [316], SLE or 
rheumatoid arthritis [245] are prone to NETosis, and healthy neutrophils can be activated by 
sera or autoantibodies isolated from these patients [70, 316, 318, 324].  
NETosis was also directly implicated in the pathogenesis of autoimmune disorders. For 
instance, in the context of SLE, neutrophils can produce DNA-peptide (LL37)-complexes upon 
stimulation. These complexes can directly activate memory B cells [325] or induce interferon 
alpha (/E&ɲ) release by plasmacytoid DCs (pDCs) via TLR9 activation [70, 324, 326]. 
Therefore, NET generation may contribute to the exacerbation of SLE. Additionally, pro-
inflammatory LDGs in SLE show spontaneous NETosis [87] and contribute to disease severity 
and tissue damage [87, 327]. Interestingly, NETosis of SLE-LDNs, as well as NETosis induced 
by immune complexes, involves mitochondrial ROS-dependent pathways. The produced 
NETs are rich in oxidized pro-inflammatory mitochondrial DNA (mtDNA) [86], which can 
further drive disease severity. Consequently, antibodies against mtDNA are elevated in sera 
from SLE patients and correlate with INFɲlevels [328]. Similar to other cell death pathways, 
defective or absent NET-clearance enhances autoimmune reactions. In SLE, namely the 
alteration or impairment of DNase activity [329, 330] was correlated with increased disease 
severity [331] and complement consumption [332]. The pro-inflammatory 
microenvironment created by inefficiently cleared NETs can facilitate disease progression by 
autoantibody generation, tissue damage, cytokine release and immune cell recruitment 
[321]. Although strong evidence points to a contribution of NETosis in autoimmune diseases, 
the exact mechanisms remain inconclusive and require further investigation [311]. 
1.3 Effect of light on human skin and neutrophils 
1.3.1 Light penetration through the human skin 
The human skin is one of the most important parts of the innate immune system. It defends 
the body from intruders by its unique composition of microbial, chemical, physical and 
immune cell barriers [333]. Additionally, it significantly protects the body from external 
factors such as mechanical stress, temperature or irradiation. Especially light of shorter 
wavelengths (UV-Vis light) can cause substantial harm and protection against it is, therefore, 
an essential function of the skin.  
 CHAPTER 1 - Scientific background 
 Dissertation - Elsa Neubert 
 
 20 
UV-Vis light is composed of 
visible (Vis, 400-700 nm) and 
ultraviolet light (UV light) 
including UVA (315-400 nm), 
UVB (280-315 nm) and UVC 
(190-280 nm). Intensity and 
spectrum of the sun-emitted 
light are altered by the earth’s 
atmosphere through reflection 
and absorption. Indeed, UVC and 
large parts of UVB light are 
absorbed within the ozone layer 
[334]. Quality and quantity of 
transmitted light that reaches 
the skin can vary due to 
geographic position, season, daytime and degree of decay of the ozone layer. Within the 
skin, the remaining light intensity is further modified by reflection (around 4-7%), 
absorption, scattering and backward-scattering [335, 336] (Fig. 7). 
Within the epidermis, light is mainly absorbed by peptide bands (< 240 nm), aromatic amino 
acids (tryptophan and tyrosine), nucleic acids (< 300 nm) and melanin (> 300 nm). Melanin 
has a very large absorption range, which is decreasing with the wavelength and is highly 
variable due to melanogenesis [335]. Almost no UVC/UVB, roughly 10-15% of UVA and 40-
50% of blue light can pass the epidermis and reach the layers below [335, 337] (Fig. 8). 
Within the dermis, the penetration depth is mainly determined by scattering through 
collagen fibers [338]. Besides scattering, blood-borne chromophores such as hemoglobin, 
oxyhemoglobin, ɴ-carotene and bilirubin with maxima between 350 nm and 500/600 nm 
can further absorb the remaining light [335]. In general, the penetration depth of light is 
inversely proportional to its wavelength [335, 337, 339, 340] with an optical window at 
around 600-1300 nm [335] (Fig. 8). 
Overall, light alterations within the skin are complex and vary depending on body region, 
individual composition, skin type, pigmentation, age, gender and ethnicity. For instance, the 
thickness of facial skin (epidermis and dermis together) can vary from 0.4 mm (upper eyelid) 
to 1.4 mm (nasal tip) [341]. Most variations are observed in the dermis. However, also 
stratum corneum and epidermis are inhomogeneous among different body regions. As an 
example, around 11 µm and 70 µm were measured on the shoulder for stratum corneum 
and epidermis, respectively, compared to 18 µm and 57 µm measured on the forearm [342]. 
Although many groups have tried to measure or model [336] the penetration for each 
wavelength, the exact penetration depth is complex and can only be estimated. 
Figure 7: Light attenuation in the human skin. Light transmission 
can be altered within the human skin by absorption, reflection, 
scattering or backward-scattering. Neubert et al., in preparation. 
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Figure 8: Penetration depth of UVB, UVA, blue light.  The penetration depth of UV and blue light increases 
with its wavelength. Light irradiation, especially UVB, can lead to enhanced infiltration of neutrophils into the 
tissue. Neubert et al., in preparation. 
1.3.2 Toxic effects of light on human skin  
Light can cause massive skin damage. Its effects can be conveyed through direct alteration of 
target molecules or can be mediated by photo-sensitive substrates and lead, for instance, to 
lipid peroxidation, DNA damage, free radical production and protein destruction [343]. Due 
to these effects, several cell components can be damaged, with a secondary impact on cell 
function, expression of adhesion molecules, and release of inflammatory modulators such as 
ROS and cytokines [344]. The extent of destruction and subsequent skin reaction depends on 
light doses, wavelength and skin predisposition.  
Through light absorption, light-sensitive molecules (chromophores) get excited to states of 
higher energy (excited state, singlet or triplet). This energy is quickly released as thermal 
energy, transferred to other molecules (photosensitization) or gets fed directly into 
photochemical reactions to form photoadducts [343, 345]. High-energy UVB light mainly 
causes direct molecular alterations, above all DNA damage. UVA, however, preferential 
causes ROS generation and secondary modifications by photosensitization [343]. 
Importantly, ROS generation via photosensitizers can also occur in response to visible light, 
especially blue light. Only recently, increased ROS formation was documented in mouse skin 
as well as human keratinocytes and attributed to blue light-excitation of flavoproteins with 
subsequent superoxide formation [346].  
Exhaustion of DNA repair mechanisms or antioxidant systems (e.g., glutathione peroxidase, 
catalase, melanin, vitamins C and E) can lead to enhanced tissue damage in the form of cell 
death and secondary inflammation [347]. Consequently, excessive irradiation evokes 
symptoms known as sunburn with painful erythema, edema, release of inflammatory 
mediators and even signs of systemic inflammation. Later, the skin develops hyperplasia and 
hyperkeratosis and, following chronic exposure, photoaging and skin cancer [343, 348].  
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Interestingly, the immune response to UV irradiation changes from an acute pro-
inflammatory reaction to immunosuppression in response to chronic exposure [344]. 
Vascular permeability, cytokine release (e.g., IL-1, IL-8, IL-6, IFNɲ), complement activation 
and influx of immune cells including neutrophils characterize the acute immune response. In 
contrast, immunosuppression induced by chronic exposure is mediated by anti-
inflammatory cytokines (e.g., IL-10) and changes in cell composition such as an increase in 
regulatory T cells [349]. This immune modulation towards immunosuppression was 
frequently correlated with enhanced photo-carcinogenesis and is exploited in phototherapy 
of inflammatory skin diseases [343, 344]. 
In photodermatoses, the skin is oversensitive to light, mainly UVA. The results are disorders 
induced by photosensitizers. These sensitizers can be either well-recognized inducers of 
phototoxic or photoallergic reactions (e.g., furocoumarins, cosmetics, chemicals and 
pharmaceuticals), or can be idiopathic or idiosyncratic triggers of polymorphous light 
eruption and solar urticaria. Additionally, manifest skin diseases can be worsened by light, 
so-called photo-aggravated dermatoses. There are two groups of these disorders. 
Facultative photo-aggravated dermatoses paradoxically often improve in response to low 
doses of light, but can exacerbate upon high-dose irradiation (e.g., psoriasis or atopic 
eczema). In contrast, obligatory photo-aggravated dermatoses are mandatorily correlated 
with skin light-sensitivity. Typical representatives are autoimmune diseases (e.g., SLE, 
dermatomyositis), porphyria and pellagra as well as specific genodermatoses [343]. Among 
these diseases, SLE is arguably the most frequent one, typically with a weeks-delayed 
reaction to light. The exact mechanisms of SLE-related photoreactions are still enigmatic. 
UVB and UVA contribute differently to the erythema and cutaneous lesions as reviewed by 
Kim et al. [350]. The proposed mechanisms include increased sensitivity of keratinocytes to 
UVB, defective clearance of apoptotic material and appearance of autoantigens on the 
surface of apoptotic keratinocytes. Additionally, UVB light can induce immune cell 
recruitment via pro-inflammatory cytokines and modify the expression of adhesion 
molecules (e.g., ICAM-1). Simultaneously, UVA enhances the release of pro-inflammatory 
cytokines and alters cell structures mainly by oxidative damage [350].  
1.3.3 Influence of UV-Vis light on human neutrophils 
In vitro irradiation of neutrophils can directly affect their functions. For instance, UVA 
reduces phagocytosis as well as migration in response to fMLP and enhances NADPH activity 
[351]. Furthermore, light of higher-energy (UVB/UVC) often leads to apoptotic cell death 
[352, 353]. Interestingly, UVC light can also cause the formation of ‘suicidal’ NETs [354]. In 
this scenario, NETosis proceeds independent of NOX but dependent on mitochondrial ROS 
and p38 MAPK activation. Due to the activation of Caspase-3, the authors termed this form 
of cell death ApoNETosis. Additionally, near-infrared light (980 nm) can activate NETosis via 
a ROS-dependent autophagy-associated pathway [355]. Whether these two forms of 
NETosis are related and whether UVB, UVA or Vis light can also induce NETosis is unclear.  
Under physiological conditions, the most superficial neutrophils are located within the 
superficial arterio-venous plexus of the papillary dermis [356]. As detailed above, almost no 
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UVB, around 10-15% of UVA and 40-50% of blue light penetrate through the epidermis into 
these zones. If the skin is harmed, inflamed or pathologically predisposed, higher numbers of 
neutrophils can be recruited into upper skin layers or be less protected from light due to skin 
barrier destruction. In these cases, the intensity of UV-Vis light reaching and activating 
neutrophils can be enhanced. Additionally, irradiation, particularly with UVB, can directly 
recruit neutrophils [357]. This is presumably due to increased release of cytokines such as IL-
8 and TNFɲ in human skin [358] or CXCL1 as shown in mice [359]. Consequently, the 
enhanced infiltration of neutrophils and the subsequent release of elastase, collagenase or 
gelatinase, were implicated into the pathogenesis of photoaging [360].  
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Chromatin swelling drives neutrophil extracellular
trap release
Elsa Neubert1,2, Daniel Meyer2,3, Francesco Rocca3,4, Gökhan Günay1,2, Anja Kwaczala-Tessmann1,
Julia Grandke1, Susanne Senger-Sander1, Claudia Geisler3,4, Alexander Egner3,4, Michael P. Schön 1,5,
Luise Erpenbeck 1 & Sebastian Kruss 2,3
Neutrophilic granulocytes are able to release their own DNA as neutrophil extracellular traps
(NETs) to capture and eliminate pathogens. DNA expulsion (NETosis) has also been docu-
mented for other cells and organisms, thus highlighting the evolutionary conservation of this
process. Moreover, dysregulated NETosis has been implicated in many diseases, including
cancer and inflammatory disorders. During NETosis, neutrophils undergo dynamic and dra-
matic alterations of their cellular as well as sub-cellular morphology whose biophysical basis
is poorly understood. Here we investigate NETosis in real-time on the single-cell level using
fluorescence and atomic force microscopy. Our results show that NETosis is highly organized
into three distinct phases with a clear point of no return defined by chromatin status. Entropic
chromatin swelling is the major physical driving force that causes cell morphology changes
and the rupture of both nuclear envelope and plasma membrane. Through its material
properties, chromatin thus directly orchestrates this complex biological process.
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1 Department of Dermatology, Venereology and Allergology, University Medical Center, Goettingen University, Göttingen 37075, Germany. 2 Institute of
Physical Chemistry, Göttingen University, Göttingen 37077, Germany. 3 Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB),
Göttingen 37073, Germany. 4Optical Nanoscopy, Laser-Laboratorium Göttingen e.V., Göttingen 37077, Germany. 5 Lower Saxony Institute of Occupational
Dermatology, University Medical Center Göttingen and University of Osnabrück, Göttingen 37075, Germany. These authors contributed equally: Elsa
Neubert, Daniel Meyer. Correspondence and requests for materials should be addressed to L.E. (email: luise.erpenbeck@med.uni-goettingen)
or to S.K. (email: skruss@uni-goettingen.de)













Neutrophilic granulocytes are the most abundant immunecells in humans and essential to defeat invading patho-gens1. Their mechanisms to target invading microbes
include well-known processes such as phagocytosis and genera-
tion of reactive oxygen species (ROS). A third defense pathway is
the release of neutrophil extracellular traps (NETs)2. The for-
mation of NETs (NETosis) can be triggered by organisms such as
bacteria or different chemicals and was originally described as an
additional form of cell death apart from apoptosis and
necrosis3–5. NETosis has been reported not only for neutrophils
but also other immune cells6,7, amoebas8 and plant cells9 indi-
cating an evolutionary conserved process3.
During NETosis, cells can release three-dimensional mesh-
works (NETs) consisting of chromatin2, antimicrobial compo-
nents including myeloperoxidase (MPO)5, neutrophil elastase
(NE)10, and LL37 of the cathelecidin family11. These fibrous
networks were initially described as a mechanism to catch and
eliminate bacteria, fungi, as well as viral particles2. However, it is
becoming increasingly clear that the role of NETs in the immune
system is far more complex than originally estimated. On the one
hand, accumulating data suggests that the immediate role of
NETs in immunoprotection against pathogens may be smaller
than originally anticipated, as mice that cannot form NETs do not
suffer from severe immunosuppression12,13. On the other hand,
dysregulated or excessive NETosis appears to be implicated in an
ever growing number of diseases, including cancer14, thrombosis
and vascular diseases15–17, preeclampsia18, chronic inflammatory
diseases19, and ischemia-reperfusion injury after myocardial
infarction16.
Various stimuli such as bacteria, fungi, viruses, platelets, as well
as small compounds including lipopolysaccharides (LPS), calcium
ionophores (CaI), or phorbol-myristate acetate (PMA) induce
NETosis and release of NETs20. In many settings, NETosis
appears to rely on the adhesion of neutrophils, in particular on
the engagement of neutrophilic integrin receptors such as
Mac-121–23, in others, adhesion via Mac-1 seems to be dis-
pensable24–26. It has also been described that hemodynamic
forces can trigger shear-induced NETosis27.
While these triggers—biochemical or mechanical—engage
diverse pathways, they all converge to a uniform outcome,
namely histone modification, chromatin decondensation and
NET release28. Cells dramatically rearrange their contents
(cytoskeleton, organelles, membranes, nucleus) during NETo-
sis; in most scenarios, they eventually die4. Chromatin decon-
densation has been described qualitatively since the discovery
of NETs4,29,30 and NET formation has been evaluated both in
high-throughput approaches, as well as on the single-cell
level29–31. Yet, the mechanistic basis of these fundamental
changes, as well as the underlying dynamic forces remain
poorly characterized. Here, we investigate NETosis from a
biophysical perspective, particularly looking at the forces and
dynamics driving this process, and provide functional links
between chromatin dynamics and biochemical behavior. We
show that NETosis is organized into well-defined phases
orchestrated by entropic swelling of chromatin, which finally
ruptures the membrane.
Results
NETosis is organized into distinct phases. To better understand
how the cell’s interior is rearranged and how NETs are released
we studied human neutrophils in real-time. First, we imaged
chromatin and cell membranes of human neutrophils stimulated
by 100 nM PMA (Fig. 1a, b, Supplementary Movies 1, 2). NETosis
was confirmed by co-localization of chromatin and MPO within
the expelled NETs (Fig. 1f).
The chromatin-filled area inside the cells followed a character-
istic time course (Fig. 1a, b) that consistently allowed the
assignment of three distinct phases. As can be seen later this
phase classification allows us to distinguish active biological
processes from materials driven processes and to identify a point
of no return. Cells were stimulated (t= 0) and during the first
phase P1 (0 < t < t1= start of chromatin expansion) the lobular
structure of the nucleus was still intact (34 min in Fig. 1a) and the
corresponding chromatin area stayed constant. In the second
phase P2 (t1 < t < t3 = NET release) chromatin expanded within a
few minutes until it reached the cell membrane as a barrier (t2=
maximal chromatin expansion in Fig. 1a). Simultaneously, the cell
rounded up (t2 to t3 in Fig. 1a and Supplementary Fig. 1a, b). In
the third and final phase (P3, t > t3) the cell membrane is ruptured
(t3) and the NET released into the extracellular space.
Additionally, released NETs were also visualized by stimulated
emission depletion (STED) nanoscopy to reveal the architecture
of hydrated NETs below the resolution limit of normal
fluorescence microscopy (Supplementary Fig. 2). The observed
architecture was in good agreement with previous electron
microscopy images of NETs2.
The above-mentioned phase classification was applied to
multiple cells (n= 139 cells) from five different donors (Fig. 1c,
Supplementary Fig. 3a-c, Supplementary Movies 3–6). Although
the onset time points for the different phases of all individual cells
followed a broad distribution (Fig. 1c), average onset values for all
five donors were remarkably reproducible, indicating low inter-
individual variability for the three distinct phases under
standardized conditions (Supplementary Fig. 3c). Decondensa-
tion of chromatin started at t1 = 56 ± 4min (standard error of the
mean, SEM) and reached a maximum at t2= 82min (±3 min).
After t3 = 116 min (±4 min) the cytoplasmic membrane ruptured
and the NETs were released. In summary, P1, as well as P2,
require around 60 min in our experimental setup.
The three distinct phases of chromatin decondensation were
not only elicited by PMA but also by LPS (Fig. 1d) or calcium
ionophores (Fig. 1e), albeit with different onset times, particularly
with respect to P1 (Supplementary Fig. 3d, Supplementary
Movie 7), which is most likely an expression of the distinct
signaling pathways engaged by different stimuli28.
To understand biophysical events during NETosis in detail, we
analyzed chromatin shape with special regard to the
most relevant internal and external boundaries (i.e., nuclear
envelope and cell membrane). In P1, cells first adhered to the
surface, flattened and showed filopodia activity (Supplementary
Fig. 4a, b, Supplementary Movies 1, 2, 8). During P2, the cell
retracted its cell body as shown by CLSM (Fig. 1a, Supplementary
Fig. 4a, b) and time-resolved reflection interference contrast
microscopy (RICM) (Supplementary Fig. 4c, d and Supplemen-
tary Movies 9–11), the cells rounded up and their height
increased as demonstrated by both three-dimensional CLSM
stacks (side view, Fig. 2a) and atomic force microscopy (AFM)
(Fig. 2b).
Interestingly, NETotic cells reached approximately the same height
as non-stimulated round cells (Fig. 2b), suggesting that chromatin
expansion/decondensation is a swelling process and the swelling
pressure caused the energetically most favorable spherical shape.
To address the question of how chromatin exits the nucleus,
we labeled lamin B1, a constitutive component of the nuclear
envelope that surrounded all individual lobuli of the nucleus
(Fig. 2c, Supplementary Fig. 5). Over time, those lobuli merged
and became less distinctive, indicating profound changes in the
separation between chromatin. Around the onset of P2 (t1; i.e.,
the start of chromatin expansion), the lamin B1 layer tore on at
least one site of the nucleus. Often, several rupture events of
this layer were discernable (arrows Fig. 2c, see also comparison
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of chromatin area at t1 in Supplementary Fig. 5). Similar
fluorescent labeling methods have been used by others to
quantify nuclear envelope rupture events32. Previous publica-
tions have described the modification of nuclear lamins by
phosphorylation as an early event, which would affect rigidity
and could facilitate the here-described breakage of the nuclear
envelope33. It should be noted that the breakage of the nuclear
envelope appears to be a distinct process from the previously
described dissolution of the nuclear envelope, which is a
hallmark of late stages of NETosis13,33.
In line with these previously published observations, we could
show that the nuclear envelope further decomposed during P2
and P3 and lamin B1 was found distributed throughout the
cytoplasm (Fig. 2c, P2/3). Subsequently, nuclear envelope break-
down allowed further expansion and swelling of chromatin
within the cell (Fig. 2d). Consequently, the temporal correlation
between t1 and the rupturing of the nuclear envelope indicates
that chromatin swelling is the physical driving force of this event.
The dissection of NETosis into distinct phases allowed us to
identify and distinguish active (biological/biochemical) and
passive (material properties) events. In the next step, we linked
the phase classification to biochemical processes.
Active and passive mechanisms during NETosis. The initial
steps of NETosis are thought to rely on several enzymes, with the
exact progression depending greatly on the activator used to
initiate NET formation28. In most scenarios, NETosis depends on
the activity of typical neutrophil enzymes such as neutrophil
lactase (NE) and myeloperoxidase (MPO)34, as well as histone
citrullination by the enzyme peptidyl-arginine deiminase 4
(PAD4). However, it is unclear at which time point during
NETosis signaling and activity by these players are essential, and
whether they initiate or maintain the process. If they were
required in P1, and later phases were governed by passive
mechanisms such as swelling of chromatin, then P2 and
P3 should not depend on an active cellular energy supply. Indeed,
ATP levels of (PMA) activated neutrophils quickly decreased in
P1 by up to 70%, particularly within the first 30 min, indicating
energy-dependent processes (Fig. 3a). In contrast, ATP levels then
remained constant throughout P2 on a low level (Fig. 3a). To
corroborate the hypothesis that energy supply is not necessary for
P2, the main energy source in neutrophils, glycolysis35,36, was cut
off by inhibiting glucose metabolism with 2-Deoxy-D-glucose
(2-Deox-Gluc)37–40, which quickly and durably reduced ATP
levels of neutrophils as early as 15 min in PMA-stimulated cells
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Fig. 1 Phases of NETosis. a Morphological changes of chromatin (blue) and cell membrane (red) during NETosis of human neutrophils (stimulated with
100 nM PMA) imaged by live-cell confocal laser scanning microscopy (CLSM). The lobular nucleus loses its shape and chromatin decondenses until it fills
the entire cell. Finally, the cell rounds up and releases the NET (white arrow). Scale bar= 5 µm. b Corresponding chromatin area of a NETotic neutrophil (a)
as a function of time reveals three distinct phases. P1: Activation, lobulated nucleus. P2: Decondensation/expansion of chromatin within the cell (t1= start
of chromatin expansion, t2=maximal chromatin expansion within the cell); cell rounding. P3: Rupture of the cell membrane (arrow a) and NET release (t3
=NET release). c Histogram of onset times of the different phases. n= 139 cells. N= 5 donors. Lines represent Gaussian distribution function fits. d Time
course of chromatin area for stimulation with LPS (Lipopolysaccharide, from Pseudomonas aeruginosa, 25 µg ml−1). e Time course of chromatin area for
stimulation with calcium ionophore (4 µM). c–e data acquired with live-cell wide field fluorescence microscopy. f Colocalization of decondensed neutrophil
chromatin (blue) and myeloperoxidase (green). Fixed cells imaged by wide field fluorescence microscopy. Scale bar= 20 µm
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and within 60 min in unstimulated neutrophils (Supplementary
Fig. 6b, c). Additionally, sodium azide (NaN3) was used in this
setup as a general inhibitor of metabolic function and, specifically,
of metalloproteases41–43, and MPO was inhibited with 4-
aminobenzoic acid hydrazide (4-ABAH)44,45. We verified the
function of these enzymatic inhibitors by showing that NaN3
inhibits ROS production in neutrophils immediately after addi-
tion for at least 30 min (Supplementary Fig. 6a and 9c) and that
4-ABAH inhibited purified MPO within 1 min and stable within
15 min after PMA activation (Supplementary Fig. 6d). Thus, 4-
ABAH directly interferes with PMA-induced NET formation5.
None of the here-used inhibitors had any measurable effect on
NET-production of naïve neutrophils (Fig. 3b), nor did any of
them show significant toxicity (Supplementary Fig. 7a). As
expected, however, effects of these inhibitors were not exclusive to
NET-formation, as 4-ABAH and 2-Deox-Gluc clearly decreased
the uptake of FITC-labeled E. coli particles, although NaN3
showed no effect in this setup (Supplementary Fig. 7b).
When added directly after stimulation all inhibitors signifi-
cantly reduced NET formation (Fig. 3b). This effect successively
decreased when inhibitors were added at later time points.
Exposure to NaN3 after >60 min and to 2-Deox-Gluc or 4-ABAH
after >75 min no longer affected the number of decondensed



















































































Fig. 2 Chromatin swelling drives morphological changes. a Live-cell CLSM side view of a neutrophil during NETosis. Chromatin (blue) decondenses/
expands, reaches the membrane (red) and the cell rounds up until the membrane ruptures. z-stack depth: 1 µm. b Cell height as measured by atomic force
microscopy (AFM) on life neutrophils. PMA stimulated cells adhere and flatten (compared to the control cells that stay more or less round) and then round
up (>8 µm) in P2. n= 3. Mean ± SEM. c Characteristic distribution of lamin B1 (green) in the three phases, CSLM images of fixed cells. Lamin B1 first
surrounds single lobuli of the nucleus/chromatin (blue). When chromatin starts to expand corresponding to the start of P2 (around t1), the lamin B1 layer/
nuclear envelope ruptures on at least on one side of the nucleus. During P2 and P3 lamin B1 further decomposes. White arrows indicate rupture sites of the
lamin B1 layer. Scale bar= 5 µm. d The original shape of the nucleus remains recognizable during the expansion process, particularly in the first part of P2
(t1 to t2), indicating isomorphic chromatin swelling and not directional transport (Supplementary Movies 13–15). In P1 the nucleus has a lobulated structure,
which is maintained (self-similarity) during P2. Finally, the membrane is reached and, for a short period of time, this barrier prevents further expansion until
it burst. Scale bar= 5 µm. Live-cell CSLM images
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and enzymatic activity, while P2 and P3 do not. So far, NETosis
has been generally considered as an active process that requires
the aforementioned enzymes. Here, we show that this general-
ization does not hold true for the complete mechanism.
Another hallmark of enzymatic activity is temperature-
dependence. We chose to show the impact of temperature
variations on the impact of NETosis as a complementary,
inhibitor-free approach to investigate the importance on enzy-
matic activity. We quantified the duration of the different phases
of NETosis at physiological core temperature (37 °C), hypother-
mia (23.5 °C) and hyperthermia/fever (40 °C). Higher tempera-
tures significantly accelerated P1 whereas P2 showed no or only a
slight temperature dependence (Fig. 3c, Supplementary Movie 12),
indicating high enzyme activity in P1. If one assumes Arrhenius-
like kinetics k ! exp " EakBT
! "! "
, the 4.14-fold shortened duration
of P1 (227.5 min at 23.5 °C vs. 55.0 min at 37 °C) corresponds to
an activation energy of around 80 kJ mol−1, which falls into the
range expected for enzyme-catalyzed reactions46, and again
corroborates our hypothesis of a switch from biochemically
driven processes to behavior governed by material properties. P3
was not evaluated in the context of temperature-dependency as it
is not possible to determine an end-point of P3 after the release of
the NET.
Additionally, this result indicates an enzyme activity independent
diffusive process in P2 since one expects lower temperature
dependence for diffusion. In the first part of P2 (Fig. 1b, 2d,
Supplementary Fig. 3a, Supplementary Movies 13–15) the
chromatin area A increased linearly with time t and can be
interpreted as a 2D diffusion process (A # x2h i ¼ 4Dt). The
corresponding effective diffusion constant D of 0.0108 µm2 s−1 at
37 °C (Supplementary Fig. 8a) is roughly in agreement with
the diffusion of a 2 × 109 DNA sequence of (D ≈ 0.002 µm2 s−1,
T= 37 °C)47,48.
Entropic chromatin swelling drives morphological changes. At
the beginning of NETosis (P1 in our classification), histones are
modified chemically (decrease of positive charge) by enzymes
such as PAD4 or NE, which reduces the counterforces that hold
the negatively charged DNA/chromatin together10,49. A con-
densed nucleus is under considerable entropic pressure as the
radius of gyration of the human genome (length around 2 m) is
approximately 150–200 µm50,51. Once the counterforces are no
longer high enough to balance the entropic pressure, chromatin
begins to swell. This time-point corresponds to t1 (onset of P2)
and marks a point of no return.
Another line of evidence pointing to entropic pressure as a
relevant factor stems from the observation that small neutrophils
rupture faster than larger ones after chromatin filled the whole
cell lumen (Fig. 4a). As all cells contain the same amount of
chromatin, entropic pressure exerted on the cell membrane is
higher if they are smaller. This should lead to earlier rupturing of
the membrane. Likewise, large intact neutrophils accumulate
during the experiments because smaller ones rupture and release
NETs first (Fig. 4b).
To analyze whether the swelling pressure generated during P2
determines if and when the membrane ruptures, we calculated the
pressure exerted by chromatin and compared it to the rupture
delay time (t2 to t3). For that purpose we modified a Navier-
Stokes equation-based theory that describes pressure as a function
of time t (see Methods52):
p tð Þ ¼ η R tð Þð Þ
l2p R tð Þð Þ
dR tð Þ
dt
R tð Þ ð1Þ
Here η is the viscosity of the chromatin (liquid), R(t) the
effective radius of the chromatin area and lp the chromatin mesh





































































































































Fig. 3 Active and passive processes during NETosis. a ATP levels in stimulated neutrophils decrease during P1 and reach a plateau in P2. Inhibition of
glucose metabolism further reduces ATP levels (Supplementary Fig. 6c). N= 3. Mean ± SEM. b Metabolic inhibitors (sodium azide/3mM, 2-deoxy-D-
glucose/5mM, 4-aminobenzoic acid hydrazide/100 µM) influence NET formation determined as relative number of decondensed nuclei after 180min
compared to activation with PMA only. All inhibitors decrease NET formation when added in P1, while P2 is not or only slightly affected, indicating a point
of no return. N= 3 donors. Statistics: two-way ANOVA (Bonferroni’s multiple comparisons test; *p < 0.05; **p < 0.01; ****p < 0.0001; ns= not significant).
Mean ± SEM. c Phase duration at different temperatures (23.5, 37, 40 °C). P1 is significantly prolonged at lower temperatures, whereas P2 displays no or
marginal temperature dependence. N= 3 (23.5, 40 °C). N= 5 (37 °C). Statistics: Kruskal-Wallis test (Dunn’s multiple comparisons test; *p < 0.05;
**p < 0.01; ****p < 0.0001; ns= not significant). Life-cell imaging. Boxplots display the 25th and 75th percentile and the horizontal line the median. Hollow
squares represent the mean and whiskers the SD
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ruptured showed no fine structure indicating that the mesh size is
below the resolution of this microscope (about ≈120 nm in xy-
direction and ≈150 nm in z-direction) (Fig. 4c, Supplementary
Fig. 8b, c). Therefore, we assumed that the whole genome (around
2 m DNA) is evenly arranged inside the cell and estimated that lp
to be around 20 nm. Cells exposed to higher pressure ruptured
faster than their smaller counterparts (Fig. 4d). The calculated
pressure values are in a similar range as pressure values known
from osmotic lysis experiments of lipid vesicles53. To find out if
these calculated pressure values were actually exerted by the cell
we measured these forces directly with AFM (Fig. 4e, Supple-
mentary Fig. 8d). A cantilever was positioned in direct contact
with the cell and deflected by the rounding cell. This is a known
approach to measure rounding forces e.g. during mitosis54. The
pressure exerted by the cell increased with time and lifted the
cantilever until the cell finally ruptured (end point of measure-
ment). The measured pressure values between 100–200 Pa are in
the same range as the calculated pressure values from Fig. 4d.
Together with the control experiments that show that energy
supply (Fig. 3) and the actin cytoskeleton (Fig. 5, below) are not
crucial for P2 this result further supports chromatin swelling as
the major driving force in P2.
In conclusion, our results show that P1 of NETosis is a
biologically active process governed by signaling and enzymatic
reactions. In contrast, P2 is mainly passive, based on entropic
chromatin swelling and cannot be stopped once it has started.
Therefore, the onset of P2 (t= t1) represents a point of no return.
Impact of cytoskeletal rearrangements on NETosis. In addition
to the unexpected importance of chromatin dynamics reported
this far, the cytoskeleton may also contribute to shape shifts and
DNA expulsion. While cytoskeletal components appear to rear-
range and F-actin may become degraded during NETosis4,34,
these processes remain poorly understood. Figure 5a shows the F-
actin distribution (labeled with SiR-actin) at different time points
after PMA-stimulation. During the first 30 min F-actin became
more prominent as expected for stimulation with the
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Fig. 4 Entropic swelling of chromatin causes membrane rupture. a Correlation between cell area at t3 (chromatin area at t3≈ total cell area at t3) and time
span until membrane rupture occurs following maximal chromatin expansion (t3– t2, rupture delay time). Larger cells rupture later than smaller cells. n=
112 cells (only cells of population 1 included, see Supplementary Fig. 3a, b). Fit lines show normalized 2D-probability density function calculated by kernel
density estimation (KDE). N= 5 donors. b Average cell area (at t3) of remaining/intact cells. The area of intact cells increases from ≈151 to ≈230 µm2 with
time, indicating earlier rupture of small cells. n= 121 cells. N= 5 donors. Mean ± SEM. c Live-cell confocal (left row) and STED (right row) images of
chromatin (SiR-DNA) of two neutrophils undergoing NETosis (late P2) show almost uniform distribution of chromatin suggesting a mesh size smaller than
the resolution of the microscope (≈120 nm (xy) and ≈150 nm (z), Supplementary Fig. 8b). Scale= 2 µm. d Time delay until rupture as a function of the
calculated pressure p at t2. n= 112 cells (only cells of population 1 included, see Supplementary Fig. 3a, b). N= 5 donors. The contour fit is generated by
fitting the maximal data points to an exponential decay curve. e Neutrophils undergoing NETosis exert an increasing pressure on a fixed AFM cantilever
until they rupture (end point of measurement). Inset: N= 5 (n= 14 cells). Boxplots display the 25th and 75th percentile and the horizontal line the median.
Hollow squares represent the mean and whiskers the SD
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neutrophils, among them the induction of chemotaxis55. Then, it
diminished and completely disassembled after 90–180 min (see
quantification in Supplementary Fig. 9a).
As recently described, α-tubulin is initially organized in
filaments originating from the microtubule organization center
(MTOC; unstimulated cells)33. One could speculate that these
MTOCs are involved in active transport of chromatin. However,
during phase I after PMA-stimulation, α-tubulin filaments
disappeared and were rearranged into dot-like structures,
reminiscent of mitotic centrosomes. These were visible until the
beginning of chromatin decondensation, namely until the
beginning of phase 2 (Fig. 5a). As we did not observe these
filaments any more during phase 2, it is unlikely that active
chromatin transport along these centrosomes like structures plays
a role during the expansion of chromatin.
Additionally, we sought to determine the role of the
cytoskeleton through specific inhibition: Jasplakinolide
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Cytochalasin D (100 nM, inhibition of actin polymerization),
Latrunculin A (1 µM, inhibition of actin polymerization) and
Docetaxel (100 nM, inhibition of tubulin depolymerization) were
added at different time points after stimulation (with 100 nM,
PMA). While Docetaxel exerted no (Supplementary Fig. 9b),
Cytochalasin D and Latrunculin A showed a significant reduction
of NETosis when added up to 15 min after activation (Fig. 5b).
Jasplakinolide inhibited NETosis completely when added from
the beginning. The latter effect decreased as NETosis advanced
(Fig. 5c). Based on this finding we concluded that reorganization
of the cytoskeleton is not only a consequence of NETosis, but also
a requirement during the active phase (P1; Fig. 5b, c).
Additionally, we manipulated cell motility by inhibiting the
rho-associated coiled-coil-containing protein kinase 1 and 2
(ROCK 1/2) signaling pathway using Y-27632 (19.2 µM). Again,
we found a strong influence on P1 (Fig. 5c). These results are in
good agreement with our results on enzyme activity (Fig. 3b).
While it has been shown that cytoskeletal inhibitors may
influence the NADPH oxidase56, we could rule out that these
off-target effects were causing the reduction in NETosis, as
Jasplakinolide inhibited ROS formation, while Latrunculin A
increased it and the Y-27632 and Cytochalasin D had no or only a
slight effect on ROS production (Supplementary Fig. 9c). Thus,
while effects on ROS production were very heterogeneous, the
effect of cytoskeletal inhibition on NET production showed the
same pattern for all used inhibitors (Fig. 5b, c). Therefore, we can
rule out that the observed effects on NETosis are exclusively
mediated by an influence on the NADPH oxidase. None of our
cytoskeletal inhibitors produced any significant cytotoxic effect
on neutrophils (Supplementary Fig. 7a).
In conclusion, NETosis requires an intact and functional
actin cytoskeleton at the beginning of P1 and the reorganiza-
tion of F-actin is essential to proceed to P2 and P3.
Rearrangement of the microtubule apparatus appears to be a
marker of the activation of biochemical pathways required for
NETosis (namely the activation of cyclin-dependent kinases 6
and 4)33 and an influence of certain microtubule inhibitors has
been postulated by isolated publications57. However, in our
setup the microtubule apparatus itself appears to be dis-
pensable for NET formation. Taken together, both the actin
cytoskeleton of the neutrophils, as well as the microtubule
apparatus become dysfunctional as NETosis progresses.
Therefore, it is unlikely that the cytoskeleton plays an active
role during the final steps of NETosis. Dissolution of these
major components, which normally stabilize the cell, likely
impairs the cell’s mechanical properties, thus helping the final
cell membrane rupture.
To test this hypothesis, the cells’ mechanical properties were
measured by atomic force microscopy (AFM) (Fig. 5d, e,
Supplementary Fig. 10, Supplementary Movie 16). Indeed, cells
became markedly softer during NETosis, particularly in P2, as
evidenced by a decrease of the Young’s modulus from E= 1.5 to
0.3 kPa (Fig. 5d).
Additionally, retraction curves of individual membrane tethers
were analyzed to distinguish the cell’s bulk mechanical properties
from the mechanical properties of the membrane alone. The
membrane tension decreased by 77% (0.35 to 0.07 mNm−1)
(Fig. 5e). Although alterations of the plasma membrane are likely
to occur in an inflammasome-dependent manner during
NETosis58, such a dramatic decrease cannot be explained by
changes of membrane composition only, but must be caused by
the disassembly of the actin cortex beneath the membrane59,60.
The membrane tension T in late P2 corresponds to a membrane
pressure p ! 2R T ! 20 Pa (Young-Laplace equation, radius
R ≈ µm). The calculated swelling pressure (Fig. 4d) is in the
same range indicating that chromatin swelling is sufficient to
break the membrane.
Location of membrane rupture. To test the hypothesis that the
chromatin swelling pressure determines the membrane breaking
point, we correlated swelling speed and anisotropy with the
position of the rupture point. Even though swelling itself should
be isotropic, the position of the nucleus/lobuli inside the cell
varied with respect to the cell boundary. We first looked at
chromatin decondensation and calculated the average swelling
speed during t1 < t < t2 (represented by a velocity field, Fig. 6a,
Supplementary Fig. 11). Interestingly, in cells in which the
nucleus was closer to one side of the cell membrane, the rupture
point was usually close to areas of low chromatin movement, e.g.,
in close proximity to the cell membrane (cell 1–3). In these cases,
there was less space for chromatin to expand (higher remaining
entropic pressure). If (in the minority of cells) the nucleus was
centered in the cell the rupture direction was random (cell 4).
Moreover, cells typically ruptured at the side that experienced
the last membrane retraction close to the long axis of the cells
before they rounded up (Fig. 6b).
In order to quantify these observations, a rupture point axis
was determined by connecting the rupture point A with the
center of mass of the respective cell (M). Then, the cells’ outlines
were fitted with an ellipse and the cell membrane shrinking
velocities of both cell sides (A and B) were analyzed along the
rupture axis (vA and vB) during the last minutes before rupture
(30 min ± 16 min) (Fig. 6c). Cells ruptured at the side that
experienced significantly more movement after the rounding
process started in late P2 (t > t2) (Fig. 6d). Most rupture events
occurred close to the previously long axis of the (elliptic) cell
(Fig. 6e), thus allowing the prediction of the NET release location.
This analysis of membrane morphology shows that cells
become circular before the membrane ruptures on the last
moving side close to the previous long axis. Additionally, the
position of the nucleus with respect to the membrane determines
Fig. 5 Rearrangement of the cytoskeleton and evolution of mechanical properties. a At the beginning of NETosis F-actin (red) is laterally enriched and
localizes in the lamellipodia. α-Tubulin filaments (green) are arranged originating from the microtubule organizing center (MTOC) in unstimulated cells.
Within the next hours (during P1) cytoskeletal components disintegrate. Remaining F-actin accumulates at the cell margin and α-tubulin is first rearranged
in centrosome-like structures which disappear at the beginning of P2. CLSM images of fixed cells. Activation= PMA (100 nM). Blue= chromatin. Scale=
10 µm. b, c Inhibition of NET formation with the F-actin polymerization inhibitors Cytochalasin D (100 nM) and Latrunculin A (1 µM), F-actin-stabilizing
drug Jasplakinolide (10 µM) and the ROCK-inhibitor Y-27632 (19.2 µM) significantly reduces the formation of NETs (measured as %-relative number of
decondensed nuclei after 180min compared to activation with PMA only) in P1, while P2 depends less or not on F-actin stabilization and ROCK-inhibition.
Statistics: two-way ANOVA (Bonferroni’s multiple comparisons test; *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001; ns= not significant). N= 3 donors.
Mean ± SEM. d Normalized tether tension of life neutrophils (measured with AFM) decreases over the entire time course (raw data: >0.35mNm to <0.07
mNm) of PMA-activated NETosis indicating a loss of cytoskeletal stability. Values of control cells remain stable. N= 3. Mean ± SEM. e Cell stiffness
(Young’s modulus) of life neutrophils decreases from >1.5 kPa to <0.3 kPa after stimulation with PMA whereas the stiffness of control cells remains
constant. N= 3. Mean ± SEM
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-06263-5





on which side of the cell entropic chromatin pressure becomes
higher.
An additional aspect that has not been addressed in detail so
far is influence of adhesion in NETosis. We used reflection
interference contrast microscopy (RICM) (Supplementary Fig. 4c,
d, Supplementary Movies 9–11) to image the interface between
cell and substrate and address this question61,62. Neutrophils
quickly and strongly adhered and left membrane behind, while
rounding up. To further test the impact of adhesion we quantified
NETosis on differently coated surfaces (Supplementary Fig. 12).
Interestingly, on surfaces passivated with poly(L-lysine)-graft-
poly(ethylene glycol) (PLL-g-PEG) neutrophils still performed
NETosis even though they could not properly adhere (Supple-
mentary Movie 17). This result does not rule out an important
role of adhesion in determining the threshold for NETosis
especially for different (weaker) activators. However, it shows that
once the cell initiated NETosis, additional adhesive cues were not
important anymore. Nevertheless, the influence of external
factors for the initiation and execution of NETosis, including
adhesive cues and surface characteristics like surface stiffness, for
example, certainly warrant further investigation in the future.
Discussion
Over the last years, much effort has been put into unraveling the
signaling cascades and enzymatic players that are indispensable
for NETosis. Here, we provide a comprehensive and unique
picture of the complex biophysical aspects that govern the dif-
ferent phases of NETosis using an interdisciplinary approach and
innovative imaging methods. We conclude that NETosis is a
highly organized process with a first phase (P1) that is governed
by biochemical modifications including histone citrullination and
phosphorylation of lamins33 that prepare the cell for later
mechanical changes. We show that a point of no return exists
after which active processes such as enzymatic activities become
secondary and the cells behavior is determined by the char-
acteristics of chromatin (Fig. 7, Supplementary Fig. 13). Mor-
phological changes, as well as rupture/burst of nuclear envelope
and cell membrane are driven by entropic swelling of chromatin.
At this point, pharmaceutical inhibition of NETosis is no longer
possible. These findings may also prove important for other
biological processes, such as cell division or other forms of cell
death54,63. Indeed, it has been shown very recently that broad
overlaps exist between NETosis and mitosis from a biochemical
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Fig. 6 Predetermination of the membrane rupture point. a Velocity plots of chromatin swelling. Changes to darker colors indicate faster movement (shorter
residence time) of chromatin. The actual rupture point (red circle) often correlates with areas of slow movement (predicted rupture point, green circle).
b Live-cell CLSM images of the cell membrane (PKH26 staining) directly before NET release. The cell rounds up and ruptures when maximum circularity is
reached (t= 98min). Scale bar= 5 μm. c Schematic of the rupture point analysis. Rupture points were analyzed by (1) fitting an ellipse to the cell before it
became round and determining the rupture axis between the rupture point A and the center of mass M and (2) determining the retraction speed (vA and
vB) on both sides of the (previously elliptic) cell (see Methods). d Shrinking velocity of the two opposing cell poles (A and B). The neutrophil retracts its
membrane with a significantly higher velocity at the future rupture site (A). n= 17. N= 4 independent experiments. Statistics: Mann–Whitney test, two-
tailed (***p < 0.001). Boxplots display the 25th and 75th percentile and the horizontal line the median. Hollow squares represent the mean and whiskers
the SD. e Angle plot shows that the membrane ruptures in proximity of the major axis. α= rupture point angle. ß=major axis angle. n= 17. N= 4
independent experiments
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point of view. It will be worthwhile studying these similarities
from a biophysical perspective33.
Ultimately, cells appear to be more than biochemical factories
and complex processes such as NETosis can therefore be driven
not only by biochemical signaling but also material properties.
Chromatin is traditionally viewed as a nuclear entity that
mainly regulates gene expression. Here, we show that chromatin
is much more than a template for information processing but is
able to actively conduct biological processes.
Methods
Isolation of human neutrophils. Neutrophils were isolated from human venous
blood of healthy donors. The study was approved by the ethics committee of the
university medical center goettingen (chairman Prof. Dr. med. Jürger Brockmöller)
and fully informed consent of all donors obtained after clearing the possible
consequences of the study. The isolation was performed according to previous
published standard protocols.1
In short, fresh blood was collected with S-Monovettes KE 7.5 ml (Sarstedt).
Blood was gently layered in a 1:1 ratio on top of Histopaque 1119 (Sigma-Aldrich)
and centrifuged at 1100 × g for 21 min. Then, the transparent third and pink fourth
layer containing the white blood cells were collected and mixed with HBSS
(without Ca2+/Mg2+, Thermo Fisher Scientific). Cells were pelleted by
centrifugation for 10 min at 400 × g. After discarding the supernatant, the pellet
was resuspended in HBSS without Ca2+/Mg2+ and layered on top of a phosphate
buffered percoll (GE Healthcare) gradient with the concentrations 85, 80, 75, 70,
and 65% and centrifuged at 1100 × g for 22 min. The accumulated neutrophils were
received by collecting half of the 70%, full 75% and half of the 80% layer and
washed with HBSS. The remaining cell pellet was resuspended in 1 ml HBSS. Cells
were counted and suspended at the required concentration for the following
procedures with RPMI 1640 (Lonza) containing 10 mM HEPES (Roth) and 0.5%
human serum albumin (HSA) (Sigma-Aldrich). Experiments with
lipopolysaccharides (LPS from Pseudomonas aeruginosa serotype 10.22, strain:
ATCC 27316, Sigma-Aldrich) or calcium ionophores (CaI, Sigma-Aldrich) were
carried out without addition of 0.5% human serum albumin. Cellular identity was
confirmed by a cytospin assay (Cytospin 2 Zentrifuge, Shanson) followed by Diff
Quick staining (Medion Diagnostics). Cell purity was >95% of isolated cells
(without erythrocytes).
Live cell imaging (fluorescence microscopy). Fresh isolated human neutrophils
were seeded (4–5 × 105 cells per ml) on ibidi treat flow chambers (µ-Slide I 0.8 Luer
ibidi Treat, ibidi GmbH) for 30 min (37 °C, 5% CO2) and stained with 1.62 µM
Hoechst 33342 (Sigma-aldrich) for 15 min (37 °C, 5% CO2). For membrane
staining, cells were stained before seeding with 2 µM PKH26 (PKH26-kit, Sigma-
aldrich) following the companies’ instructions. Cells were activated for NETosis
with 100 nM Phorbol-12-myristate-13-acetate (PMA, Sigma-aldrich), 4 µM CaI or
25 µg ml−1 LPS. Live cell imaging was performed at 23.5, 37 or 40 °C (ibidi heating
system, ibidi GmbH) for 3–5 h with minimized light exposure. Bright field
microscopy movies were obtained ×16 magnified (EC Plan-Neofluar Ph1/440331-
9901-000, Zeiss) using the camera CoolSNAP ES (Photometrics) and the micro-
scope Axiovert 200 (software: Metamorph 6.3r2., Molecular Devices, Zeiss) with a
frame rate of one picture per minute in the blue channel (Filter set 02 shift free/
488002-9901-000, Zeiss). For CLSM images an Olympus IX83 inverted microscope
(software: Olympus Fluoview Ver.4.2, Olympus) was used and the movies were
recorded ×60 magnified (UPlanSApo 1.35 oil, Olympus). Hoechst fluorescence was
detected at 405 nm and PKH26 fluorescence at 561 nm. All 2D-movies were
obtained with a frame-rate of one picture per 2 min and the 3D-movies with one
picture per ten minutes and a z-stack depth of 1 µm per slice. All videos and
pictures were further processed with ImageJ (v. 1.46r ad 1.50c4; National Institutes
of Health) and MATLAB (v. R2008a/R2014a; The MathWorks, Inc.) as described
in the section statistics and data analysis.
Inhibitor experiments. Fresh isolated human neutrophils (10,000 per well) were
seeded in 96-glassbottom-well-plates (In vitro scientific) and activated for NETosis
with PMA, final concentration 100 nM. Subsequently, the function of cytoskeletal
components was inhibited with Cytochalasin D (100 nM, Abcam), Latrunculin A
(1 µM, Sigma-Aldrich), Docetaxel (100 nM, Abcam), Jasplakinolide (10 µM, Enzo)
or Y-27632 (19.2 µM, Abcam) and enzyme activity inhibited with 2-deoxy-D-
glycosis (2- Deox-Gluc, 5 mM, Sigma-aldrich), sodium azide (NaN3, 3 mM, Merck)
or 4-Aminobenzoic acid hydrazide (ABAH, 100 µM, Cayman) at defined time
points (0 min, 15 min, 30 min, 45 min, 60 min, 75 min, 90 min, 105 min, and 120
min) after activation. All experiments were performed in triplicates. To stop NET
formation, cells were fixed with 2% PFA final concentration (Roth) after 3 h
incubation (37 °C, 5% CO2) and stored over night at 4 °C. The fixed probes were
washed 10 min with 1× PBS (Lonza) and chromatin stained with Hoechst at room
temperature. After staining, cells were washed with PBS and imaged with the
microscope Axiovert 200 (×16 magnification, Zeiss; software: Metamorph 6.3r2,
Molecular Devices) and a CoolSNAP ES camera (Photometrics) in the blue channel
(Filter set49 DAPI shift free, 488049-9901-000, Zeiss). For each well in total 5-6
images of different regions were collected. For all experiments, the amount of
decondensed nuclei, as well as the total cell count was quantified (blinded) with
ImageJ. Percentages of decondensed nuclei/NETs were calculated relative to the
amount of decondensed nuclei/NETs after stimulation of cells with PMA for 3 h.
ATP measurements. Fresh isolated human neutrophils (10,000 per well in RPMI
(10 mM HEPES, 0.5% HSA without phenolred)) were seeded in white 96-well-
plates (Greiner bio-one) and activated with PMA in a final concentration of 100
nM for defined time points (5 min, 15 min, 30 min, 60 min, 90 min, and 120 min).
After incubation, CellTiter-Glo® Reagent (Promega) was added in a 1:1 ratio and
the ATP amount was determined following the company instructions. In short, the
mixture was shaken for 2 min to induce cell lysis and incubated for 10 min at room
temperature to stabilize the luminescence signal. Subsequently, luminescence was
measured (GLOMAX® 96 Microplate Luminometer, Software: GLOMAX 1.9.3,
Turner BioSystems) and the ATP levels were calculated relatively to the ATP
amount of unstimulated cells incubated for 120 min.
Staining procedures. Fresh isolated human neutrophils (200,000 per well) were
seeded on pretreated (99% alcohol) glass cover slips (#1.5) in 24-well plates (Greiner
bio-one) and NET formation induced with 100 nM PMA. Cells were then fixed at
different time points after NET formation with 2% PFA and stored in PBS over night.
The following staining procedure was carried out based on previous published pro-
tocols64. Briefly, cover slips were gently removed from the 24-well plate and layered
upside down on the washing solution (1xPBS). Cells were then permeabilized with a
0.1% TritonX (Merck) containing solution for 10min at 4 °C, washed and blocked
with 5% fetal calf serum (FCS, Merck) or 3% BSA (Lamin B1 staining). Subsequently
cells were stained with monoclonal anti-human MPO (IgG, mouse, 1:500) (ab25989,
Abcam), monoclonal anti-human α-Tubulin (IgG, rabbit, 1:50) (#2125, Cell Signaling
Technology) or polyclonal anti-human lamin B1 (IgG, rabbit, 1:1000) (ab16048,
Abcam) as primary antibodies over night (4 °C) and visualized with polyclonal anti-
mouse Alexa488 (IgG, goat, 1:1000) (#4408, Cell Signaling Technology) or polyclonal
anti-rabbit Alexa488 (IgG, goat, 1:500) (A-11034, ThermoFisher Scientific) as sec-
ondary antibodies. In case of staining with SiR-dyes, cells were not permeabilized but
directly stained after washing with SiR-Actin (SC001, Spirochrome AG/Tebu-bio) or
SiR-DNA (SC007, Spirochrome AG/Tebu-bio) at 3 µM. Then, chromatin was stained
with Hoechst if applicable and cover slips were mounted with Faramount Mounting
Medium (Dako Agilent Technologies) on microscopy slide. After complete drying
and fixation with nail polish, samples were imaged with 40x magnification (Plan-
Neofluar 40×/1.30 oil Iris/4440456-0000-000, Zeiss) in a fluorescence microscope
(AxioImager M1, Software: AxioVision Rel.4.7, Zeiss) or ×60 magnified with confocal
laser scanning microscopy (Olympus IX83 inverted microscope, software:
Olympus Fluoview v.4.2).
3D-STED microscopy. In conventional optical microscopy, the resolution is











Chromatin swelling + 
rupture of nuclear envelope
Chromatin swelling + cell rounding + 
rupture of cell membrane
Fig. 7 Biophysical model of NET release NETosis can be divided into three distinct phases (according to chromatin status) that are separated by a point of
no return. The major physical driving force for morphological changes and NET release after phase 1 is entropic swelling of chromatin
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about the wavelength (λ ≈ 600 nm) in the lateral and axial direction, respectively.
To resolve smaller features samples were stained with SiR-DNA as described in the
staining procedure section and were imaged with a super-resolution STED (Sti-
mulated Emission Depletion) microscope65. For live cell imaging, cells (10,000 per
well) were seeded for 30 min in 10-well CELLviewTM glass slides (Greiner Bio-one)
in RPMI (10 mM HEPES, 0.5% FCS without phenolred) and activated with 100 nM
PMA and stained with 1 µM SiR-DNA. In a canonical STED microscope, the
diffraction-limited excitation spot is superimposed with a red-shifted donut-shaped
laser beam (STED beam) featuring a zero-intensity at its center. The STED beam
has the ability to inhibit fluorescence from excited molecules. The higher the STED
intensity, the more efficient this inhibitory effect is. As a consequence, fluorescence
is confined to a sub-diffraction sized area. The super-resolution image is recorded
by scanning this area across the sample.
To assess information beyond the diffraction limit, experiments were performed
with a custom-built 3D-STED microscope. The excitation beam of 640 nm
wavelength is emitted from a Picosecond Pulsed Diode Laser Head (LDH-P-C-
640B, PicoQuant, Berlin, Germany). As STED light source at 775 nm, sub-
nanosecond laser (Katana-08, Onefive GmbH, Zurich, Switzerland) is used. To
achieve a super-resolved image in 3D, the Easy3D-STED Module (Abberior
Instruments GmbH, Göttingen, Germany) is used: a programmable spatial light
modulator (SLM) creates the STED light phase patterns required for 3D STED
microscopy. It allowed a lateral (xy) and axial (z) resolution enhancement with
only one STED beam instead of two separate STED beams. The relative pulse delay
between the excitation laser and the STED laser is set electronically. Laser focusing
and fluorescence collection are performed by the same oil immersion objective
(UPlanSApo 60 × 1.35 Oil, Olympus Corporation, Tokyo, Japan). An appropriate
series of dichroic mirrors and optical filters separates the fluorescent signal from
both, the excitation and the STED light, and sends it into the detector. Fluorescence
photons are detected by a Single Photon Counting module (SPCM-AQRH-13-FC,
Excelitas Technologies Corp., Waltham, MA).
Experiments were run with the software ImSpector (MPI für biophysikalische
Chemie, Göttingen, Germany); data analysis was performed with ImageJ (U. S.
National Institutes of Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/).
Atomic Force Microscopy (AFM). For all AFM-experiments, 60,000 cells (62 cells
per mm2) were seeded on an ibidi-treaded µ-dish (81156, Ibidi) for 30 min. Sub-
sequently, the cells were activated with 100 nM PMA. For imaging, an Olympus
IX81 microscope was used and steered with an Olympus CellSense Dimension
software (v. 3.15). A custom-made heating system integrated into the dish holder
enabled the temperature regulation of the sample (T= 37 C°).
For elasticity measurements, a non-conductive silicon nitride tip (MLCT, f0=
10–20 kHz, k= 0.02 Nm−1, Bruker) was directed by a JPK AFM-head system (JPK
Instruments 00996, Nanowizard 3), calibrated according to the manufacturer’s
instructions (Nanowizard 3 user manual) and kept in the medium to equilibrate
the temperature. The tip was slowly approached to the cell via force-feedback
recognition and positioned above the middle of the cell. In general, the sample was
measured over a 20 × 20 µm area with 8 × 8 force curves for each time point and
controlled by a JPK SPM Control software (v.5). To prevent plastic deformation a
relative set point of 0.5 nN was chosen together with an extension speed of 3 µm s−1
and a delay time of 1 s between each force curve measurement resulting in a total
iteration time of around 6min. All force curves were manually reviewed, baseline







with a Poisson’s ratio set to v= 0.5, a face angle of α= 20°, the measured force F
and the tip-sample distance δ of the force curve. The mean Young’s modulus was
calculated from the force-curve in the middle of the cell and four direct neighbors
to avoid edge effects.
Parallel imaging to verify NETosis and healthiness of the cells were performed
on the same system. Here, cells were stained before with 1.62 µM Hoechst (Sigma-
Aldrich) and observed with an Orca Flash 2.8 camera (C11440, Hamamatsu) at
×40 magnification (LUCPlan FLN, Olympus). For illumination, an integrated lamp
system (cellTIRF-4Line System+ IUX-C2, Olympus) was used and filtered by a
DAPI filter set (#86-370-OLY, Olympus).
To measure tether tension during NETosis, the baselines of all AFM retraction
curves on the cell were analyzed for step like deflection changes that indicate tether
formation (sharp increase of cantilever deflection and constant values before and
after). All restoring forces were measured with a JPK Data Processing Software
(V. spm 5.0.69, JPK Instruments) and stored separately for each frame time t. The
membrane tension T(t) was then calculated by using the relation66–68




with B representing the bending stiffness of a lipid membrane (set to 3 × 10−12
dyne cm) and F(t) the respective tether force2. For each frame, these values were
averaged (n ≈ 3) and each data set was normalized to its first value T(t0) to enable
comparisons between varying base values of control cells.
For pressure measurements, a tipless cantilever (MLCT-O10, f0 = 10–20 kHz,
k= 0.03 Nm−1, Bruker) was chosen in order to enlarge the contact area of the
probed cell. Neutrophils were seeded according to the mentioned protocol,
activated with PMA and subsequently incubated for 90 min at 37 °C, 5% CO2 to
ensure unmodified cell properties before cell rupture. Afterwards, cells were placed
into the aforementioned setup and the cantilever was manually approached to a
single cell using 0.2 µm driving steps of the z-piezo motor until cell contact
(deflection increase of the cantilever) could be observed. Henceforth, the height of
the z-piezo was set constant and the pushing forces of the swelling cell were
passively quantified using the Live Tracker function of the JPK SPM Control
software (v.5, JPK Instruments). When the pushing forces reached maximal
measurable values of the sensor consecutively, the amount of deflection had to be
manually reset by readjusting the alignment mirror (reallocation of laser spot on
the sensor). This resulted in a vast decline of the deflection data at certain times
(dashed lines in Supplementary Fig. 8d), however an effect on the following process
could not be observed. Measurements were continued until a rupture of the cellular
membrane occurred which was proven afterwards by both a fast breakdown of the
deflection data, as well as propidium iodide stainings (Sigma-Aldrich, c ≈ 1 µM).
To calculate the interior pressure of the cell, a phase contrast image of the
respective cell was taken directly after reaching the contact point. With this, the
contact area A of the cell could be extracted by thresholding the visible cell area and
the result was combined with the force F(t) of the deflection measurements to
generate the pressure value p(t)= F(t)/A.
Statistics and data analysis. For data analysis Prism 6 for Mac OS X (v. 6.0 h,
GraphPad Software, Inc.), origin (OriginPro8, OriginLab Corporation) and
MATLAB (v. R2008a/R2014a; The MathWorks, Inc.) were used.
Statistical analysis was performed with Prism 6 for Mac OS X. For all data sets
GAUSS distribution was verified with Shapiro-Wilk normality test if applicable and
significance proved by t-test or one-/two-way-ANOVA/ Bonferroni’s multiple
comparisons test (mean ± standard deviation (SD) or standard error of the mean
(SEM); *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001). For non-Gaussian
distributed data sets Mann-Whitney or Kruskal–Wallis/Dunn’s multiple
comparisons tests (*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001) were used.
Time-lapse analysis. To quantify the change of chromatin area and eccentricity
over the time course of NETosis an image segmentation script was developed in
Matlab (v. 2014a). Live-cell images generated by wide field fluorescence microscopy
were used for the quantification of the chromatin area. This area is a projected
chromatin area because it is derived from 2D images. CLSM derived time traces
were analyzed similarly and are shown for example in Fig. 1b.
For single cells, areas of high contrast (mainly at the edge between stained
regions and the background) were carved out, smoothed and filled to generate an
outlined image of each object that could be analyzed. Furthermore, total intensity
values were normalized to circumvent problems coming from background
fluctuations or different staining intensities. From the resulting area-time curves,
four characteristic time points were determined manually as shown in
Supplementary Fig. 3a: t1/start of P2: start of first chromatin area increase, tD: end
of uniform/isotropic area increase in P2, t2: maximal area in P2, t3/start of P3:
second start of increase in chromatin area. Hence, the duration of P1 (activation (0
min) to t1) and P2 (t1 to t3), as well as the diffusion coefficient of the expanding
chromatin in P2 (t1 to tD) were calculated. For determination of the diffusion
coefficient only cells of population 1 (t2 ≠ t3) were used (see Supplementary Fig. 3a).
Quantitative membrane and chromatin analysis (Fig. 6a–d) was based on the
same segmentation procedure and extended: For chromatin swelling analysis
(Fig. 6a), detected chromatin areas of each frame were binarized first and stacked to
produce the shown density plots. Moreover, each frame was divided in a grid of
15 × 15 pixel sized sub-windows and analyzed by measuring the average additional
or lost chromatin area per window resulting in a growth/shrinking vector for each
of these segments. The final vector plot results from averaging all frame vectors of a
respective segment. For membrane analysis (Fig. 6b–d), the position of the rupture
point was manually determined from the first frame after membrane burst and
then compared with the computed major axis of the fitted cell ellipsoid. Only cells
with a clear single rupture point were analyzed.
Pressure calculation. Swelling pressures values shown in Fig. 4d were calculated
by using an approach motivated by Mazumder et al.52 Here, Newtonian properties
of the swelling process were assumed and the Stokes-equation was used (effects of
inertia were expected to be negligible).
∇p tð Þ ¼ ηΔv tð Þ ð4Þ
In this case, p(t) describes the inherent pressure of the fluid/chromatin network,
η is the viscosity of the liquid and v(t) is the velocity field at time point t. The
physical problem was simplified in two different ways: First, a radial symmetric
force field was assumed ∇p % pR
" #
and secondly the resistance was assumed to be
dominated by viscous forces at the scale of interstices (pores) in the network, which
ultimately leads to ηΔv tð Þ % ηl2p
dR
dt with lp describing the average mesh size and R(t)
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the radius of the (chromatin) network. Consequently, it follows
p tð Þ # η R tð Þð Þ
l2p R tð Þð Þ
dR tð Þ
dt
R tð Þ: ð5Þ
The exact value of η(R(t)) is unknown. However, in previous studies the
viscosity of the nucleus of an eukaryotic cell before expansion was determined to be
η0= 0.1 Pa s52. It is also known that the viscosity of semiflexible polymer network
scales η(R) ~ 1/R3 with the overall radius R (correlated to the mesh size)69. This
relation and η0 were used to approximate η(R(t)). Furthermore, to approximate the
average mesh size lp(R), a single DNA strain (L ≈ 2 m, d ≈ 2.2 nm) was arranged
into a cubic lattice inside a sphere with a radius R(t). R(t) was measured in the
time-lapse movies exemplarily shown in Supplementary Movie 2 using




) and dR tð Þdt was calculated by fitting the two dimensional diffusion




















¼ R2t to the chromatin data between
R(t1) to R(tD) and R(tD) to R(t2) and extracting the resulting slope.
Code availability. All Matlab codes used to analyze data are available from the
corresponding authors upon request.
Data availability
Data supporting the findings of this manuscript are available from the corresponding
authors upon request.
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2.2 Supplementary information, manuscript I 
Supplementary Movies 
(All movies can be found as an attachment to this thesis in form of a DVD) 
 
Supp. movie 1: Time-lapse confocal laser scanning microscopy (CLSM) movie of human 
neutrophils undergoing NETosis stimulated with 100 nM PMA. Cells are 
stained for chromatin (blue, Hoechst 33342) and membrane (red, PKH26). 
Supp. movie 2: Neutrophil during PMA-induced NET formation (example cell in Fig. 1a 
and 1b). 
Supp. movie 3: Time-lapse movie of chromatin decondensation of human neutrophils 
observed with conventional fluorescence microscopy during PMA-induced 
NET formation. Chromatin stained by Hoechst 33342. 
Supp. movie 4: Example cell 1 of Supp. movie 3. 
Supp. movie 5: Example cell 2 of Supp. movie 3. 
Supp. movie 6: Example cell 3 of Supp. movie 3. 
Supp. movie 7: Time-lapse movie of chromatin decondensation of neutrophils activated to 
undergo NET formation by PMA (100 nM) (left), LPS (25 µg ml-1, middle) or 
CaI (4 µM, right), respectively. Chromatin stained by Hoechst 33342. 
Supp. movie 8: Time-lapse 3D-CLSM movie of human neutrophils undergoing NETosis 
stimulated by 100 nM PMA. Cells are stained for chromatin (blue, Hoechst 
33342) and membrane (red, PKH26). z-Stack-depth = 1 µm, 10 minutes/ 
frame. 
Supp. movie 9: Reflection interference contrast microscopy (RICM) time-lapse movie on a 
glass substrate (Supp. fig. 4c). Neutrophils are activated with 100 nM PMA. 
Supp. movie 10: RICM-time-lapse movie on an ibidi treat substrate (surface equal to CLSM 
time-lapse movies). Neutrophils are activated with 100 nM PMA. 
Supp. movie 11: RICM-time-lapse movie on an ibidi treat substrate coated with Poly-L-lysine 
(PLL). Neutrophils are activated with 100 nM PMA. 
Supp. movie 12:  Time-lapse movie of chromatin decondensation of neutrophils activated to 
undergo NET formation by PMA (100 nM) at 23.5°C (left), 37°C (middle) or 
40°C (right), respectively. Chromatin stained by Hoechst 33342.  
Supp. movie 13-15: Example cells 1-3 in Fig. 2d (cells from Supp. movie 1). 
Supp. movie 16: Time-lapse movie of a typical height (left) and stiffness map (right) during 
life cell AFM measurement. The raw data of the marked pixel (force curve) 
is shown below for each frame. 
Supp. movie 17: Time-lapse movie of chromatin decondensation during PMA-induced NET 
formation on a poly(L-lysine)-graft-poly(ethylene glycol) (PLL-g-PEG) coated 
ibidi treat substrate (right) in comparison to only ibidi treat (left, 









Supplementary	 fig.	 1:	 Eccentricity	of	 chromatin	during	NETosis.	Chromatin	rounds	up	during	Phase	1	and	2	
and	reaches	maximal	circularity	(minimal	eccentricity)	exactly	before	NET	release	(t3).	a,	Eccentricity	over	time	
displayed	 for	 the	 example	 cell	 of	 Fig.	 1b	 (Supplementary	 movie	 2).	 b,	 Comparison	 of	 the	 eccentricity	 at	
different	time	points	(t1,	t2,	t3)	for	in	total	139	cells	of	five	donors.		
	













t2	 cannot	be	defined	 for	 this	population	 (cell	2).	Cell	1,	3	and	4	 represent	 cells	of	population	1	and	cell	2	of	
population	2.	Therefore,	only	population	1	(>	90	%	of	cells)	has	been	used	to	analyze	the	correlation	between	
cell	 area	 at	 rupture/pressure	 P	 at	 t2	 and	 the	 time	 between	 t2	 and	 t3	 (rupture	 delay	 time)	 (Fig.	 4a,	 d).	 The	
diffusion	coefficient	shown	in	Supplementary	fig.	S8a	is	calculated	based	on	the	slope	of	the	linear	fit	from	t1	
to	 tD.	Mean	 ±	 SEM.	 c,	Distribution	 of	 the	 time	 points	 t1,	 t2	 and	 t3	 of	 all	 cells	 of	 five	 individual	 experiments	

















Supplementary	 fig.	 4:	 Membrane	 rearrangement	 during	 NETosis.	 a,	 CLSM	 images	 of	 a	 human	 neutrophil	






human	 neutrophils	 undergoing	 PMA-induced	 NET	 formation	 recorded	with	 real-time	 reflection	 interference	
contrast	microscopy	(RICM)	on	glass.	Images	allow	the	label-free	analysis	of	the	cell/surface	contact	area	(black	
=	cell	closer	to	the	surface,	white	=	further	away	from	the	surface).	During	NETosis,	the	cells	round	up,	 leave	
membrane	 closely	 bound	 to	 the	 substrate	 behind	 (arrows,	 t	 =	 90	 min)	 and	 expel	 the	 NET	 (see	 also	








lamin	 B1	 (green)	 of	 unstimulated	 and	 NETotic	 human	 neutrophil	 (CLSM,	 fixed	 samples).	 Average	 chromatin	
area	at	rupture	point	of	the	surrounding	lamin	B1	(t1)	is	41.9	±	6.3	µm
2	(n	=	26	cells	from	two	donors)	and	in	
good	 agreement	with	 the	 chromatin	 area	 at	 t1	 determined	 during	 live	 cell	 imaging	 (Fig.	 1a,	 b).	 At	 this	 time	
point,	 the	 nuclear	 envelope	 rupture	 events	 increase	 (t1/start	 P2)	 until	 a	 high	 rate	 of	 rupture	 events	 (small	






sodium	 azide	 (NaN3)	 on	 PMA	 (100	 nM)-induced	 ROS	 production	 of	 human	 neutrophils	 determined	 by	
chemiluminescence	of	 luminol.	NaN3	inhibits	ROS	directly	after	addition	and	enables	a	stable	 inhibition	for	at	
least	30	min,	as	shown	in	Supplementary	fig.	9c.	Experimental	setup	comparable	with	the	setup	used	for	the	
experiments	shown	 in	Fig.	 3b.	N	=	1	 (triplicates).	Mean	±	SD.	b,	ATP	 levels	of	unstimulated	neutrophils	after	
incubation	 with	 5	mM	 2-Deoxy-glucose	 (2-Deox-Gluc)	 for	 different	 time	 intervals.	 2-Deox-Gluc	 reduces	 ATP	
levels	already	after	short	incubation	and	significantly	after	more	than	60	min	compared	to	untreated	cells	(t	=	0	
min).	 Statistics:	 One-way	 ANOVA	 (Bonferroni’s	 multiple	 comparison	 test,	 **p<0.01,	 ***p	 <	 0.001,	 ****p	 <	
0.0001).	N	=	3.	Mean	±	SEM.	c,	ATP	levels	of	PMA	(100	nM)-stimulated	neutrophils	with	and	without	incubation	

































of	 chromatin	 expansion	 in	 P2	 (t1	to	 tD)	 at	 different	 temperatures	 (Median:	 23.5°C	 =	 0.0047	 µm





STED	 images	 of	 living	 neutrophils	 during	 PMA-induced	NET	 formation	 (z-direction:	 around	 2-4	 µm	 from	 the	















Supplementary	 fig.	 9:	 Influence	 of	 the	 cytoskeleton:	 	 a,	 Quantification	 of	 F-Actin	 disassembly.	 The	 mean	
fluorescence	 intensity	 of	 F-actin	 decreases	 with	 time	 during	 NETosis.	 At	 the	 same	 time	 the	 heterogeneity	
decreases,	 which	 is	 a	 measure	 for	 F-actin	 structure	 and	 not	 biased	 by	 bleaching.	 Thus,	 F-actin	 gets	
disassembled	 during	 NETosis.	 N	 =	 1	 donor,	 data	 fitted	with	 95%	 confidence	 ellipse.	b,	NET	 formation	 after	
treatment	 with	 Docetaxel	 (100	 nM,	 inhibition	 of	 tubulin	 depolymerization)	 at	 different	 time	 points	 after	
induction	 of	 NETosis	 with	 PMA.	 Docetaxel	 shows	 no	 influence	 on	 NET	 formation	 (measured	 as	 %-relative	
number	decondensed	nuclei	after	180	min	compared	to	exclusive	activation	with	PMA).	n	=	3.	Mean	±	SEM.	ns	
=	 not	 significant.	 Statistics:	 One-way	 ANOVA	 (Bonferroni’s	 multiple	 comparison	 test)	 c,	 Influence	 of	 actin	
cytoskeletal	 inhibition	 on	 PMA	 (100	 nM)-induced	 ROS	 production	 of	 human	 neutrophils	 determined	 by	 the	
chemiluminescence	of	luminol.	Latrunculin	A	(violet)	increases	ROS,	while	Cytochalasin	D	(violet)	and	Y-27632	
(red)	have	no	or	only	slight	effects	on	ROS	production	in	the	concentrations	used	for	the	experiments	shown	in	
Fig.	 5b,	 c.	 In	 contrast,	 Jasplakinolde	 (yellow)	 shows	 a	 strong	 inhibitory	 effect.	 As	 controls,	 the	ROS	 levels	 of	























































incubated	 over	 night	 with	 5	 µg	 ml-1	 GP1bα	 (R&G	 Systems)	 at	 4°C.	 Then,	 the	 wells	 were	
washed	 with	 1x	 PBS	 followed	 by	 blocking	 with	 3%	 BSA	 (Roth)	 for	 2	 h	 at	 37°C	 and	 an	
additionally	washing	step.	
For	 Poly-L-lysine	 hydrobromide	 (PLL,	 Sigma-Aldrich)	 and	 poly(L-lysine)-graft-poly(ethylene	
glycol)	 (PLL-g-PEG,	 SuSoS	 AG)	 coating,	 96-glassbottom-well-plates	 were	 incubated	 either	
with	0.5	mg	mL-1	 PLL	 in	10	nM	HEPES	or	0.5	mg	mL-1	 PLL-g-PEG	 in	10	nM	HEPES	at	 room	














(100	 nM).	 Then,	 cells	were	 fixed	with	 2%	 PFA	 final	 concentration.	 Subsequently,	 the	 cells	
were	 stained	with	Hoechst	 and	 the	 amount	 of	 remaining	 cells	 calculated	 relatively	 to	 the	
glass	 sample	 using	 ImageJ	 (six	 images/well	 counted	 in	 defined	 regions,	 counting	 blinded).	
Representative	RICM	images	of	 the	 fixed	samples	were	recorded	 in	the	setup	described	 in	
the	section	Reflection	Interference	Contrast	Microscopy	(RICM)	in	Methods.	
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For time-lapse observations, 4 x 105 cell per ml were seeded in an ibidi treat flow chamber 
coated with PLL-g-PEG and the movie recorded as described in the section Live Cell Imaging” 
in Methods. 
 
Reflection Interference Contrast Microscopy (RICM) 
For RICM, ibidi treated petri dishes (Ibidi GmbH) with a 35 mm radius glass bottom (81158, 
ibidi) or ibidi treat flow chambers uncoated or coated with PLL were used. 100 000 
neutrophils per petri dish or 4 x 105 cells per ml per flow chamber were seeded and stained 
with Hoechst. The microscope setup contained a heating chamber (ibidi heating system, ibidi 
GmbH) on top of the microscope stage (Axiovert 200, Zeiss) and the temperature was 
adjusted to 37 C° for all experiments. NETosis was induced by 100 nM PMA. Time-lapse 
movies were recorded (1 frame per min) 63x magnified (EC Plan-Neofluar Ph3 
objective/420481-9911-000, 1.6x Optovar, Zeiss) for both DAPI as well as RICM images. 
Samples were illuminated by a XCite Series 120Q or HBO 100 (1007-980, Zeiss) lamp 
together with a respective DAPI (Filter set 02 shift free/488002-9901-000, Zeiss) or RICM 
filter set (reflector module Pol ACR P&Cfor HBO 100/424924-9901-000, emission filter 416 
LP, AHF-Nr.: F76-416/000000-1370-927, Zeiss) and observed with a Zyla SCMOS camera 
(AndorZyla 5.5) using Micro Manager software (v.1.4) or a CoolSNAP ES camera 
(Photometrics) using the software Metamorph 6.3r2. (Molecular Devices Inc.). Subsequently, 
the image contrast was adjusted with ImageJ. 
 
ATP measurements/ 2-Deox-Gluc 
Fresh isolated human neutrophils (10 000 per well in RPMI (10 mM HEPES, 0.5% HSA, 
without phenolred) were seeded in white 96-well-plates and metabolic activity inhibited by 
adding 5 mM 2-Deox-Gluc for defined time periods at 37°C (5 min, 15 min, 30 min, 60 min, 
90 min and 120 min). Simultaneously, cells were activated with PMA in a final concentration 
of 100 nM or left untreated. After incubation the ATP amount was measured as described in 
the section ATP measurements in Methods. All experiments were carried out in triplicates 
and ATP levels were calculated relatively to the ATP amount of unstimulated cells incubated 
for 120 min without addition of 2-Deox-Gluc. 
 
MPO activity 
The activity of MPO was measured with the myeloperoxidase chlorination fluorometric assay 
kit from Cayman chemical following the company’s instructions. To prove the inhibitory 
effect of 100 µM 4-ABAH on MPO, two different setups were used. First, the effect on 
purified MPO supplied by the company was studied in presents or absents of 4-ABAH. The 
activity of MPO was determined by the formation of fluorescein (Thermo Scientific 
APPLISKAN®, Software: Skanlt RE for Appliskan 2.3, Thermo Fisher Scientific) at 485 nm/535 
nm over 29.5 min (frame rate: 1.5 min) at room temperature. All experiments were 
performed in triplicates. Second, human neutrophils (1 000 000 per well in RPMI (10 mM 
HEPES, 0.5% HSA)) were seeded in 24-well plates and activated with 100 nM PMA in the 
presents or absents of 4-ABAH for 15 min or 30 min at 37°C, respectively. After incubation, 
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the culture medium was removed and cells were washed with 1x PBS. Then, the cells were 
scraped from the plate and pelleted by 1000 g for 10 min at 4°C. Cell lysis was induced by 
ultra shall sonication in combination with freeze-thraw cycles. After lysis, cell remnants were 
removed by centrifugation at 10 000 g for 10 min at 4°C and MPO activity in the supernatant 
was determined as described above. For all conditions the change in fluorescence signal 
between 1 min and 29.5 min was determined and the relative MPO activity was calculated 
between 4-ABAH treated and untreated cells.  
 
Reactive oxygen species (ROS) measurement 
Fresh isolated human neutrophils (10 000 per well in HBSS (10 mM HEPES, without 
phenolred) were seeded in white 96-well-plates (Greiner bio-one) at 37°C. After seeding, 
luminol (Sigma-Aldrich) was added at a final concentration of 60 µM and actin cytoskeletal 
components were inhibited by Cytochalasin D (100 nM), Latrunculin A (1 µM), Jasplakinolide 
(10 µM) or Y-27632 (19.2 µM) respectively. Directly after addition of inhibitors, NETosis was 
activated with 100 nM PMA and the luminescence was measured (GLOMAX® 96 Microplate 
Luminometer, Software: GLOMAX 1.9.3, Turner BioSystems) at room temperature (frame 
rate: 1 min). As controls the change in luminescence signal was recorded for unstimulated 
cells, cells treated with the maximal solvent concentration of 1% DMSO (used in 
Japlakinolide studies) and cells which were inhibited with 3 mM NaN3. All experiments were 
carried out in triplicates and the luminescence signal was determined relatively to ROS levels 
after exclusive PMA activation.   
For evaluation of NaN3 activity, cells were seeded (90 000 per well) and activated as 
described above. NaN3 (3 mM) was added 5 min after activation with PMA and the change in 
the luminescence signal was continuously recorded. 
 
Cell toxicity 
Cell toxicity of cytoskeletal and metabolic inhibitors was measured by the release of 
lactatdehydrogenase (LDH) with the CytoTox 96® Non Radioactive Cytotoxicity Assay 
(Promega) as instructed by the company. By analogy with the assays described in the section 
Inhibitor Experiments in Methods, 10 000 cells were seeded in plastic 96-well plates (Greiner 
bio-one) and incubated in RPMI (10 mM HEPES, 0.5% HSA, without phenolred) with 
Cytochalasin D (100 nM), Latrunculin A (1 µM), Docetaxel (100 nM), Jasplakinolide (10 µM), 
Y-27632 (19.2 µM), 2-Deox-Gluc (5 mM), NaN3 (3 mM), 4-ABAH (100 µM), DMSO (1%) or 
only culture medium for 3 hours at 37°C. The released LDH was measured in the supernatant 
as described in the assay protocol and cell toxicity was calculated relatively to maximal cell 
lysis. 
 
Uptake of particles 
Fresh isolated human neutrophils (100 000 per well in RPMI (10 mM HEPES, 0.5% HSA) were 
seeded on pretreated (99% alcohol) glass cover slips (#1.5) in 24-well plates followed by pre-
incubation for 30 min with or without 2-Deox-Gluc (5 mM), NaN3 (3 mM) or 4-ABAH (100 
µM), respectively. Then, cells were further incubated with fluorescein-labeled Escherichia 
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coli (K-12 strain) BioParticles® (0.1 mg ml-1, VybrantTMPhagocytosis Assay Kit (V-6694), 
Thermo Fisher Scientific) in presents of 2-Deox-Gluc (5 mM), NaN3 (3 mM) or 4-ABAH (100 
µM) and incubated for additionally 30 min. For fixation, 2% PFA final concentration was 
added and samples then stored after washing with 1x PBS. Cells were stained as described in 
the section Staining Procedure in Methods for F-actin and chromatin with Phalloidin 
(PromoFlpur-555P, PromoKine) and Hoechst directly after blocking. For each condition the 
particle uptake was analyzed manually by 3D confocal laser scanning microscopy (60x 
magnified, Olympus IX83 inverted microscope, software: Olympus Fluoview v.4.2) and the 
percentage of particle uptake calculated relatively to the total cell count of 60 cells per 
condition.  
 
Quantification of fluorescence imaging  
For the quantification of Lamin B1 rupture, the rupture of the nuclear envelope was 
determined for different time points after induction of NETosis with PMA. Therefore, cells 
were stained for Lamin B1 and Chromatin as described in the section Staining Procedure in 
Methods and the nuclear envelope rupture was analyzed manually by 3D confocal laser 
scanning microscopy (60x magnified, Olympus IX83 inverted microscope, software: Olympus 
Fluoview v.4.2). For each condition the loss of the nuclear envelope (small rupture up to 
complete loss) was determined for 100 cells and calculated relatively to the total cell count. 
 
Similarly, to quantify the loss of actin within phase 1, CLSM images of stained F-actin areas of 
fixed cells (exemplarily shown in Fig. 5a) where analyzed using the ImageJ thresholding 
plugin. More precisely, within all pictures, the F-actin area of individual cells were 
segmented first (Yen thresholding method) and the intensity values of the enclosed actin 
area was averaged to obtain both, a mean intensity value as well as a number for the 
intensity variation within the respective area (standard deviation). Both values were plotted 
to visualize the correlation between the amount and the homogeneity of actin within P1 and 
a 95% confidence ellipse was drawn.  
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The formation of neutrophil extracellular traps (NETs) is an immune defense mechanism
of neutrophilic granulocytes. Moreover, it is also involved in the pathogenesis of
autoimmune, inflammatory, and neoplastic diseases. For that reason, the process of
NET formation (NETosis) is subject of intense ongoing research. In vitro approaches
to quantify NET formation are commonly used and involve neutrophil stimulation with
various activators such as phorbol 12-myristate 13-acetate (PMA), lipopolysaccharides
(LPS), or calcium ionophores (CaI). However, the experimental conditions of these
experiments, particularly the media and media supplements employed by different
research groups, vary considerably, rendering comparisons of results difficult. Here, we
present the first standardized investigation of the influence of different media supplements
on NET formation in vitro. The addition of heat-inactivated (hi) fetal calf serum (FCS),
0.5% human serum albumin (HSA), or 0.5% bovine serum albumin (BSA) efficiently
prevented NET formation of human neutrophils following stimulation with LPS and CaI,
but not after stimulation with PMA. Thus, serum components such as HSA, BSA and
hiFCS (at concentrations typically found in the literature) inhibit NET formation to different
degrees, depending on the NETosis inducer used. In contrast, in murine neutrophils,
NETosis was inhibited by FCS and BSA, regardless of the inducer employed. This shows
that mouse and human neutrophils have different susceptibilities toward the inhibition
of NETosis by albumin or serum components. Furthermore, we provide experimental
evidence that albumin inhibits NETosis by scavenging activators such as LPS. We also
put our results into the context of media supplements most commonly used in NET
research. In experiments with human neutrophils, either FCS (0.5–10%), heat-inactivated
(hiFCS, 0.1–10%) or human serum albumin (HSA, 0.05–2%) was commonly added to
the medium. For murine neutrophils, serum-free medium was used in most cases for
stimulation with LPS and CaI, reflecting the different sensitivities of human and murine
neutrophils to media supplements. Thus, the choice of media supplements greatly
determines the outcome of experiments on NET-formation, which must be taken into
account in NETosis research.
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INTRODUCTION
The discovery of neutrophil extracellular traps (NETs) in 2004
(1) marked the beginning of an impressive scientific career
of these extracellular DNA meshworks. NETs are expelled by
neutrophilic granulocytes under certain (patho) physiological
conditions. Different signaling pathways and forms of NET
formation have been described in the last years (2, 3). In
most studied scenarios, the cells release the NET consisting of
decondensed chromatin, decorated with antimicrobial peptides
and, most likely, a plethora of cytokines and other proteins.
This release occurs after the rupture of the cell membrane into
the extracellular space, ultimately leaving the neutrophil to die.
This pathway has been called “NETosis” or “suicidal NETosis”
(4), in analogy to previously known cell death pathways such
as apoptosis and necrosis. In contrast, some publications have
also described a faster, different form of NET formation mainly
in response to bacteria which leaves the neutrophil alive and
functional (“vital NETosis” or “vital NET formation”) (5). It
remains a matter of debate whether these phenotypes are truly
distinct biological processes.
While originally described as a novel immune defense
mechanism to trap and kill pathogens like bacterial, fungi and
even viruses, it has become increasingly clear that the role of
NETs goes far beyond these initial discoveries. Indeed, excessive
NET production or a dysregulation of NET clearance have been
negatively implicated in an ever growing number of diseases,
many of them associated with considerable morbidity and
socioeconomic impact such as chronic inflammatory diseases
like rheumatoid arthritis (6), systemic lupus erythematosus
(7), chronic obstructive pulmonary disease (COPD) (8, 9) and
psoriasis (10, 11), ischemia-reperfusion injury after myocardial
infarction (12), thrombosis (13), impaired wound healing (14),
preeclampsia (15), and cancer (16, 17). Therefore, it is not
surprising that publications involving NETs have increased
exponentially within the last couple of years and reliable methods
to study NET formation are highly desired.
Initially, reports of NETs as contributors to different
diseases relied mainly on the ex vivo detection of NETs
and NET-related proteins by immunofluorescence and
immunohistochemistry protocols in affected tissues. More
recently, real-time observations of NETs forming in vivo,
published in several very sophisticated mouse models, has led to
great advances of our understanding of NETs and their role in
different diseases. Similarly, flow cytometry-based protocols as a
means for detecting NETs in blood from mice or humans have
facilitated the screening for NET production in full blood under
different pathological conditions (18, 19).
Nevertheless, in vivo models possess a high level of
complexity, which does not allow the assessment of inhibitors
and activators of NETosis in a high-throughput fashion and
in a well-defined setting. Additionally, observing NETosis on a
single-cell level remains very challenging in any in vivo setting.
For example, testing the isolated influence of different stimuli
such as bacterial proteins or inhibitors of certain neutrophilic
enzymes on NETosis is hardly feasible in vivo; more so, if
one aims to determine at which time-point of NETosis these
activators or inhibitors play a role (20). Finally, in vivo studies
(apart from the ex vivo assessment of existing NETs in peripheral
blood by flow cytometry) are strictly limited to animal models.
Currently it is not possible to determine whether neutrophils
from patients with certain diseases show a greater propensity
for NETosis unless one isolates neutrophils from these patients
and stimulates them ex vivo. For these reasons, NET research
heavily relies on the isolation of fresh neutrophils from donors
and their ex vivo stimulation. Indeed, as of today, the isolation of
neutrophils from patients, healthy donors, or animals followed
by an ex vivo stimulation of these cells to assess and quantify
NET formation is what may be called the gold standard of
NET-experiments.
Considering the importance of this method for the whole
field of neutrophil biology and the ever-growing number of
laboratories performing NET studies, it is alarming to note that
experimental conditions under which NETosis experiments are
performed vary fundamentally from lab to lab, sometimes from
publication to publication in the same group and occasionally
even from assay to assay, rendering any comparison of research
results nearly impossible. Looney at al. showed early on that
the production of NETs by mice depend strongly on exterior
influences on the mice. This group was one of the first to perform
systematic NETosis experiments, in the context of transfusion-
related acute lung injury (TRALI) (21, 22). Relocation of the
mouse colony to a housing facility with a stronger barrier and
less exposure of the mice to pathogens led to the inability of the
group to repeat their own experiments—presumably, neutrophils
from the new group of mice were not sufficiently pre-stimulated
anymore. Only after exposure of the mice to low amounts of
LPS prior to the experiments was the group able to recapitulate
their previous results. This very instructive example shows how
vulnerable NETosis is to external influences. One would expect
neutrophils to be similarly or even more susceptible to variations
of experimental conditions. Neutrophils are sensitive to subtle
changes in the density and type of surface receptors (23),
ranging from different methods of neutrophils isolation (24),
type of activator used for the ex vivo stimulation of neutrophils
[for a comprehensive review on activators of NETosis see also
(25)] and kind of culture medium used to incubate neutrophils
during NETosis. In human experiments, supplements added
to culture media typically vary from no supplement to heat
inactivated FCS (0.05 to 10% or 0.1 to 10%) and human serum
albumin (HSA; 0.05 to 2 %), yet other supplements such as
(heat inactivated) human plasma, (heat inactivated) human
serum, and BSA can also be found at variable concentration
(Supplementary Table 1, Figure 5). For murine neutrophils, the
most frequently used supplements are FCS and BSA, though
some activators of NETosis such as CaI and LPS are largely being
studied in serum-free medium. These differences may greatly
influence the outcome of NET-experiments, as albuminmay bind
proteins like lipopolysaccharides (LPS) (26, 27). Furthermore,
an effect of supplements on in vitro NET formation has been
considered from several groups. For instance, an inhibition of
NET-formation was seen at very high FCS concentrations under
Phorbol-12-myristate-13-acetate (PMA) in a dose-dependent
way (4). Another group observed more cells involved in
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NET formation in serum-free medium after stimulation with
nanoparticles (28), while others reported decreased NET-rates in
HSA-containing media and pointed out, that a harmonization
of culture conditions is still pending (4, 28, 29). Furthermore,
it has been shown that serum-free culture conditions may allow
a certain degree of spontaneous NET formation (30). Here, we
selected the most commonly used supplements and analyzed the
effect of their addition or omission on (suicidal) NETosis in
a standardized setup. Additionally, we systematically compared
media supplements for in vitro NETosis experiments in use in
the literature.
MATERIALS AND METHODS
Isolation of Human Neutrophils
Human neutrophils were isolated from venous blood of healthy
donors. For all human studies, a pool of 15 healthy donors was
available. For all experiments with human neutrophils, blood
from at least 3 different donors from this pool was collected
to isolate neutrophils. This study was carried out in accordance
with the recommendations and with the approval of the Medical
Ethics Committee of the University Medical Center Göttingen
(UMG), protocol number 29/1/17 with written informed consent
from all subjects and in accordance with the Declaration of
Helsinki.
The isolation was performed under sterile conditions
based on previously published protocols (31) using gradient
centrifugation. In brief, fresh blood of healthy donors was
collected in S-Monovettes EDTA (7.5ml, Sarstedt) and
immediately layered in a ratio of 1 to 1 on top of Histopaque
1119 (Sigma Aldrich). After centrifugation and washing with
HBSS (without Ca2+/Mg2+) (Lonza) cells were separated a
second time on a gradient consisting of 65, 70, 75, 80, and 85%
of 10:1 diluted Percoll (GE Healthcare). Then, cells were washed
and resuspended in 1ml HBSS without Ca2+/Mg2+. Cellular
identity and a purity of the isolated cells of >95% was confirmed
by cytospin (Cytospin 2 Zentrifuge, Shanson) followed by Diff
Quick staining (Medion Diagnostics).
Isolation of Mouse Neutrophils
Mouse neutrophils were isolated from 6 to 10-week-old wild
type C57BL/6J mice (male and female mice, equally distributed
between groups). The blood was collected from the retroorbital
venous plexus under full anesthesia with isoflurane and collected
into the 15mM EDTA (Gibco) containing BSA/PBS-solution.
The isolation was performed according to previously published
standard protocols (32, 33). After centrifugation, the cells were
layered on top of a 10:1-diluted percoll gradient consisting of 78,
69, and 52% layers in PBS. Afterwards, erythrocytes were lysed
with deionized water followed by a washing-step. Then, cells were
resuspended in HBSS and cellular identity as well as purity>95%
were confirmed as described above.
Stimulation Assay
Freshly isolated human or murine neutrophils were counted
and suspended in RPMI 1640 (Lonza) containing 10mM
HEPES (Roth) (RPMI/HEPES) and 0.5% HSA (Sigma-Aldrich),
0.5%/1%/2% FCS (Biochrom GmbH, Merck Millipore) or 0.5%
BSA (Roth), respectively. FCS was heat inactivated at 56◦C
(Thermostat plus, Eppendorf, Hamburg) for 30min before
use. 10,000 cells per well were seeded in 96-glassbottom-well-
plates (in vitro scientific) for 30min (37◦C, 5% CO2) and
stimulated to undergo NET formation with either LPS from
Pseudomonas aeruginosa (Sigma-Aldrich) at 10, 25, or 100µg/ml,
CaI (Sigma-Aldrich) at 4µM, or PMA (Sigma-Aldrich) at
100 nM. After an incubation time of 3 h, cells were fixed with
2% PFA (Roth) to end NET formation and stored over night
at 4◦C. The fixed samples were washed with PBS (Sigma-
Aldrich) and stained with 1.62µM Hoechst (Sigma-Aldrich)
for 15min at room temperature. After staining, cells were
washed and imaged by fluorescence microscopy (Axiovert 200,
Zeiss; software: Metamorph 6.3r2., Molecular Devices) with the
camera CoolSNAP ES (Photometrics). For each well, in total
5–6 images of clearly defined regions were obtained blinded
in an automated fashion. For all experiments, the number of
decondensed nuclei and the total cell counts were assessed
using ImageJ (https://imagej.nih.gov/ij/download.html) and the
percentage of decondensed nuclei/ NETs calculated by Excel
(version: 14.3.0; Microsoft corporation).
Immunofluorescence Staining
Human neutrophils were isolated, seeded (200,000/well) in 24-
well plates on glass coverslips and activated to undergo NET
formation as described above. After fixation with 2 % PFA (Roth)
over night, cells were permeabilized 0.1 % TritonX (Merck) and
incubated with 5 % FCS (Biochrom) to block unspecific antibody
binding. Subsequently, cells were stained using monoclonal
anti-human MPO (IgG, mouse) as primary antibody (Abcam,
ab25989, 1:500) and polyclonal anti-mouse Alexa 555 (IgG,
goat) as secondary antibody (Life technologies, A21422, 1:2000).
Neutrophil DNA was stained with 1.62µM Hoechst (Sigma-
Aldrich) as described above. After the staining procedure,
cells were stored protected from light at 4◦C. Representative
confocal fluorescence images were obtained with the olympus
IX83 inverted microscope (software: Olympus Fluoview Ver.4.2,
Olympus) and recorded 60x magnified (UPlanSApo 1.35 oil,
Olympus). All pictures were recorded at equal exposure times for
MPO to ensure comparability.
Neutrophil Elastase NET Assays
1 × 106 human neutrophils in RMPI/HEPES with or without
0.5% HSA were seeded in 24-well-plates and stimulated with
LPS from Pseudomonas aeruginosa (100µg/ml), CaI (4µM) or
PMA (100 nM) for 2–3 h at 37◦C. Measurement of neutrophil
elastase (NE) bound to extracellular neutrophil chromatin was
carried out with the NETosis assays kit (Cayman) according to
the company’s instructions. In short, NETs were washed after
stimulation to remove unbound NE, chromatin was decomposed
by DNase and subsequently the activity of NE was measured
in the supernatant by formation of the 4-nitroaniline product
from a NE-substrate (N-methoxysuccinyl-Ala-Ala-Pro-Val p-
nitroanilide). Absorption of the resulting product was measured
at 405 nm (Thermo Scientific APPLISKAN R⃝ Software: Skanlt RE
for Appliskan 2.3, Thermo Fisher Scientific). All measurements
were carried out in duplicates.
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Anisotropy Measurements
Fluorescence anisotropy measurements were performed with
a Fluoromax-4 spectrofluorometer (Horiba Scientific). All
fluorescence emission spectra were recorded with excitation at
280 nm for BSA and 295 nm for HSA using excitation and
emission slit widths of 5 nm. Emission detection wavelength
was set at λem = 344 nm for BSA and λem = 350 nm for
HSA, integration time was 1 s and detection steps were 1 nm.
The cuvette used was a QS high precision cell (10x2m; Hellma
Analytics). First, anisotropy of 0.005% BSA, or 0.005% HSA
was monitored for 500 s. Then, 10, 25, or 100µg/ml LPS
from pseudomonas aeruginosa were added to 0.005% BSA or
0.005% HSA for another 500 s. The system was allowed to reach
equilibrium for 50 s.
Calcium Measurements
Calcium concentrations in presents or absence of 0.5%HSA were
determined in the medical laboratory of the University Medical
Center Göttingen using standard protocols.
Systematic Literature Review
For the literature review the online data base PubMed was used
with the search terms “Neutrophil extracellular trap,” “NETosis”
and “Neutrophil + NET” up to 1st of March 2018. We included
460 human and 108 murine in vitro NET studies published
after 2004 with full access to the PDF and written in English.
Reviews and exclusive in vivo studies were excluded. Moreover,
we included only studies performed on murine or human
neutrophils, not on other cell types, co-cultures, transfected
cells or cell lines. This study required unequivocal primary
information on the used medium and the performed stimulation
method to be included in this work (Supplementary Figure 1).
For comparison of spontaneous NET formation in serum-free
culture conditions, we analyzed all human in vitro NET studies
performed with neutrophils from healthy donors in media
without addition of solvents or stimuli that reported relative
spontaneous NETosis rates (29 out of 255 publications).
Statistics and Data Analysis
All statistics were calculated with GraphPad Prism (Version 6.0,
GraphPad Software Inc.). Significance was tested using standard
two-way-ANOVA with Bonferroni’s multiple comparisons test
(ns, not significant; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p <
0.0001), after testing for normal distribution, where applicable.
Fluorescence images were processed with ImageJ.46r (National
Institutes of Health) and all cell counts obtained using the Plugin
“Cell Counter”.
RESULTS
Albumin and Serum Inhibit CaI- and LPS-,
but Not PMA-Induced NETosis in Human
Neutrophils
In the first series of experiments, we determined whether
the different medium supplements have an influence on NET
formation in vitro. To this end, we tested the frequently used
supplements BSA, HSA and (hi)FCS at different concentrations
on human neutrophils, taking into account the most commonly
used concentrations in the literature (Supplementary Table 1).
Firstly, we added FCS which had been heat-inactivated at
56◦C (56◦C hiFCS) to avoid side effects and degradation by
serum nucleases, which is the most commonly applied manner
of heat-inactivation. In 2009, von Köckritz-Blickwede et al.
reported that even 56◦C hiFCS may still contain heat-stable
nucleases and recommended the use of FCS inactivated at
70◦C (34). Nonetheless, we did not observe any difference
in NETosis studied in 70◦C hiFCS compared to 56◦C hiFCS
on the results in our setup (data not shown) and therefore
decided for the more frequently used 56◦C hiFCS for this
study. We stimulated freshly isolated human neutrophils with
CaI at 4µM, PMA at 100 nM and LPS at 10µg/ml, 25µg/ml
and 100µg/ml to assess whether neutrophils stimulated by
different inducers of NETosis would react differently to themedia
supplements (Figure 1). The identity of NETs was confirmed by
co-staining of DNA and the neutrophil marker myeloperoxidase
(MPO) (Figure 2) as well as release of neutrophil elastase (NE)-
containing extracellular DNA (Supplementary Figure 2). The
decondensed DNA of neutrophils having undergone NETosis
in supplement-free RPMI/ HEPES clearly colocalized with
MPO in confocal microscopy images after stimulation with
CaI, PMA, or LPS. Furthermore, the NE-based NETosis assay
showed the release of DNA-bound NE into the extracellular
space after stimulation with the aforementioned stimuli, thus
corroborating the induction of NETs in our experimental
system.
We found that addition of BSA 0.5% as well as HSA 0.5%
to RPMI/ HEPES significantly inhibited spontaneous NETosis
and completely abolished NET formation mediated by CaI and
LPS at 10, 25, and 100µg/ml, whereas stimulation in pure
RPMI/ HEPES led to a robust induction of NETs (Figures 1A,B).
Interestingly, stimulation of neutrophils by 100 nM PMA was
not influenced by either BSA or HSA (Figures 1A,B). In line
with these observations, the release of DNA-bound NE after
stimulation with CaI or LPS (100µg/ml) was inhibited by
addition of 0.5% HSA, but was not reduced in response to PMA
(Supplementary Figure 2). Similarly, addition of hiFCS led to a
dose-dependent decrease of CaI-induced NET formation but did
not inhibit PMA-mediated NETosis (Figure 1C). Moreover, the
addition of hiFCS significantly inhibited LPS-induced NETosis
in a manner dependent on the concentration of both LPS
and hiFCS itself. When 10µg/ml LPS were used for the
induction of NETosis, 0.5% hiFCS were sufficient to reduce NET
formation dramatically from 95 to 5%. When 100µg/ml LPS
were employed, a significant reduction of NETosis to 22% could
only be reached by adding 2% hiFCS (Figure 1C).
Murine and Human Neutrophils React
Differently to Media Supplements
As many studies addressing NETosis are being conducted with
murine neutrophils (Supplementary Table 2), we also sought
to study whether media supplements such as FCS or BSA
would influence murine NETosis in a similar way as described
above for human neutrophils. Again, the three well established
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FIGURE 1 | Influence of serum and serum albumin supplements on NET formation of human neutrophils. (A) Representative fluorescence images of human
neutrophils (chromatin stained by Hoechst) after stimulation with CaI (4µM), PMA (100 nM), or LPS (25µg/ml) for 180min, respectively. NET formation of neutrophils
was studied in RPMI 1,640 with 10mM HEPES (RPMI/HEPES), RPMI/ HEPES + 0.5% human serum albumin (HSA) or + 1% heat inactivated (56◦C) fetal calf serum
(hiFCS). Chromatin decondensation induced by PMA is clearly visible with all three culture conditions, while LPS or CaI only cause NET formation in BSA- and
HSA-free RPMI/HEPES. Scale = 50µm. (B) Neutrophils were stimulated to undergo NET formation with CaI (4µM), PMA (100 nM) or LPS (10, 25, or 100µg/ml),
respectively. Both, HSA and BSA inhibit CaI and LPS-induced formation of NETs (determined as percentage of decondensed nuclei/NETs of total neutrophils). NETosis
stimulated by PMA is independent of serum albumin addition. Error bars = mean ± SEM. ns, not significant. *p < 0.05, ****p < 0.0001. N = 4–9 [pool = 15 donors,
6–9 (unstimulated), 4 (CaI, 25 and 100µg/ml LPS), 4–5 (10µg/ml LPS), 5–8 (PMA)]. Two-way-ANOVA, Bonferroni’s multiple comparisons test. (C) NET formation of
neutrophils stimulated in RPMI/ HEPES supplemented with 0.5, 1, or 2% heat inactivated (56◦C) fetal calf serum (hiFCS). Addition of hiFCS to RPMI/ HEPES
decreases the percentage of decondensed nuclei/NETs after stimulation by CaI or LPS in a dose-dependent manner. PMA-induced NET formation occurs
independently of FCS addition. Error bars = mean ± SEM. ns, not significant. *p < 0.05. ****p < 0.0001. N = 3–8 [pool = 15 donors, 5–8 (unstimulated), 3–5
(100µg/ml LPS), 4–5 (PMA, CaI, 10 and 25µg/ml LPS)]. Two-way-ANOVA, Bonferroni’s multiple comparisons test.
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FIGURE 2 | Extracellular NETotic DNA is rich in MPO. Representative fluorescence images of NETs induced by CaI (4µM), PMA (100 nM), or LPS (25µg/ml) activated
in supplement-free RPMI/HEPES. The images show a clear colocalization of MPO (red) with the extracellular DNA-fibers (blue) of released NETs. Scale = 10µm.
NET-inducers, CaI, PMA and LPS were used (Figure 3). This
question was especially interesting in light of the fact that murine
studies typically forego the addition of media supplements for
selected stimuli as CaI and LPS, whereas human studies more
often include either albumin or serum in the media (see also
Figures 5, 6). While CaI was able to induce a strong response,
causing almost 100% of neutrophils to undergo NETosis, PMA
(at 100 nM) induced NETosis only in 28% of the neutrophils,
which is in line with published results from the literature (4).
Interestingly, the addition of 0.5% BSA or 2% 56◦C hiFCS
to RPMI/ HEPES was able to significantly inhibit both CaI-
and PMA-induced NET-formation, contrary to what we had
observed for human neutrophils. Similar results have been
published for PMA-induced NETosis of murine neutrophils
after the addition of hiFCS (4). For LPS from Pseudomonas
aeruginosa, a minimum concentration of 25µg/ml was needed
to induce significant NET formation in murine neutrophils
(23%) even without addition of media supplements. In general,
LPS-induced NET formation was lower compared to that of
human neutrophils at the same LPS concentration (Figure 3).
However, similar to human neutrophils, addition of 0.5%
BSA, or 2% hiFCS sufficed to completely inhibit LPS-induced
NETosis.
Human and Bovine Serum Albumin Bind
LPS From Pseudomonas aeruginosa
As bovine and human albumin diminished NET-formation in
most tested scenarios, we hypothesized that albumin, as part of its
action in our setup, may bind part of the activators and thus lower
their biologically active concentration. Indeed, it has already been
shown that CaI binds to albumin (35, 36) and it appears likely that
a similar mechanism exists for PMA.
To test the hypothesis that direct binding of activators
to albumin diminishes NETosis, we performed fluorescence
anisotropy measurements to quantify binding of LPS to albumin
as an example of such an interaction. Fluorescence anisotropy
measurements are a quantitative and standardized method to
determine interactions between proteins and binding partners
in solution (Figure 4). Solubilized albumin performs a certain
rotational movement, which results in the emission of a
fluorescence signal when the solution is excited by polarized
light. The binding of molecules such as LPS to BSA or HSA
causes this rotational diffusion to slow, which results in a
measurable increase of fluorescence anisotropy. We used a
concentration of 0.005% BSA (Figure 4A) or 0.005% HSA
(Figure 4B), respectively, in our experimental system and added
LPS at concentrations between 10 and 50µg/ml. We found a
dose-dependent increase of anisotropy with LPS, indicating that
both BSA and HSA do indeed bind LPS. Even at concentrations
of HSA and BSA that were lower than those used in our
NETosis experiments, a clear binding between partners could
be observed, which would be higher at higher HSA/BSA
concentrations. Consequently, the presence of albumins in
the medium, even at low concentrations, lowers the effective
concentration of LPS, which explains the inhibiting effect in
our in vitro setup. Due to the small size of PMA and CaI
similar measurements could not be performed but it is likely that
there is a similar binding as albumins are known to bind many
different molecules (37–39), among them CaI, as indicated above
(35, 36).
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FIGURE 3 | Influence of serum and serum albumin supplements on NET formation of murine neutrophils. (A) Representative fluorescence images of nuclei of murine
neutrophils (Hoechst) after stimulation with CaI (4µM), PMA (100 nM) or LPS (25µg/ml) for 180min, respectively. NET formation of neutrophils was studied in RPMI/
HEPES without supplements and RPMI/ HEPES supplemented with 0.5% BSA or 2% hiFCS, as indicated. Chromatin decondensation is only inducible in RPMI/
HEPES (white arrow heads). Scale = 50µm. (B) Percentage of decondensed nuclei/ NETs after stimulation with PMA (100 nM), CaI (4µM), or LPS (10, 25, or
100µg/ml) for 180min. Murine neutrophils were studied in RPMI/ HEPES and RPMI/ HEPES supplemented with 0.5% BSA or 2% hiFCS. Addition of 0.5% BSA or 2%
hiFCS to RPMI/ HEPES, inhibits chromatin decondensation induced by PMA, CaI and LPS completely. Error bars = mean ± SEM. ns = not significant. ****p < 0.0001.
N = 3–13 mice [3–13 (unstimulated), 3–5 (100µg/ml LPS), 3–4 (CaI, 10 and 25µg/ml LPS), 3–5 (PMA)]. two-way-ANOVA, Bonferroni’s multiple comparisons test.
Media Supplements Reveal Functional
Differences Between Human and Mouse
Neutrophils
We conducted a systematic literature research regarding human
and mouse experiments studying NETosis ex vivo/in vitro to
assess which supplements were commonly used by other groups
working in the NETosis field (Supplementary Figure 1). Media
supplements in studies dealing with human neutrophils (460
publications total) ranged from no supplement to FCS (0.05%
to 10%), hiFCS (0.1 to 10%), human plasma (HP, 3 to 100%),
hiHP (2 to 5%), human serum (HS, 0.2 to 100%), hiHS (0.1
to 100%) and serum albumin (HSA, 0.05 to 2%; BSA, 0.1
to 2%) (Supplementary Table 1). Ex vivo studies with murine
neutrophils (108 publications) were carried out in media without
supplements or medium supplemented with FCS (0.5 to 10%),
hiFCS (0.1 to 10%), mouse serum (MS, 1 to 100%), BSA (0.1–2%)
or in medium with HSA and bovine growth serum (BGS, 2%)
(Supplementary Table 2).
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FIGURE 4 | Binding of LPS to serum albumins. Box plots represent fluorescence anisotropy values for (A), bovine serum albumin (0.005%) and (B), human serum
albumin (0.005%) after addition of LPS from Pseudomonas aeruginosa at 10, 25, or 50µg/ml, as indicated. The anisotropy of albumin increases with higher LPS
concentrations. For each concentration, the average anisotropy value (monitored for 500s) between two LPS additions is shown. Box plots show 25 and 75 percentiles
with the midline as median, the square as arithmetic middle and crosses as 99%/1% values. Whiskers include all data points within the 1.5 interquartile range. N = 1.
Approximately half of the experiments in human (51 %)
and mouse (56 %) neutrophils were performed without any
supplement (Figures 5A, 6A) and the other half with very
heterogeneous supplements. Additionally, even within the group
that refrained from using media supplements, experimental
conditions were overall quite diverse, as different basal media and
different stimuli were used (see Supplementary Tables 1, 2).
As it is possible that the choice of media supplements is
influenced by the activator of NETosis, we also plotted our
extracted data into five groups according to the “major” NETosis
stimulants (PMA, LPS, ionophores/ionomycin, pathogens, and
cytokines/chemokines). Indeed, after this selection, certain
activator-specific characteristics became apparent, such as the
fact that for LPS, used in human studies, more than half of the
publications forewent the use of media supplements, while in the
publications using Ionophores or pathogens this approach was
less common. Interestingly, studies using pathogens or cytokines
and chemokines as inducers of NETosis generally showed
the highest use of human plasma at different concentrations
(Figure 5B).
In mice, the specific differences between experiments
performed with different inhibitors were even more striking.
While the use of PMA and pathogens led to a heterogeneous
picture relatively similar to that seen with human neutrophils,
LPS and ionophores were rarely or not at all employed in media-
containing supplements (Figure 6B).
These striking differences led us to propose that media
supplements might differentially influence different activators
of NETosis and might lead to different results in human or
mouse neutrophils. We would like to emphasize that in this
analysis we did not differentiate between “vital” and “suicidal”
NETosis and that we did not assess whether an assay successfully
caused NET release or not. We included all manuscripts which
clearly stated to study in vitro NETosis. Nonetheless, several
of the included publications reported problems or failure to
achieve a robust activation especially in media supplemented
with serum or serum albumin. For instance, Wang et al. did
not observe NETosis of TNFα-primed mouse neutrophils after
stimulation with 100 ng/ml LPS in media containing 0.5% BSA
and Papayannopoulos et al. clearly showed that peritoneal
mouse neutrophils did not respond to PMA (100 nM) in media
supplemented with 10 % FCS (40, 41). In ex vivo studies with
human neutrophils several groups reported no or only a slight
response to LPS in FCS containing media (Hoppenbrouwers
et al.: 10% FCS, 5µg/ml LPS; Barquero-Calvo et al.: 1% FCS, 0.7–
100µg/ml LPS; Hoffmann et al.: 2% FCS, 300 ng/ml LPS; Zhu et
al.: 4% hiFCS, around 10% activation with 100 ng/ml LPS) or BSA
(Ohbuchi et al.: 1% BSA, 10 ng−1µg/ml LPS) (25, 29, 42–44)
and Clark et al. did not observe any activation after stimulating
human neutrophils with 5µg/ml LPS in the presence of 10%
plasma (45). As the publication of negative data is relatively rare,
it is reasonable to assume the omission of media supplements
in over half of the publications here analyzed indirectly reflects
the difficulties of neutrophil stimulation in media containing
albumin or serum supplements, at least for certain stimuli. In
any case, the starting conditions of different studies are very
divergent, which makes the publications in the field virtually
impossible to compare, thus potentially diminishing the scientific
significance and making the overall picture difficult to interpret.
DISCUSSION
NETosis and NET-related topics are currently intensely
investigated topics with the number of publications steadily
rising for the last couple of years. Despite the attention that
the process of NETosis has attracted since its first publication
in 2004 (1), little effort has been put into the standardization
of experimental conditions for in vitro experiments. We are
therefore advocating a consensus to define the experimental
conditions as uniformly as possible in order to be able to
better compare the results of different groups and better define
important biological processes.
Previous sporadic publications had addressed the question
of different culture media and media supplements such as FCS
in an arbitrary manner (29), some of them hinting that indeed
the addition of such components might greatly influence the
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FIGURE 5 | Heterogeneity in media supplements for human in vitro NETosis studies. Pie charts of serum, plasma, or serum albumin supplements used in human
in vitro NETosis studies, as indicated (numbers represent the absolute numbers of publications using a certain supplement while the slices represent percentages of all
considered publications). (A) chart for all stimuli combined (all publications were counted once). (B) charts for PMA, Ionophore/ Ionomycin, LPS, pathogen and
cytokines/chemokines, respectively. Publications were counted for multiple activator-specific pie charts if more than one NET-activator was used. N = 460
publications up to the 1st of March 2018.
outcome of NETosis experiments (4, 28–30). For this reason, we
systematically tested the popular media supplements BSA, HSA
and hiFCS and compared the effect of their addition to NETosis
experiments without supplements.We used three of the currently
best-established and most-used inducers of NET-formation, CaI,
PMA, and LPS isolated from Pseudomonas aeruginosa. We chose
these three activators because their mechanism of NET-induction
has been well studied and they are known to involve different
signaling cascades (46). Other popular inducers of NETosis
include CXCL8 (IL-8) (15), reactive oxygen species such as
H2O2 (4), activated platelets (47), microcrystals (48), Aspergillus
fumigatus and Candida albicans hyphae (49) as well as live
bacteria (1) [for a comprehensive review on activators of NETosis
please see (25)].
We found that in media without albumin or serum
components, CaI, PMA and LPS at all tested concentrations
induced a strong and reproducible NET-formation in human
neutrophils. On the other hand, spontaneous NETosis
rates were relatively high in serum-free and serum-low
conditions with a mean of 10.6% NET-rates. The increase
of spontaneous NETosis rates in serum-free media is in
line with results that have been reported in the literature
(Supplementary Figure 3) (30).
The addition of BSA or HSA at 0.5% (which is at the
lower range of concentrations used in the literature) led to an
almost complete inhibition of NETosis induced by CaI or LPS.
Thus, the experimental system appeared to be highly vulnerable
to the influence of these media components. Astonishingly,
PMA-induced NETosis remained unaffected by the addition of
albumin (Figures 1A,B). Similarly, PMA-induced NETosis was
not inhibited by any of the three tested concentrations of hiFCS
(Figures 1A,C). This is in line with a plethora of publications that
show robust induction of NETosis of human neutrophils by PMA
in media containing albumin or serum components (14, 31, 50).
We cannot exclude an inhibitory effect of FCS on PMA-induced
NETosis at very high FCS concentrations, as has been shown by
Fuchs et al. who used up to 20% FCS to inhibit NETosis (4),
however we refrained from reproducing this setup as such high
FCS concentrations are rarely used in the literature.
In contrast, CaI-induced and LPS-induced NETosis were
inhibited not only by BSA or HSA, as discussed above, but also
by hiFCS. Again, this corroborates previously published data
which has described LPS as a poor and unreliable inducer of
NETosis when using media complemented with FCS or BSA
(25, 29, 42–44, 51). It is interesting to note that for human
neutrophils, which are often cultured in media containing either
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FIGURE 6 | Heterogeneity in media supplements for murine in vitro NETosis studies. Pie charts of serum, plasma, or serum albumin supplements used in murine
in vitro NETosis studies, as indicated (numbers represent the absolute numbers of publications using a certain supplement while the slices represent percentages of all
considered publication). (A) chart for all stimuli combined. (B) charts for PMA, Ionophore/ Ionomycin, LPS, pathogen, and cytokines/chemokines, respectively.
Publications were counted for multiple activator-specific pie charts if more than one NET-activator was used. N = 108 publications up to the 1st of March 2018.
albumin or serum components, LPS is used as an inducer of
NETosis more rarely than inmouse studies, which are carried out
without media supplements in the majority of cases (52). This
becomes especially obvious in publications using both human
andmouse neutrophils (14, 53). On the other hand, many human
studies which do employ LPS as an inducer use serum-free
media (54–57) (see also Supplementary Table 1). The reason for
these observations may be that LPS, even at high concentrations,
fails to adequately activate neutrophils to produce NETs in
the presence of BSA, HSA or hiFCS (Figure 1C). A possible
explanation for this phenomenon is a strong binding of LPS by
large proteins such as albumin (Figure 4) and, very likely, also
by other serum components. Additionally, NETosis induction
by LPS relies heavily on integrin receptors such as MAC-1 (58)
and this outside-in signaling may be influenced by the addition
of large proteins and certainly also of serum components which
contain a mixture of active components that can engage integrin
receptors. In contrast, PMA is a direct activator of protein kinase
C (PKC) (59), a vital and relatively far downstream step in most
pathways leading to NETosis. Therefore, outside-in signaling
could be expected to be less crucial during the activation cascade,
at least for human neutrophils.
However, it is important to bear in mind that the isolation and
stimulation of neutrophils ex vivo is a complex process, which
depends on many factors apart from the used media and media
supplements. It is likely that the method of neutrophil isolation,
activation as well as the predisposition of the donor will also
influence whether stimulation of neutrophils is successful or not.
To minimize side-effects of the isolation method such as pre-
activation of the used neutrophils, we decided to employ well
characterized density gradient methods for neutrophil isolation
(14, 33). Gradient-based isolation technics are one of the most
commonly used methods in NETosis-studies. Compared to
isolation by polymorphprepTM or combinations with lysis of
erythrocytes, pure gradients reveal comparably low spontaneous
NET formation, as reported in the literature and corroborated
in our own results (Supplementary Figure 3). Furthermore, the
used anticoagulant can significantly influence pre-activation,
calcium levels, and number of obtained neutrophils (60). For
instance, heparin anticoagulation can influence the expression
of adhesion molecules (61). For this reason, we have employed
EDTA as an anticoagulant in this study (60).
Additionally, for LPS also the bacterial source has a significant
impact on the success of stimulation and concentrations
needed for this assay (62). Therefore, it is not surprising that
concentrations of LPS used for ex vivo studies differ widely
and, in some cases, LPS-induced NETosis occurred even in
media containing albumin or serum components (63–65) or
occasionally revealed only low NET-rates in supplement-free
media (66, 67).
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For mouse neutrophils, PMA-induced NETosis was,
surprisingly, strongly inhibited by addition of 0.5% BSA and
2% hiFCS. In general, mouse neutrophils appear to be harder to
activate than human neutrophils, they require higher threshold
concentrations for LPS and produce less NETs upon PMA
activation. One may speculate that mouse neutrophils may need
a higher concentration of PMA to reach the same threshold
of activation and that a minimal scavenging of available PMA
or a certain unspecific “stabilizing effect” of BSA/HSA would
thus affect murine NETosis more profoundly than it would for
human cells. This would be in line with the data shown by Fuchs
et al. (4) for the inhibitory effects of high concentrations of FCS
(up to 20%) on PMA-activated human neutrophils: If human
neutrophils required much lower concentrations of PMA to
still perform NETosis, then a considerable “scavenging” effect
of the activator would be of consequence only at high FCS
concentrations.
Another possible explanation that must be taken into account
for the differences seen between inductors of NETosis in response
to media supplements is a possible influence on extracellular
calcium levels. Calcium has been shown to be bound by albumin
(68, 69) and appears to be essential for NETosis activation
by PMA and, to a lesser extent, for CaI (46, 70). However,
in our experimental setup we could not observe a significant
influence of HSA on calcium levels (Supplementary Figure 4)
and doubling of calcium-concentration (to 0.8mM) did not
reverse the inhibitory effect of HSA in our hands (data not
shown).
Concerning the differences seen between PMA-induced
NETosis in humans and mice, it must be taken into account
that PMA-induced NETosis in mice may in part rely on
different biochemical pathways in these two different species.
For example, for murine neutrophils an involvement of enzymes
such as PAD4 has been reported previously (71), whereas the
involvement of PAD4 in PMA-induced human NETosis is still
under discussion (46, 72). A similar observation, namely that
decondensation of chromatin andNETosis in human neutrophils
depends on PAD4 function to a lesser extent, was reported for
Staphylococcus (73). In the context of different human diseases,
a number of endogenous and receptor-mediated, inflammatory
pathways have been identified that may lead to and regulate NET
formation. For instance, in COPD the chemokine IL-8 (CXCL-
8) and signaling through the CXCR2 receptor are thought to
be involved in the disease (74) and in lupus nephritis, NET
formation is thought to be regulated by engagement of the
uniquely human FcγRIIA by soluble immune complexes (75). It
remains to be explored how these pathways differ in humans and
mice and how environmental conditions may influence them.
The effect of media supplements on NETosis experiments
is most likely a complex one, however one may speculate that
a great part of this effect is brought about by binding of the
activators to albumin or to other serum proteins. In fact, for LPS
and CaI binding to albumin has already been reported, and we
here confirm and exemplify the binding of LPS to albumin by
fluorescence anisotropy measurements. Indeed, binding of toxic
and immune-activating substances like LPS or chemoattractants
is likely a mechanism to protect the host from an overactive
immune system and dysregulated NETosis, which has been
shown to have deleterious effects (76–78). Additionally, serum
even contains active DNases which are able to degrade already
released NETs, which also shows that the composition of the
environment in which neutrophils become activated are part of
an immune regulation to limit excess inflammation (79).
On the other hand, serum condition in the tissue to which
neutrophils are recruited in case of an inflammation to fight
pathogens might be different from those of the blood, i.e.,
serum composition in the blood is arguably different from
that in solid tissues. It is thus likely that, in part, a different
grade of inhibition of neutrophil function under different
conditions directs neutrophil behavior and orchestrates immune
responses (30).
Our experimental results are indirectly reflected in the
literature of experiments studying NETosis. While generally
there is a plethora of different experimental conditions being
employed in the field, it is striking to note the differences
between human and mouse experiments and particularly in the
experimental conditions used when LPS or CaI are employed as
activators. Here, the vast majority of all publications refrained
from adding any culture supplements, which is in line with our
observation that CaI- and LPS-inducedNETosis are very strongly
inhibited by albumin.
Thus, the choice of media supplements greatly determines
the outcome of in vitro experiments on NET-formation, which
must be considered when planning and comparing NET-
studies. Studies using different media settings may not be
comparable and in general the question must be asked to which
extent experiments omitting media supplements are actually
recapitulating the natural function of neutrophils and NETs. On
the other side, in vivo compartments are also different and differ
in concentrations of chemokines, adhesion receptors, and other
cells. Therefore, the questions we addressed in this paper is not
restricted to in vitro experiments but also highly relevant for the
assessment of in vivo experiments.
A standardization of protocols for NET experiments would
allow for a better comparison between results from different
groups.
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2.4 Supplementary information, manuscript II 
Supplementary tables 
 
Supplementary tables including full lists of supplementary references are available online. 














Supplementary	 figure	 2:	 Neutrophil	 elastase	 (NE)	 is	 released	 together	 with	 extracellular	 DNA	 after	
stimulation.	DNA-bound	NE	was	measured	after	stimulation	of	human	neutrophils	by	PMA	(100	nM,	3h),	CaI	(4	
µM,	2h)	or	LPS	 (100	µg/ml,	3h)	 in	RPMI/HEPES	with	and	without	HSA.	Neutrophils	 release	DNA-bound	NE	 in	




Supplementary	 figure	 3:	 Spontaneous	 NETosis	 in	 literature.	 (A)	 Percent	 of	 spontaneous	 NET	 formation	 in	
publications	using	serum-	and	albumin-free	culture	conditions.	NETosis	without	further	stimulation	of	isolated	
human	 neutrophils	 range	 between	 0%	 and	 more	 than	 20%	 NETotic	 cells.	 N	 =	 29	 publications	 with	 clear	
displayed	percentage	of	NETs	 (out	of	 all	 255	publication	without	 serum-supplements).	 (B)	 Spontaneous	NET	
formation	depending	on	neutrophil	isolation	technique.	In	literature	neutrophils	isolated	by	PolymorphprepTM	
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Key points:  
 
Ultraviolet A (UVA) and blue light induce NET formation in a neutrophil elastase- and 
myeloperoxidase-dependent fashion. Riboflavin acts as a photosensitizer that generates 
extracellular ROS. This process may contribute to light-sensitivity in autoimmune diseases 




Neutrophil Extracellular Traps (NETs) are produced by neutrophilic granulocytes and consist 
of decondensed chromatin decorated with antimicrobial peptides. They defend the 
organism against intruders and are released upon various stimuli including pathogens, 
mediators of inflammation or chemical triggers. NET formation is also involved in 
inflammatory, cardiovascular, malignant diseases and autoimmune disorders like 
rheumatoid arthritis, psoriasis or systemic lupus erythematosus (SLE). In many autoimmune 
diseases like SLE or dermatomyositis, light of the ultraviolet-visible (UV-VIS) spectrum is well 
known to trigger and aggravate disease severity. However, the underlying connection 
between NET formation, light exposure and disease exacerbation remains enigmatic. 
Therefore, we studied the effect of UVA (375 nm), blue (470 nm) and green (565 nm) light 
on NETosis in human neutrophils ex vivo. Our results show a dose- and wavelength-
dependent induction of NETosis. Light-induced NETosis depended on the generation of 
extracellular ROS in response to riboflavin excitation and subsequent reaction with 
substrates like tryptophan. This process required both neutrophil elastase (NE) and 
myeloperoxidase (MPO) activation. These findings suggest that NET formation as a response 
to light could be the hitherto missing link between elevated susceptibility to NET formation 
in autoimmune patients and photosensitivity for example in SLE and dermatomyositis 
patients. This novel connection could provide a clue for a deeper understanding of light-
sensitive diseases in general and for the development of new pharmacological strategies to 




Neutrophilic granulocytes (hereafter referred to as neutrophils) are able to expel fibril 
networks of decondensed chromatin, decorated with a variety of antimicrobial substances, 
in a process termed neutrophil extracellular trap (NET) formation or NETosis [1]. Initially, 
NETosis was seen as an immune defense strategy against intruding pathogens, distinct from 
phagocytosis and the release of cytotoxic substances [2]. Apart from their role in the 
defense within the innate immune system, the dysregulation of NETosis appears to be 
involved in the pathology of various diseases [3] such as rheumatoid arthritis [4], systemic 
lupus erythematosus (SLE) [5], psoriasis [6, 7], thrombosis [8], atherosclerosis [9] and cancer 
[10]. The activation mechanisms and underlying cascades of NETosis depend highly on the 
particular stimulus [11, 12]. Additionally, neutrophils are very sensitive to environmental 
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cues that affect for example adhesion [13, 14]. Therefore, factors that govern adhesion such 
as substrate stiffness or other environmental factors such as the presence of serum proteins, 
affect NETosis [15, 16]. In most scenarios, the cell undergoes a characteristic sequence of 
morphological changes during NETosis including chromatin decondensation, cytoskeleton 
degradation, cell rounding and softening, which ultimately lead to NET expulsion and cell 
death (‘suicidal’ NETosis) [2, 17]. Initially, active enzyme-dependent mechanisms dominate 
these processes (‘first phase’ of NETosis). For instance, the initiation of chromatin 
decondensation often involves the release of neutrophil elastase (NE) and myeloperoxidase 
(MPO) from the neutrophil granules and subsequent translocation to the nucleus [18, 19]. 
After start of chromatin decondensation, which represents the point of no return in NETosis, 
further progression until the NET release is mainly driven by the material properties of the 
NETotic cell such as the entropic swelling of its chromatin (‘second phase’) [17] . 
 
Interestingly, a connection between dysregulated NET formation and the production of 
autoantibodies against NET components has been implicated in several diseases including 
SLE, rheumatoid arthritis and small-vessel vasculitis [20, 21]. Mechanistically, NET formation 
often relies on the activity of peptidylarginine deiminase 4 (PAD4), which travels to the 
nucleus and citrullinates histones contributing to chromatin decondensation [22-27]. This 
hypercitrullination has been linked to the development of autoantigens against citrullinated 
histones for instance in the pathogenesis of rheumatoid arthritis [28]. Strikingly, a defect in 
the clearance of NETs (for example through impaired DNase activity or increased NET 
formation) appears to be directly associated with the development of autoimmune diseases, 
which has become especially evident in the pathogenesis of systemic lupus erythematosus 
[29]. The latter, as well as other autoimmune disorders such as dermatomyositis, can be 
triggered and/or aggravated by light. Interestingly, although for systemic lupus 
erythematosus both the increased propensity for NET formation as well as the marked light 
sensitivity is well documented [30-32], the connection between these two phenomena has 
not been yet thoroughly investigated.  
 
Electromagnetic radiation of wavelengths above ultraviolet C (UVC) light passes the ozone 
layer of the stratosphere and is therefore able to reach the human skin [33]. Once there, the 
light intensity is modified by reflection, absorption and scattering [34]. The penetration 
depth of the light into the human skin increases with higher wavelengths, while the energy 
decreases [35, 36]. This connection could lead to a ‘window’ in which light, whose energy is 
sufficient to initiate certain biological processes, penetrates into skin layers in which 
susceptible cells occur. The actual penetration of each wavelength depends strongly on the 
specific skin composition, as well as body region, age, gender, skin type, pigmentation and 
therefore ethnicity.  
High-energy UV light causes severe skin damage. This has been linked not only to 
photodermatoses but also to phototoxic and photoallergic reactions, skin cancer and 
photoaging [37, 38]. Many of these reactions are mediated by highly reactive radicals and/or 
reactive oxygen species (ROS) originating from the excitation of photosensitive substances 
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[39]. Prominent examples are flavin-based molecules originating from riboflavin (also knows 
as vitamin B2). After excitation, flavins can react with biological substrates such as DNA, 
proteins, lipids and aromatic amino acids (tryptophan and tyrosine) and forms a variety of 
photo-adducts [40]. Under physiological conditions, these reactions are kept in balance by 
antioxidants, but can be strongly dysregulated in the context of diseases and after persistent 
exposure to UV light. Furthermore, light has immunomodulatory activities and affects cell 
functions within the skin [41-43]. For instance, irradiation with UVB light recruits neutrophils 
into upper layers of the skin and has been linked to photoaging [38, 46]. Furthermore, 
increased apoptosis rates of neutrophils occur upon direct irradiation with high doses of 
UVB or UVC light [44, 45]. UVC light can also induce a unique form of NOX-independent 
NETosis (named apoNETosis) [44]. However, the physiological relevance of this observation 
is questionable, as UVC light does not reach the earth’s surface at all and even if it did, it 
would not penetrate human skin in large amounts. Direct contact with neutrophils is 
therefore precluded. In consequence, the connection between NET formation and light in a 
physiologically relevant setting is still elusive. Thus, a deeper understanding of direct effects 
of light on immune cells could greatly add to our understanding of light-induced or -
aggravated diseases and facilitate the development of therapeutic strategies.  
Here, we show that neutrophils release NETs ex vivo in response to UVA/blue light in a ROS- 
and NE/MPO-dependent manner. This process depends on the excitation of the 
photosensitive substance riboflavin and subsequent generation of extracellular ROS. Thus, 
these results provide a link between NET formation and direct effects of UVA and blue light 
on neutrophils.   
 
Material and Methods 
 
Isolation of neutrophils 
All experiments with human neutrophils were approved by the Ethics Committee of the 
University Medical Center (UMG) Göttingen (protocol number: 29/1/17). Neutrophils were 
isolated from fresh venous blood of healthy donors. Beforehand, all donors were fully 
informed about possible risks, and their informed consent was obtained in writing, consent 
could be withdrawn at any time during the study. Blood was collected in S-Monovettes EDTA 
(7.5 ml, Sarstedt), and neutrophils were isolated according to previously published protocols 
based on histopaque 1119 (Sigma Aldrich) as well as percoll (GE Healthcare) density 
gradients [17, 47].  Neutrophils were resuspended in HBSS-Ca2+/Mg2+ and further diluted in the 
desired medium as described in the appropriate methods sections and figure legends. Purity 
of the cell preparation was > 95% as assessed by cytospin (Cytospin 2 centrifuge, Shanson) 
and Diff Quick staining (Medion, Diagnostics). 
 
Irradiation of neutrophils with LED light 
Neutrophils were suspended in either Roswell Park Memorial Institute (RPMI) comp. (RPMI 
without phenol red (Gibco) + 0.5% heat-inactivated (at 56°C) fetal calf serum (hiFCS, 
Biochrom GmbH, Merck Millipore)) +/- 10 mM HEPES (Roth) or Hank’s balanced salt solution 
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(HBSS) comp. (HBSS+Ca2+/Mg2+ without phenol red (Lonza) containing 0.5% hiFCS and glucose 
(AppliChem) equalized to RPMI). If applicable, these media were supplemented with 0.2 or 2 
mg/l riboflavin (Sigma-Aldrich) and 1 mM tryptophan (Sigma-Aldrich) as indicated in the 
figure captions. Cells were seeded at 10,000 cells per well in CELLviewTH black glass-10-well-
slides (Greiner bio-one) and left to settle for 30 minutes (37°C, 5% CO2). Afterward, the 
appropriate medium (volume equal to PMA stimulation) was added and cells were irradiated 
with the indicated LED-light at 37°C (ibidi heating system). Cells were irradiated in the 
heating chamber from below with LEDs of 375 nm (ultraviolet light, M375L3 Mounted LED, 
Thorlabs GmbH), 470 nm (blue light, M470L3 Mounted LED, Thorlabs GmbH) or 565 nm 
(green light, M565L3 Mounted LED, Thorlabs GmbH), which were attached to an uncoated 
convex lens  (PLANO-CONVEX LA1131, f = 50.0 mm, uncoated, Thorlabs GmbH) and a T-cube 
LED Driver (Thorlabs GmbH). For evaluation of light dose-dependent effects, cells were 
irradiated with cumulative doses of 3.5 J/cm2, 18 J/cm2, 35 J/cm2 and 70 J/cm2 at 375 nm or 
21 J/cm2, 54 J/cm2, 107 J/cm2 and 214 J/cm2 at 470 nm. The light doses were calculated with 
respect to the actual power of the LED as measured with the PM12-122 Compact USB Power 
Meter (Thorlabs GmbH), taking into account the actual distance between the light source 
and the cells as well as the light transmission through the CELLviewTH glass-10-well-slides 
according to the manufacturer’s specifications. For experiments with equal light energy or 
photon flux, the light-doses or duration of exposure, respectively, were adjusted for 470 nm 
and 565 nm, the reference value was irradiation with 70 J/cm2 at 375 nm. Exclusive 
treatment with the indicated medium without irradiation was used as negative control and 
activation with 100 nM PMA (Sigma Aldrich) as positive control. Before, during and after 
activation with light or PMA the cells were carefully shielded from other light sources. After 
the activation, the cells were incubated for 3 hours, and NETosis was stopped by fixing the 
cells in 2% paraformaldehyde (PFA, Roth). Before further staining, the cells were kept at 4°C.  
 
Inhibitor experiments 
For inhibition experiments, cells were isolated, settled in RPMIcomp. supplemented with 10 
mM HEPES and activated as described above. Inhibitors or ROS scavengers were added at 
least 20 minutes (in case of MitoTEMPO 1h) before cell irradiation with 70 J/cm2 of 375 nm 
or 214 J/cm2 of 470 nm, at 37°C. For an additional control experiment, Trolox and 
catalase/SOD were separately added after irradiation. The cells were then incubated for an 
additional 3 hours in the presence of the inhibitors to allow for NET formation and fixed by 2 
% PFA. Pure medium or 100 nM PMA without irradiation were used as negative and positive 
controls, respectively. The following inhibitors and ROS scavengers were used in this study: 
GW-311616A hydrochloride (iNE, Axon Medchem) at 5 µM, 4-aminobenzoic acid 
hydrazide (4-ABAH, Cayman chemicals) at 100 µM, z-VAD-FMK (Promega) at 20 µM, 
necrostatin-1 (Nec-1, Enzo) at 50 µM, Y-27632-dihydrochloride (Abcam) at 20 µM, Cl-
amidine (Merck Millipore) at 200 µM, MitoTEMPO (Sigma-Aldrich) at 5 µM, 
diphenyleneiodonium chloride (DPI, Sigma-Aldrich) at 1 µM, Trolox (Sigma-Aldrich) at 50 
µM, and a mixture of catalase (filtered, Worthington) and superoxide dismutase (SOD, Sigma 
Aldrich/Merck) at 2,000 U/ml and 50 U/ml, respectively.  
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To investigate levels of NETosis, cells were washed two times with PBS (Sigma-Aldrich) and, 
subsequently, neutrophil DNA was stained with 1.62 µM Hoechst 33342 (Thermo Fisher 
Scientific) for 15 minutes. After staining, the cells were stored in PBS for further analysis. For 
blinded quantification, six microscopic fluorescence images (16x) were obtained in a 
standardized manner (Axiovert 200 equipped with EC Plan-Neofluar Ph1 and DAPI filter Set 
49, Zeiss, software: Metamorph 6.3r2., Molecular Devices or Micro Manager 1.4) using the 
camera CoolSNAP ES (Photometrics). The number of decondensed vs. condensed nuclei was 
counted in these images using ImageJ 1.46r (National Institutes of Health), and the relative 
number of decondensed nuclei/expelled NETs was determined as percentage of total cells 
(‘NETosis rate’) according to previously published studies [17, 48]. Relative NETosis rates 
were calculated for the inhibitor experiments vs. experiments without inhibitor.   
 
Live cell imaging/discontinuous irradiation of neutrophils 
Neutrophils (5x106 per ml in RPMI + 0.5% HSA + 10 mM HEPES) were seeded in ibidi channel 
slides (µ-Slide l0.6 Luer, ibidi) and stained with 1.62 µM Hoechst at 37°C for 10 min. Cells 
were irradiation with broad-spectrum UVA light (300-400 nm) for 3 min using the DAPI filter 
Set 49, and NET formation was observed in real time for 3.5 hours with a frame rate of one 
picture (Uniblitz stutter driver, model VCM-D1, Visitron Systems) per minute and 15 ms 
exposure time. Images were recorded at 16x magnification. To exclude toxic effects by 
photo-activation of Hoechst, a control experiment was performed without DNA staining 
during live cell imaging. In this case, NET rates were determined by Hoechst staining directly 
after 3.5 hours. Images in the center of the light beam and in non-irradiated areas were 
obtained in a standardized pattern and in a blinded manner, and NETosis rates determined 
as described above. The representative combined panorama image in figure 1 was obtained 
with the Plugin MosaicJ for ImageJ [49].  
 
Immunofluorescence staining  
To prove co-localization of MPO with decondensed chromatin as a marker for NETosis, 
activated cells were analyzed by immunofluorescence according to previously published 
protocols [17]. For the staining, the primary monoclonal anti-human antibody against 
myeloperoxidase (IgG1, mouse, clone:2C7, ab25989, 1:1000, Abcam) and the polyclonal anti-
mouse Alexa488 secondary antibody (IgG, goat, 1:1000, #4408, Cell Signaling Technology) 
were used. Directly before mounting with fluorescence mounting medium (Dako), DNA was 
stained with Hoechst. Co-localization of MPO and DNA was imaged at 40x magnification 
(Plan-Neofluar 40x/1,30 Oil, Zeiss) by fluorescence microscopy (Axiovert 200, Zeiss; 
software: Metamorph 6.3r2., Molecular Devices). 
 
ROS Detection/AmplexRed assay 
Cells were seeded at 10,000 cells per well in RPMIcomp. + 10 mM HEPES, HBSScomp. or 
HBSScomp. + 2 mg/l riboflavin + 1 mM tryptophan and activated at 70 J/cm2 of 375 nm light. 
After activation, 5 µl-samples of the supernatant were taken at defined time points (0, 10, 
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20, 30, or 40 min) close to the slide bottom for reactive oxygen species (ROS) detection. As 
controls, cells in all three media were either left without irradiation, only media was 
irradiated or cells were treated with 100 nM PMA without irradiation. The obtained samples 
were diluted in a black 96-well-plate (BRANDplates, BRAND GMBH) with PBS containing 50 
µM of AmplexRed reagent (Thermo Fisher Scientific), a highly sensitive probe for H2O2, and 
0.5 U/ml horseradish peroxidase (HRP, Sigma-Aldrich/Merck). Additionally, 10 U/ml SOD 
(Sigma Aldrich/Merck) were added, to ensure complete detection of ROS by transformation 
of superoxide radicals to H2O2. During the sample collection, cells were gently rocked to 
ensure equal distribution of ROS. For all samples, the fluorescence intensities of the formed 
resorufin were measured with the microplate reader Clario Star (software 5.40.R3, BMG 
labtech), and the results were processed with the software MARS (version 3.32, BMG 
labtech). Absolute H2O2 concentrations were determined via calibration with H2O2 (Roth) in 
HBSScomp. After ROS detection, cells were further incubated for a total of 3 hours before 
terminating the activity with 2% PFA, and relative NET amounts were determined. 
 
Light absorption by riboflavin 
The absorbance spectrum of riboflavin (Sigma-Aldrich) was obtained in PBS against PBS 
alone with the UV-VIS-NIR spectrometer (JASCO V-670, Spectra Manager Software) using a 
10 mm-path cuvette.   
 
Statistics 
Statistical analysis was performed using GraphPad Prism (version 6.0 for Mac, GraphPad 
Software Inc.). If applicable, GAUSS distribution was confirmed by the Shapiro-Wilk 
normality test. Significance was assessed by a one-way or a two-way ANOVA/Bonferroni’s 
multiple comparisons test with *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. Error = 




UVA and blue light induce NETosis dose-dependently  
To investigate whether UVA light is sufficient to activate NETosis, freshly isolated human 
neutrophils were irradiated for 3 minutes with physiologically relevant broad-spectrum UVA 
light in a standard microscopy setup (wavelengths 300-400 nm, approx. 60 J/cm2). 
Morphological changes of the nuclei were recorded using Hoechst staining over 3.5 hours in 
real-time (Supplementary movie). Neutrophilic chromatin readily decondensed over time, 
rounded up and finally formed cloud-like structures of decondensed chromatin 1-2 hours 
after exposure to light. This characteristic rearrangement of chromatin is consistent with 
previously published live-cell studies of NETosis [17, 50-52] and morphologically similar to 
PMA-induced NETosis (100 nM) observed in the same setup [17]. Interestingly, this dramatic 
effect was restricted to the light-exposed area and did not occur in unexposed areas (> 1500 
µm from the light center) (Figure 1). In addition, the effect was reproducible with 













For	 the	 initial	 experiments	 in	 figure	 1,	 broad-spectrum	UVA	 (300-400	nm)	 light	was	used,	
and	cells	were	observed	over	3.5	hours	with	a	 combination	of	 continuous	 (cell	 activation)	
and	intermittent	 light	exposure	(live-cell	 imaging).	Therefore,	to	verify	the	obtained	results	
in	 a	 controlled	 fashion,	 we	 established	 a	 precisely	 defined	 LED-light-based	 setup	 and	
irradiated	the	cells	from	below	with	light	of	distinct	wavelengths	and	doses	(Figure	2).	Cells	
were	 exposed	 to	 3.4	 J/cm2,	 18	 J/cm2,	 35	 J/cm2	 or	 70	 J/cm2	of	UVA	 light	 (375	 nm)	 and	 21	
J/cm2,	 54	 J/cm2,	 107	 J/cm2	 or	 214	 J/cm2	 of	 visible	 blue	 light	 (470	 nm).	 Light-induced	
chromatin	decondensation	was	dose-dependent	and	started	with	significant	rates	of	NETosis	









fluorescence	 images	of	neutrophils	exposed	 to	different	doses	of	 LED-light	 (375	nm	 (3.4	 J/cm2,	18	 J/cm2,	35	
J/cm2	and	70	J/cm2)	or	470	nm	(21	J/cm2,	54	J/cm2,	107	J/cm2	and	214	J/cm2)).	Decondensation	of	chromatin,	
stained	by	Hoechst,	clearly	increases	with	duration	of	light	exposure	and	shows	a	similar	morphology	as	seen	
after	activation	with	100	nM	PMA.	 (B)	NET	 rates	 significantly	 increase	 for	both	 tested	LEDs	with	 light	doses.	
Statistics:	one-way-ANOVA	with	Bonferroni’s	multiple	comparisons	test	(tested	against	unstimulated	cells).	**p	
<	0.01,	***p	<	0.001,	****p	<	0.0001.	N	=	3-5	 independent	experiments.	Error	bars	=	SEM.	(C)	Decondensed	
chromatin	 (blue/Hoechst,	 arrows)	 after	 irradiation	 colocalizes	 with	 MPO	 (green/alexa488)	 for	 both	 tested	
wavelengths,	similar	to	PMA-induced	NETosis.	Cells	were	fixed	before	performing	microscopy.	Cells	were	kept	
in	RPMIcomp.	+	10	mM	HEPES.	
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Light-induced NETosis depends on MPO and NE 
One of the hallmarks of NET formation is the strong dependency on enzyme activity, 
especially in the first phase of NETosis, enabling histone modification and, consequently, 
chromatin decondensation [17]. The involved enzymes can vary among different stimuli. In 
most cases, the activation of granular enzymes such as NE and MPO or members of the PAD 
family, particularly PAD4, are indispensable. Therefore, we inhibited the activity of various 
enzymes known to be involved in chromatin decondensation or required for associated 
signaling cascades of well-described activators of NETosis. 
For both tested wavelengths a significant reduction of NETosis was observed in the presence 
of the MPO-inhibitor 4-aminobenzoic acid hydrazide (4-ABAH, 100 µM) [53] or the NE-
inhibitor GW-311616A (iNE, 5 µM) [54] (Figure 3A/B). Both inhibitors efficiently blocked the 
decondensation of chromatin (Figure 3A), thus indicating that decondensation in light-
induced NETosis depended on MPO and NE activity as reported for PMA-induced NETosis 
[18, 19]. Additionally, inhibition of PAD activity by Cl-amidine (200 µM) [55] reduced NET 
formation after irradiation with light of both wavelengths by around 25-50%. This effect 
reached significance for irradiation with blue light (470 nm-LED; Figure 3B). Therefore, it is 
likely that the activity of PAD enzymes can enhance light-induced NETosis by modifying 
proteins, particularly histones by citrullination [22, 23, 56]. Dependency on Rho-associated 
coil kinase 1 and 2 (ROCK 1/2) activity, which is implicated in cytoskeleton regulation, has 
only recently been linked to PMA-induced NETosis [17]. Nonetheless, irradiation of 
neutrophils in the presence of Y-27632 (20 µM) blocking the ATP binding site of ROCK 1/2 
[57], showed no effect on NETosis rates in response to light (Figure 3B). It is important to 
note that inhibitors were still functional after irradiation with UVA light as demonstrated in 
PMA-induced NET formation (Supplementary figure 2A).  
In order to exclude that the observed effects are associated with neutrophil apoptosis or 
necroptosis, the involvement of caspases and the receptor-interacting protein kinase (RIPK) 
1/3-mixed lineage kinase domain-like protein (MLKL)-necroptosis-pathway after UVA 
irradiation was investigated. Toward this end, cells were irradiated in the presence of the 
pan-caspase inhibitor z-VAD-FMK (20 µM) [58] and the RIP1 kinase inhibitor necrostatin-1 
(Nec-1, 50 µM) [59], respectively. Indeed, the involvement of apoptotic or necroptotic 
pathways was not detected (Supplementary figure 2B). 
Altogether, these findings suggest that UVA and blue light induce NETosis in an MPO- and 
NE-dependent manner. This process can be supported by PAD enzymes and appears to be 








or	 blue	 light	 (214	 J/cm2	 of	 470	 nm)	 in	 the	 presence	 of	 specific	 inhibitors.	 NETosis	 is	 clearly	 reduced	 upon	
inhibition	of	MPO	(4-ABAH,	100	µM),	NE	(GW-311616A,	iNE,	5	µM)	and,	to	a	lower	extent,	of	PAD	enzymes	(Cl-
amidine,	 200	 µM).	 However,	 neutrophils	 were	 still	 able	 to	 undergo	 NETosis	 in	 the	 presence	 of	 ROCK	 1/2	
inhibition	by	Y-27632	(20	µM).	(B)	Quantification	of	NETosis	rates	after	irradiation	with	LED-light	of	375	nm	or	
470	nm,	 respectively,	 in	 the	presence	of	Y-27632,	Cl-amidine,	4-ABAH	or	 iNE.	The	 inhibition	of	MPO	and	NE	
significantly	 reduces	 light-induced	NET	 formation.	 Inhibition	of	 PAD-enzymes	decrease	NET	 rates	 induced	by	





The	 penetration	 of	 light	 through	 the	 human	 skin	 depends	 strongly	 on	 the	 wavelength.	
Approximately	 10-15%	 of	 UVA	 light	 and	 40-50%	 of	 blue	 light	 can	 pass	 the	 epidermis	 and	
reach	deeper	layers	[35,	36].	In	principle,	light	of	higher	wavelengths	penetrates	deeper	into	
the	skin	[36].	To	evaluate	whether	light	of	higher	wavelengths	is	also	sufficient	to	induce	NET	













in	 the	UV-VIS	 region	and	were	 reported	 to	enhance	 light-mediated	 tissue	damage.	One	of	
the	most	prominent	and	well-documented	photosensitizer	is	riboflavin	[40,	60].	Riboflavin	is	
present	 in	 tissues	with	 permanent	 light	 exposure	 such	 as	 skin	 and	 eyes	 (3	mg/kg	 and	 1.7	
mg/kg	 dry	matter,	 respectively	 [40])	 and	 has	multiple	 essential	 biological	 functions.	Most	
prominently,	 it	 acts	 in	 flavoprotein-dependent	processes	 as	 a	 precursor	 for	 FAD	and	 FMN	
[60,	61].	Photosensitizing	mechanisms	of	riboflavin	are	based	on	the	absorption	of	UVA	and	
blue	 light	with	maxima	at	373	nm	and	445	nm	as	 confirmed	within	 this	 study	 in	 line	with	
previously	published	data	[62]	(Figure	4C).	Riboflavin	is	excited	to	a	stable	triplet-state	via	a	
short-lived	 singlet-state.	 The	 excited	 triplet-state	 can	 directly	 react	 with	 oxygen	 (type	 II	
photoreaction)	 or	 with	 reactive	 substrates	 (type	 I	 photoreaction)	 to	 radicals	 or	 radical	
anions.	These	radicals	can	 then	 further	 react	with	molecular	oxygen	to	hydrogen	peroxide	
(H2O2)	or	hydroxyl	 anions	 via	 superoxide	anion	 radicals	 [40,	 63,	 64]	 (for	 a	potential	 type	 I	
photoreaction	 with	 tryptophan	 see	 Supplementary	 figure	 3).	 Importantly,	 riboflavin	 is	
present	in	the	culture	medium	RPMI	at	0.2	mg/l	and	was	previously	 linked	to	an	increased	
phototoxicity	in	culture	media	in	in	vitro	studies.	Such	reactions	were	observed	for	instance	




blue	 light	 significantly	 induce	NET	 formation	at	 (A)	 the	 same	energy	and	 (B)	 the	 same	photon	 flux,	whereas	
green	light	(565	nm)	does	not	induce	NETosis	under	either	condition.	Cells	were	kept	in	RPMIcomp.	+	10	mM	
HEPES.	 Statistics:	 one-way-ANOVA	with	 Bonferroni’s	multiple	 comparisons	 test	 (tested	 against	 unstimulated	
cells).	 **p	 <	 0.01,	 ***p	 <	 0.001,	 ****p	 <	 0.0001.	 N	 =	 3	 independent	 experiments.	 Error	 bars	 =	 SEM.	 (C)	
Riboflavin	 absorbs	 light	 in	 the	 UVA/blue	 light	 region	with	maxima	 at	 373	 nm	 and	 445	 nm.	 At	 375	 nm,	 the	
absorption	is	slightly	higher	(0.138),	than	at	470	nm	(0.130).		
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Given the wavelength-dependency of NETosis, the absorption spectra of riboflavin (Figure 4) 
and the fact that H2O2 as a ROS can induce NETosis [2, 67-69], it appeared likely that the 
observed light-induced NETosis was mediated by the excitation of riboflavin and subsequent 
ROS production. To test this hypothesis, we first scavenged ROS by the cell-permeable 
vitamin E derivate Trolox at a concentration of 50 µM [70]. Indeed, scavenging ROS with 
Trolox significantly reduced NET formation in response to UVA irradiation (Figure 5A). To 
further analyze this mechanism in detail, extra- and intracellular ROS generation were 
addressed separately. Extracellular ROS was scavenged by a mixture of catalase and 
superoxide dismutase (SOD) (2,000 U/ml and 50 U/ml, respectively) [71, 72], NADPH 
oxidase-derived ROS was blocked by diphenyleneiodonium chloride (DPI, 1 µM) [73] and 
mitochondrial-derived ROS was inhibited by MitoTEMPO (5 µM) [74]. While the inhibition of 
intracellular ROS generation showed no effect on the obtained NETosis rates, scavenging 
extracellular ROS by catalase and SOD abrogated NETosis completely (Figure 5A). This result 
strongly supported the hypothesis that extracellular substrate-mediated production of ROS 
facilitated light-induced NETosis. Furthermore, the addition of the catalase-SOD-mixture 
after the irradiation was still fully sufficient to inhibit NETosis (Supplementary figure 4C) 
excluding that side products of catalase or SOD themselves after UVA irradiation were 
responsible for the observed effect.  
In a second step, we studied the mechanism of extracellular ROS generation in greater 
depth. As described above, aromatic amino acids such as tryptophan can react with excited 
riboflavin/flavoproteins. As essential components of proteins, these amino acids are 
frequently expressed in human skin and can, therefore, contribute to ROS formation 
triggered by riboflavin excitation. To precisely evaluate the contribution of tryptophan to 
NET formation, neutrophils were irradiated in the culture buffer HBSS containing 0.5% FCS 
(HBSScomp.) supplemented with 0.2 mg/l or 2 mg/l riboflavin, a reasonable physiological 
range of riboflavin within human skin [40], in the presence or absence of 1 mM tryptophan. 
Indeed, in comparison to non-irradiated cells, UVA light exposure resulted in marked 
NETosis in the presence of both riboflavin and tryptophan. This effect was increased with the 
higher riboflavin concentration. In contrast, no NET formation was observed in pure 
HBSScomp. or in buffer supplemented exclusively with riboflavin (Figure 5B). These results 
strongly support the hypothesis that riboflavin mediated NET formation increases in the 
presence of additional substrates like tryptophan. Interestingly, a similar effect was 
observed for HEPES-buffer in RPMIcomp. NET rates markedly increased in the presence of 
HEPES, the standard medium condition used for this study, compared to RPMIcomp. without 
HEPES (Supplementary figure 4A).  
To confirm this hypothesis, extracellular ROS levels were measured after irradiation in the 
above-described solutions based on an AmplexRed assay. In line with the observed NET 
rates (Figure 5B), irradiation with UVA light led to dramatically increased extracellular ROS 
levels in both RPMIcomp. + HEPES as well as HBSScomp. + riboflavin (2 mg/l) + tryptophan 
(Figure 5C). Sole irradiation of these two media compositions consistently resulted in stable 
ROS levels of 60 µM to 100 µM. In contrast, irradiation of supplement-free HBSScomp. as 





control,	 extracellular	 ROS	 levels	 were	 determined	 after	 activation	 with	 100	 nM	 PMA.	 As	
expected,	 low	 levels	 of	 extracellular	 ROS	 were	 observable	 after	 PMA	 treatment,	 which	
increased	over	 time	 (Figure	 5C)	 [71].	 Importantly,	 in	 this	experimental	 setup,	we	obtained	








induced	NETosis	 is	 significantly	 inhibited	by	 the	ROS	scavenger	Trolox	 (50	µM)	and	by	exclusively	scavenging	
external	ROS	by	a	combination	of	catalase/SOD	(2	000	U/ml	and	50	U/ml).	NETosis	appears	to	be	independent	
of	intracellular	ROS	production	by	NADPH	oxidase,	as	shown	by	inhibition	of	DPI	(1	µM)	or	mitochondrial	ROS,	
which	were	 inhibited	by	MitoTEMPO	(5	µM).	Cells	were	kept	 in	RPMIcomp.	+	10	mM	HEPES.	 	Statistics:	one-





independent	 experiments.	 (C)	 Irradiation	 of	HBSScomp.	 +	 2	mg/l	 riboflavin	 +	 1	mM	 tryptophan	 (dashed	 red	
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line, symbol ) or RPMIcomp. (0.2 mg/l riboflavin) + 10 mM HEPES (dashed blue line, symbol Q) induces stable 
extracellular ROS levels between 60 and 100 µM, as detected by AmplexRed. Similar ROS levels are measurable 
after irradiation of neutrophils in these two media (left graph). In the presence of cells, ROS levels are 
continuously reduced over 40 min to around 20 to 40 µM (solid red line, symbol  and solid blue line, symbol 
Q). In HBSScomp. without riboflavin and tryptophan, neither direct irradiation (dashed light red line, symbol ً)  
nor irradiation in the presence of neutrophils (solid light red line, symbol ً) causes any increase in ROS levels 
(left graph). Without irradiation (right graph), ROS levels are stable in all three tested media at background 
values. After stimulation with 100 nM PMA (solid grey line, symbol ) extracellular ROS increase within 40 min 
up to 1.5 to 3 µM. N = 3-4 independent experiments. Error bars = SEM. Left graph: with irradiation (70 J/cm2 of 




UVA and blue light penetrate into human skin and especially the energy-rich UV light can 
cause severe tissue injury via immunological and inflammatory effects [43]. Both UVA and 
blue light from the sun reach the earth’s surface and penetrate into the human epidermis. 
Although it has been shown that in vitro irradiation of neutrophils with UVB [45] or UVC light 
[78] can cause cell death and exposure to UVA light can enhance ROS production [79], the 
influence of light on NET formation remained largely enigmatic. We have discovered that 
light of the UVA or blue spectrum is able to induce the release of NETs. The formation of 
NETs in this scenario depends on extracellular ROS, which are generated through the 
excitation of riboflavin in conjunction with substrates such as tryptophan. During the 
‘classical’ NETosis cascade, NE and MPO are typically released from neutrophil granules and 
translocate to the nucleus where they promote chromatin decondensation. According to our 
findings, light-induced NET formation also depends on MPO and NE. Additionally, inhibition 
of PAD activity by Cl-amidine during irradiation with UVA or blue light clearly showed 
reduction in NET formation especially after exposure to light of 470 nm wavelength. 
Therefore, the citrullination of histones most likely contributes to decondensation of 
chromatin in this setting. Altogether, these results imply that this novel light-mediated NET 
formation culminates in the initiation of the ‘classical’ pathway of suicidal NETosis by 
engaging the enzymes MPO, NE and PAD4 (Figure 6), as extensively described for different 
stimuli throughout the last years [12]. 
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Figure 6: Proposed mechanism of light-induced NETosis. 1. Riboflavin absorbs UVA and blue light and is 
excited to the triplet state. 2. Tryptophan or other substrates (e.g., HEPES-buffer, tyrosine) transfer electrons or 
protons to triplet-riboflavin, which leads to ROS production. 3. Extracellular ROS generation (e.g., H2O2/ OH- or 
O.-2) by excited riboflavin in the presence of reactive substrates is required for further progression of NET 
formation. Extracellular ROS can be scavenged by Trolox or catalase/SOD. 4. Extracellular ROS activates the 
translocation of granular enzymes like NE and MPO to the nucleus, which leads to the decondensation of 
chromatin. The activation of NE and MPO is mandatory for chromatin decondensation and can be inhibited by 
4-ABAH and iNE. Citrullination by PAD enzymes can presumably enhance decondensation. 5. After full 
decondensation, cells release the NET.  
Interestingly, in response to near infrared (980 nm) laser light, a ROS-dependent form of NET 
formation has been reported recently [80], which was shown to involve autophagy signaling. 
In spite of the fact that NETs have been shown to impair wound healing [48], this laser light-
mediated NET formation was suggested to be particularly relevant in the context of 
photobiostimulation with 980 nm diode lasers used to improve wound healing [80]. 
However, the exact mode of action of the laser light remains unclear.  
In a different study, UVC light was reported to trigger apoptosis and/or NOX-independent 
suicidal NETosis in a dose-dependent manner [44]. Highly energetic UVC light had triggered 
NETosis dependent on mitochondrial ROS and p38 MAPK activation. Additionally, certain 
biochemical features of apoptosis such as caspase-3 activation accompanied UVC-dependent 
NETosis. Therefore, the authors termed this new NETosis pathway ‘ApoNETosis’ [44]. Of 
note, one must bear in mind that naturally occurring UVC light is almost completely 
absorbed by the ozone-layer [33] and thus does not reach the human skin. Moreover, while 
artificial light sources are able to generate UVC light, this would not be expected to 
penetrate in high amounts across the stratum corneum of the skin. Thus, the physiological 
relevance of UVC light in the context of NETosis remains disputable. Nevertheless, there may 
be some relevance for ex vivo neutrophil studies.  
 
In contrast to the above-discussed reports, our study focused on the physiologically relevant 
and naturally occurring light spectra. Therefore, it is difficult to compare the mechanism 
unraveled by us with UVC-induced ApoNETosis. Nevertheless, the mechanism described 
here is also NOX-independent, similarly to ‘ApoNETosis’. However, UVA or blue light-induced 
NETosis does not involve mitochondrial ROS production, but clearly depends on MPO and NE 
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activation (Figure 3 and Figure 5A). The release of NE from the azurosome depends on MPO 
activity and NADPH-dependent H2O2-generation [18]. In this study, we detected a high 
extracellular light-induced ROS-production in riboflavin-containing media, which was stable 
for over 40 min after irradiation (Figure 5C). This result indicates that riboflavin excitation 
together with reactive substrates induces high levels of stable ROS species like H2O2 [81]. 
H2O2 can easily diffuse into the cell and directly activate the release of serine proteases from 
the neutrophilic granules. Thus, in NETosis induced by extracellular ROS, additional 
production of H2O2 via NADPH-oxidase would not be required, which explains our 
observation that light-induced NETosis was independent of NADPH.  
Importantly, the production of H2O2 in these media (especially RPMI + HEPES) and the 
subsequent release of NETs has to be considered for live cell imaging of neutrophils, 
especially when working with light of the blue or UVA spectrum. Choosing media without 
light-sensitive substances would avoid light-induced, ROS-mediated NETosis ex vivo. 
 
Typically, in non-inflamed skin, neutrophils closest to the skin surface are found within the 
superficial arterio-venous plexus of the papillary dermis [82]. The transmission of light 
depends on the local skin composition, but one can estimate that 10-15% of UVA light and 
40-50% of blue light reach the upper papillary dermis [35, 36].  
In our study, we observed NET formation after irradiation of neutrophils starting with 18 
J/cm2 of 375 nm and 54 J/cm2 of 470 nm LED-light (Figure 2). This dose corresponds to 
around 40 hours (375 nm) or 9 hours (470 nm LED spectrum) sun exposure at the specific 
wavelength, respectively. However, under real-life conditions one must consider the 
complex spectrum of sunlight, which is not limited to single wavelengths, as well as factors 
such as the thickness of the local ozone-layer, location on earth, weather, irradiation angle, 
level above the sea as well as time of day and season will affect those numbers [33]. 
Nonetheless, UVA and blue light-induced NET formation may play a more important role in 
pathological situations of skin. For example, this mechanism could be of great importance in 
individuals with a generally heightened propensity for light-induced NET formation but also 
in conditions where neutrophils are present in higher layers of the skin. 
 
In healthy skin, ROS levels are closely regulated by enzymatic and non-enzymatic 
antioxidants like glutathione-peroxidase and catalase, vitamin C and vitamin E. As human 
skin contains significant amounts of riboflavin, ROS generation by excitation of riboflavin and 
subsequent reaction with active substrates (e.g. in a type I photoreaction) including aromatic 
amino acids is very likely [40, 66, 75-77]. Nonetheless, the antioxidants systems mentioned 
above balance out these reactions under normal circumstances. In the context of diseases, 
this complex antioxidant system can be dysregulated or exhausted. For instance, extensive 
or continuous exposure of sunlight causes increased ROS levels with associated 
inflammation and tissue damage, even in healthy individuals [83]. This ROS-associated 
oxidative tissue damage is mostly mediated by the deeper-penetrating UVA portion of the 
spectrum. 
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Interestingly, increased redox stress has been documented in autoimmune disorders [84]. 
For instance, SLE appears to be frequently associated with high oxidative stress indicated by 
decrease in antioxidant systems, general increased ROS levels as well as elevated antibodies 
against oxidatively modified proteins [85]. In fact, neutrophils from SLE patients reveal 
higher oxidative burst [86] with decreased intracellular antioxidant systems [87], what 
makes them less resistant towards extracellular ROS generation. 
Additionally, neutrophils of patients suffering from psoriasis and SLE were reported to be 
generally primed for NETosis [4, 88][89] and NETosis is clearly involved in the pathogenesis 
of many chronic inflammatory and autoimmune diseases [21]. For example, autoantigens 
against NET components were detected in SLE [90]. Furthermore, impaired clearance of 
NETs has been described in the pathogenesis of systemic lupus, leading to an accumulation 
of potential autoantigens in the form of NET components [29]. 
Most likely both conditions - ROS imbalance and an increased propensity for NET formation - 
will add to one another and result in a ROS-mediated inflammatory loop. To what extent 
NETosis induced by light contributes to this cycle, has to be investigated within in vivo 
studies. 
 
Several autoimmune diseases, most prominently the above-mentioned systemic and 
cutaneous lupus erythematosus as well as dermatomyositis, show severe photosensitivity. 
Patients suffering from lupus, whether acute, subacute or chronic, develop new cutaneous 
lesions after sun exposure. Even an exacerbation of systemic symptoms like fatigue or joint 
pain has been well documented after light-exposure [30]. Nevertheless, the exact 
pathophysiological mechanism has not been unraveled yet and involves a differential 
interplay between different light-induced effects [30].  
Most likely, the abnormal response of lupus patients to light is not a monocausal one but 
given the importance of NETs in this disease and other autoimmune disorders it appears 
likely that a connection between light exposure and NET formation is an important factor. 
The question of whether neutrophils of lupus and dermatomyositis patients are per se more 
prone to light-induced NETosis and whether these reactions can be prevented warrant 
further translational studies. In this context, also the question as to what extent light-
induced NETs are targets for autoantibody formation remains a highly interesting one. 
 
Altogether, it is important to bear in mind that, according to our calculations, NET formation 
in response to moderate doses of light is most likely not a frequent event and that in healthy 
individuals NETs are usually rapidly cleared by DNases and subsequent phagocytosis [91, 92]. 
Thus, it is unlikely that exposure to modest doses of sunlight in healthy individuals will lead 
to a profound inflammatory reaction.  
 
On the other hand, light-mediated, ROS-dependent NETosis may also be instrumentalized in 
a clinical setting to help fight bacteria in bacterial keratitis, as a recent study has impressively 
shown. Here, the combination of UVA light with riboflavin was used in the ‘photochemical’ 
therapy of bacterial keratitis due to its bactericidal effect [93]. Furthermore, one may 
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speculate whether at least a part of the effect of photodynamic therapy (PDT), can be 
explained by NET generation. Visible light irradiation, especially of the red but also blue light 
spectrum is used in combination with photosensitizers such as aminolevulinic acid (ALA) or 
methyl aminolevulinate (MAL) in the therapy of basal cell carcinomas, Bowen’s disease and 
actinic keratosis (carcinoma in situ) [94]. This therapy is based on the excitation of the 
photosensitizer porphyrin originating from ALA or MAL and subsequent ROS generation 
similar to what we have reported in this study for riboflavin. Therefore, the highly 
interesting question remains whether NETosis can be activated by ROS generation also in 
this therapeutic context.  
 
In conclusion, we show that UV-Vis light causes ROS-dependent NET formation, which most 
likely bears great clinical relevance for important diseases such as systemic lupus 
erythematosus and dermatomyositis.  
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2.6 Supplementary information, manuscript III 
Supplementary movie 
(The movie can be found as an attachment to this thesis in form of a DVD) 
 
Changes of the nuclear morphology of human neutrophil granulocytes during UVA-induced 





Supplementary figure 1: Quantification of locally-restricted light-induced NETosis. NETosis rates are 60-70% 
higher in the center of light exposure compared to non-illuminated areas (> 1500 µm distance from light 
center). Cells were kept in RPMIcomp. + 10 mM HEPES. N = 2 donor. Error = SD.  
Supplementary figure 2: Functionality of inhibitors and exclusion of other cell death pathways.  (A) NETosis in 
response to PMA (100 nM) is inhibited by 4-ABAH (100 µM), iNE (5 µM), DPI (1 µM) and Y-27632 (20 µM), even 
after inhibitors were treated with 70 J/cm2 of 375 nm, ruling out that inhibitor function was altered by light 
exposure. Induction of NETosis by PMA is not altered upon the addition of DMSO (solvent for inhibitors) in the 
highest used concentration (1%).  Cells were kept in RPMIcomp. + 10 mM HEPES. N = 2. Error = SD. (B) Light-
induced NETosis (70 J/cm2 of 375 nm) occurs independently of nec-1 (RPI1 kinase inhibitor) and z-VAD-FMK 
(pan-caspase inhibitor). Statistics: one-way-ANOVA with Bonferroni’s multiple comparisons test. ns = not 
significant. Cells were kept in RPMIcomp. + 10 mM HEPES. N = 3. Error = SEM.  
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Supplementary figure 3: Reaction of triplet-riboflavin with tryptophan. Tryptophan can transfer an electron 
or a proton to excited triplet-riboflavin (type I photoreaction). This intermediate can further react with 
molecular oxygen and thus generate ROS. Riboflavin is transferred back to the ground state. This schema is 
based on previous published reactions between riboflavin and tryptophan [1-4].  
 
Supplementary figure 4: Light-induced NETosis is dependent on extracellular ROS. (A) NET rates in response 
to light of 375 nm 70 J/cm2 are enhanced in the presence of the culture buffer HEPES (10 mM). N = 3-4. Error = 
SEM. (B) During AmplexRed measurements NETosis is stably induced by PMA (100 nM) and light. N = 3-4. Error 
= SEM. (C) Catalase/SOD significantly inhibits NETosis and Trolox clearly reduces NET rates, when added after 
full illumination with 70 J/cm2 of 375 nm. Cells were kept in RPMIcomp. + 10 mM HEPES. N = 3. Error = SEM. 
Statistics: one-way-ANOVA with Bonferroni’s multiple comparisons test. ****p < 0.0001. 
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CHAPTER 3 - Summary 
3.1 Summary - Manuscript I 
„Chromatin Swelling Drives Neutrophil Extracellular Trap Release“ 
(Nature Communications, 2018) 
 
Detailed real-time observations on single human neutrophils conducted within this study, 
led to the conclusion that NETosis occurs in three distinct phases (P1-P3). These phases were 
reproducible among different donors as well as with frequently used NET-inductors such as 
PMA, calcium ionophore (CaI) and LPS. The first phase (P1) depended strongly on 
temperature and enzyme activity as verified by time-resolved inhibition of energy 
generation and MPO activity. Within this phase, the cell consumed substantial amounts of 
ATP, started to rearrange membranes and degraded the cytoskeleton. During this process, 
the cell softened and decreased its membrane tension. The chromatin within the neutrophil 
nucleus remained condensed in P1. The second phase (P2) was characterized by chromatin 
decondensation and was mostly independent of enzymatic activity and temperature 
variation. Consequently, the main driving force of P2 was the entropic swelling of chromatin. 
The onset of P2, the start of chromatin decondensation, was interestingly also accompanied 
by the rupture of the nuclear envelope as determined by lamin B fluorescence staining. After 
this time-point, NETosis could not be inhibited any more. Therefore, the onset of P2 in 
NETosis marks a point of no return. After complete chromatin decondensation, cytoskeleton 
degradation and cell rounding, the cell membrane ruptured and released the NET (P3). The 
point of cytoplasmic membrane rupture was biomechanically pre-determined by the 
position of the nucleus within the cell as well as plasma membrane dynamics during NETosis.  
In summary, NETosis consists of an active first phase and a second phase driven by material 
properties, which are separated by a clear point of no return. These results present a 
detailed insight into the exact regulation of NETosis and demonstrate how material 
properties can drive the complex behavior of cells.  
 
CONTRIBUTION: 
General: Experimental design together with all authors; main parts of the manuscript with Sebastian 
Kruss, Luise Erpenbeck and Daniel Meyer (D.M.); figure arrangement; co-supervision of Susanne N. 
Senger-Sander and Anja Kwaczala-Tessmann, who both contributed with selected data sets. 
Data generation and analysis: Figures: Fig. 1a-e; Fig. 2a/d; Fig. 2c (imaging); Fig. 3; Fig. 4b; Fig. 4a/d 
(all raw data; data analysis by D.M.); Fig. 4c (sample preparation); Fig. 5a (F-actin); Fig. 5b 
(Latrunculin A); Fig. 5c (Jasplakinolide); Fig. 6a-e (all raw data; data analysis together with D.M.) and 
Fig. 7 (together with D.M.). Supplementary figures: Supp. fig. 1; Supp. fig. 2 (sample preparation); 
Supp. fig. 3; Supp. fig. 4a/b; Supp. fig. 4d (together with D.M.); Supp. fig. 5; Supp. fig. 6; Supp. fig. 7; 
Supp. fig. 8a; Supp. fig. 8b/c (sample preparation); Supp. fig. 9a (all raw data, data analysis by D.M.); 
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of D.M.: Fig. 1b-e; Fig. 3c; Fig. 4a/b/d; Supp. fig. 1; Supp. fig. 3 and Supp. fig. 8a. 
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3.2 Summary - Manuscript II 
“Serum and Serum Albumin Inhibit in vitro Formation of Neutrophil 
Extracellular Traps (NETs)”  
(Frontiers in Immunology, 2019) 
 
As the composition of cell culture media can massively alter the results of in vitro cell 
studies, the effect of serum supplement in culture media on NETosis was analyzed in vitro. A 
complementary systematic literature search was also conducted. In vitro NETosis induced by 
PMA, calcium ionophore (CaI) or LPS depended strongly on supplementation of serum or 
serum albumin to culture media. In serum-free media, all tested stimuli activated NETosis as 
verified by colocalization of extracellular DNA with MPO and release of active NE-DNA-
complexes. The addition of serum albumin (HSA, BSA), however, significantly inhibited CaI- 
and LPS-induced NETosis of human neutrophils. The same effect occurred in media 
supplemented with heat-inactivated fetal calf serum (hiFCS). This pronounced inhibitory 
effect of serum supplements could be mediated by activator binding effects, as shown for 
LPS and albumin by fluorescence anisotropy measurements. Remarkably, these supplements 
did not affect PMA-induced NETosis of human neutrophils. However, in assays with murine 
cells, which in general showed lower NETosis rates, serum and serum albumin were 
sufficient to inhibit NETosis in response to all three stimuli. This observation emphasizes the 
variability of NETosis in different species.  
These results are of particular interest regarding the considerable variation in serum and 
serum albumin supplements used for in vitro NETosis studies in the literature, as shown in a 
comprehensive literature search. Interestingly, the choice of supplement varies according to 
the applied NET inducer reflecting our experimental results. 
The experimental data together with the literature research corroborate the importance for 
the standardization of culture conditions used in in vitro NET assays in order to obtain 
comparable results. It also allows speculations about the remarkable susceptibility of 
NETosis by small variations of the neutrophil environment and therefore regulation of 
NETosis in vivo. 
 
CONTRIBUTION: 
General: Experimental design together with all authors; main parts of the manuscript together with 
Luise Erpenbeck and Susanne N. Senger-Sander (SN. S-S.); complete data plotting, statistics and 
figure arrangement; co-supervision of SN. S-S. (who provided the literature research and contributed 
to the data set of Fig. 1). 
Data generation and analysis: Figures: Fig. 1 (main raw data except one selected data set by SN. S-
S.); Fig. 2; Fig. 3 (main raw data, except stimulation with PMA and LPS (10 and 25 µg/ml) in 
RPMI/HEPES (Veit S. Manzke) and one selected data set by Sophie E.F. Scheidmann). Supplementary 
figures: Supp. fig. 1; Supp. fig. 2. and Supp. fig. 4. Literature research: co-supervision of SN. S-S. (who 
provided complete data set) and independent verification of all data. 
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3.3 Summary - Manuscript III 
“Blue and Long-wave Ultraviolet Light Induce in vitro Neutrophil Extracellular 
Trap Formation” 
(Prepared for submission to Frontiers in Immunology) 
 
The effect of UV-Vis light on in vitro NET formation is the main focus of the third manuscript. 
Neutrophils, freshly isolated from healthy human donors, released NETs in response to UVA 
and blue light. The identity of these NETs was verified by colocalization of MPO with 
extracellular decondensed chromatin. NE and MPO regulated this novel pathway of 'suicidal' 
NET formation (NETosis) supported by PAD activity. There was no involvement of 
necroptotic, apoptotic or RHO/ROCK-related pathways as verified by RIPK1, pan-caspase and 
ROCK1/2 inhibition.  
Interestingly, light-induced NETosis could be activated in a locally restricted fashion and 
depended strongly on light doses and wavelength. While UVA and blue light (375 nm and 
470 nm LEDs) revealed high NET rates, green light (565 nm LED) failed to induce NETosis. 
This wavelength-dependency was reproducible for equal light energy and photon flux and 
correlated with the absorption spectrum of the photosensitive substance riboflavin (vitamin 
B2). In contrast to several previously described NETosis pathways, light-induced NETosis 
took place independently of mitochondrial ROS production or NADPH oxidase activation but 
required extracellular ROS generation. The formation of ROS was triggered by riboflavin 
excitation in combination with sensitizing substances such as tryptophan or HEPES buffer 
present in culture media.  
Since riboflavin and tryptophan are present at high concentrations in human skin and UVA as 
well as blue light can penetrate the epidermis in significant amounts, light-induced NETosis 
could be relevant for skin light-sensitivity. Particularly a contribution to disease onset and 
exacerbation of autoimmune disorders is conceivable, especially in the context of the 
frequently documented dysregulation of NETosis, high ROS imbalance and increased light 
sensitivity in these disorders. Therefore, a more profound understanding of NETosis in 
response to UV-Vis light can shed light into this still enigmatic correlation. 
 
CONTRIBUTION: 
General: Experimental design together with all authors; manuscript draft; final manuscript together 
with Luise Erpenbeck and Katharina M. Bach (KM. B.); complete data plotting, statistics and figure 
arrangement; co-supervision of KM. B (who provided a main data sets for this study). 
Data generation and analysis: Figures: Fig. 1; selective data for Fig. 3 (N = 4-5 for Cl-amidine and 4-
ABAH at 375 nm); Fig. 4c; Fig. 5 (except ROS measurements in RPMIcomp. + HEPES (KM. B.)) and 
Fig. 6. Supplementary data: Supp. fig. 1; Supp. fig. 2a (analysis), Supp. fig 2b; Supp. fig. 3; Supp. fig. 4 
and Supp. movie. 
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CHAPTER 4 - Discussion and outlook 
Many studies investigating NETosis focus on the identification of specific players in the 
multiple NET pathways in physiological and pathological contexts [193, 212, 214]. These 
experiments are essential in order to understand the signaling, which underlies NETosis and 
can profoundly accelerate the development of new therapeutic strategies of NET-associated 
disorders. Most of them are carried out in mouse models or in vitro with isolated human 
neutrophils. However, the outcome of these experiments can vary among different species 
(manuscript II), donors [225] or even when using the same stimulus (e.g., LPS stimulation 
[212, 225, 277], manuscript II). The central question remains, why a certain stimulus does 
sometimes fail to induce stable NETosis rates, and therefore, how onset and progression of 
NETosis are regulated for a specific stimulus. In addition, the question arises what these 
observations tell us about in vivo processes and their involvement in underlying pathologies 
as discussed in manuscript II and III.  
The detailed biophysical analysis of NET formation presented in manuscript I is of particular 
interest to address these questions. The three distinct phases of NETosis, differentially 
orchestrated by different driving forces, provide a valuable tool to analyze which specific 
influencing factor acts as a modulator, accelerator or inhibitor during NET formation. The 
following paragraphs will address the questions of how NETosis is actively modified and 
regulated within the first phase (P1) (paragraph 4.1), what factors possibly alter the entropic 
chromatin swelling in the second phase (P2) (paragraph 4.2) and how these results can be 
implicated in therapeutically strategies of NET-associated diseases (paragraph 4.3 and 4.4). 
4.1 Active modulation of NETosis dynamics 
4.1.1 Variations in NETosis activation 
As discussed in manuscript I, NETosis has three distinct phases, of which only the first phase 
(P1) depends on active enzyme-driven processes. NETosis also relies immensely on external 
factors. Whether a specific activator induces NETosis can depend on access of the stimulus 
to its target, pre-activation of the cell or requirement for co-stimulation. For instance, as 
shown in manuscript II, even a small amount of serum or serum albumin within culture 
media can effectively inhibit NET formation of human and mouse neutrophils (manuscript II, 
Fig. 1 and 3). It is reasonable to assume that these interactions are mainly due to the binding 
of the activator to serum proteins [361, 362] as discussed in manuscript II and verified for 
the binding of LPS to serum albumin (manuscript II, Fig. 4). Besides direct activator binding, 
other mechanisms are also conceivable to explain the obtained results. The serum proteins 
studied in manuscript II can attach to the cell surface or assay substrate and thereby restrict 
the access of the stimulus to its receptors or intervene with cell adhesion. Indeed, serum, as 
well as serum albumin, can strongly decrease the spreading area of cells as shown for 
neutrophils on human serum albumin (HSA)-coated surfaces [363] or hamster kidney cells in 
serum-containing media [364]. This observation is of particular interest for stimuli, which 
require preceding adhesion for NET formation. One prominent example is LPS, a frequently 
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used NET stimulus known for its inconsistent activation in in vitro NET assays. NETosis 
induced by LPS depends on Mac-1 activation as demonstrated by inhibition of the integrin 
subunit ɲM (CD11b) [281]. In a current study, we were able to corroborate these findings.  
Induction of NETosis with LPS directly correlated with the spreading area of neutrophils on 
their substrate (Erpenbeck, Gruhn et al., preprint uploaded to bioRxiv [365], data not 
shown). These experiments were performed by using different substrate stiffnesses 
(indicated by the Young’s (E) modulus) together with collagen I- or fibronectin coatings. 
Interestingly, the spreading area of neutrophils after LPS stimulation not only correlated 
with NET rates but also with increasing substrate stiffness [365]. These observations 
together with the data obtained in manuscript II highlight once more how the cells’ 
environment can alter the onset of in vitro NETosis and how important standardized assays 
are for the comparability of in vitro experiments as well as their transferability to in vivo 
conditions. For instance, distinct tissues reveal different amounts of serum albumin [366], 
adhesion molecule expression [66] and stiffness [367]. 
Based on these considerations, it is not surprising that activation with stimuli which do not 
require receptor-mediated signaling, like PMA, are more stable against modifications of 
environmental parameters. The same applies for neutrophil adhesion. PMA-induced NETosis 
progresses mainly independently of Mac-1-mediated adhesion [368] and is functional even 
in suspended neutrophils derived from patients with leukocyte adhesion deficiency 1 (LAD1; 
deficiency in the ɴ2-integrin) [369] and on passivated surfaces (manuscript I, Supp. fig. 12), 
which severely limit neutrophil adhesion. In direct comparison, PMA-induced NETosis 
progressed independently of surface passivation, but NETosis was completely impaired in 
response to LPS [365]. Therefore, the differential requirement of adhesion for NET formation 
represents an additional explanation for the results presented in manuscript II, namely fully 
functional PMA-induced NETosis of human neutrophils in serum or serum albumin 
supplemented media in contrast to LPS (manuscript II, Fig. 1). However, as also reported by 
Fuchs et al., high serum concentrations (5-20% hiFCS) are sufficient to decrease PMA-
induced NETosis even in human neutrophils [98]. One can, therefore, assume that serum 
proteins still reduce the active PMA concentration or act through other, as yet unidentified, 
pathways. This provides an additional explanation for the apparent inhibition of PMA-
induced NETosis by serum proteins observed for mouse neutrophils (manuscript II, Fig. 3), 
especially since NET stimulation of murine cells is weak either way.  
Apart from direct alteration of NETosis, neutrophils can exhibit an activated or primed 
phenotype, e.g. in infections and chronic diseases. For instance, neutrophils isolated from 
patients with diabetes or SLE are more prone to NETosis, presumably owing to their lower 
activation level for the onset of P1 [69, 70]. In vitro, neutrophil priming was frequently 
considered for different cytokines such as TNFɲ, which enabled NETosis after IL-8 or LPS 
activation [76]. Similar mechanisms are conceivable for light-induced NETosis 
(manuscript III) in vivo. It is unlikely that neutrophils in tissues respond to light with high NET 
rates under physiological circumstances. However, under pathophysiological conditions, 
priming of neutrophils possibly decreases the activation level for NETosis particularly in 
combination with a pathological infiltration of neutrophils into the skin. Additionally, ROS 
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induction by light-sensitive substances (manuscript III, Fig. 5) can possibly act additively 
within the cell and therefore enhance NET rates. Since H2O2 reacts downstream of NADPH 
oxidase activation within the signaling cascade of ROS-dependent NETosis, it is conceivable 
that the increasing H2O2 levels not only facilitate or enhance NETosis but also shorten the 
time of the first phase/P1 and hence accelerate the formation of NETs. 
4.1.2 Active modulation of NETosis progression  
After stimulation, the progression of NETosis depends on the induction of a specific signaling 
cascade. Indeed, the duration of P1 varies for different stimuli (manuscript I, Supp. fig. 3). 
Not surprisingly and extensively discussed in manuscript I, general alterations of active 
processes such as temperature variation and energy depletion can profoundly alter the 
duration of P1 or even entirely abrogate NET formation (manuscript I, Fig. 3). In line with 
this, even small variations of the neutrophils’ surrounding can interfere with the progression 
of NETosis. A prominent example is an increase in extracellular pH towards alkaline 
conditions. In three independent studies, alkaline pH was correlated with enhanced NOX-
dependent as well as NOX-independent NETosis. The increased NET rates were linked to 
enhanced ROS generation (NOX-dependent and NOX-independent), histone 4 cleavage and 
PAD4-mediated citrullination [370-372]. Therefore, changes in the surrounding conditions 
not only interfere with the onset of NETosis as discussed in paragraph 4.1.1 (see also 
manuscript II), they can also directly alter NET progression; an essential observation for 
studying NETosis in vitro and in vivo. 
Specific inhibition of NET-associated enzymes in P1 prevents the further progression of 
NETosis whereas P2 is not affected as studied by time-resolved MPO inhibition in 
manuscript I (Fig. 3). Simultaneously to our study (manuscript I), Tatsiy et al. reported a 
model, which included active modulation of early and late events in NETosis. For all tested 
inhibitors, they observed a clear inhibition from the beginning on, which became negligible 
for most inhibitors within the first hour. This observation is in perfect agreement with our 
data. However, for selected substances, they obtained a sufficient reduction of NOX-
dependent NET formation at time-points up to 120 min [224], which would match with our 
P2. At a first glance, this observation is contradictory to our model. However, the authors 
use significantly different experimental conditions, which can massively alter the onset and 
progression of NETosis as already discussed above. Additionally, the quantification of 
NETosis by extracellular DNA release (PlaNET dye) used in this study, does not allow to draw 
conclusions regarding chromatin state of the analyzed cells and therefore on how many cells 
reached the point of no return after 120 min in their setting.  
Interestingly, although cells initially spread on the surface (manuscript I, Fig. 1 and 2), 
adhesion is no prerequisite for PMA-induced NETosis in our model. In contrast, during P1, 
the cell retracts its body to allow cell rounding and free chromatin swelling within the cell. 
One can postulate that the functionality of this cell body retraction is required for the 
progression of NETosis. In this context, Uotila et al. analyzed the involvement of filamin A 
[373]. Filamin A is an actin cross-linker [374] involved in uropod retraction of neutrophils 
[375] and inhibits integrin-dependent cell adhesion [376]. Although neutrophils show regular 
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surface expression of integrins, knockout of filamin A enhanced integrin-mediated adhesion 
and subsequently decreased NETosis in response to LPS and PMA in mice [373]. In 
agreement with the diminished NETosis rates, enhanced integrin activity was correlated with 
a decrease of neutrophil elastase (NE) production [373]. Therefore, Uotila et al. suggested 
that enhanced ŝŶƚĞŐƌŝŶ ɴ2 activity has a negative impact on NETosis [373]. They also 
proposed a more mechanistic function of filamin A in NET formation because of its actin 
cross-linking activity and involvement in uropod retraction. Indeed, filamin A depletion may 
interfere with cell rounding and softening which is, based on our results, a requirement for 
NET formation within P1. Interestingly, the retraction of the cell membrane from the 
substrate (manuscript I, Fig. 2, Supp. fig. 4 and Supp. movies 1/2/8/9) is accompanied by 
significant degradation of the cytoskeleton and stabilization of actin filamentation by 
jasplakinolide inhibits NETosis persistently and significantly until early P2. In contrast, 
interaction of actin filament formation with cytochalasin D or latrunculin A can only diminish 
NETosis in the first half of P1 (manuscript I, Fig. 5). Thus, a functional cytoskeleton seems to 
be required for early events of NETosis such as translocation of proteins within the cell and 
most likely active uropod retraction, but the degradation of actin appears to be 
indispensable for later events such as translocation of NE into the nucleus [228] and further 
cell softening. Consequently, the cell gets biomechanically prepared for membrane 
rearrangement, rounding, chromatin decondensation and rupture in P2.  
4.2 Chromatin swelling – a new function of chromatin? 
For a long time, neutrophils were considered as terminally differentiated cells with a unique 
nuclear structure allowing them to squeeze through tissues. With the discovery of NETosis, 
entirely new properties of neutrophil nuclei became interesting. The striking finding that 
these cells can actively initiate chromatin reorganization such as decondensation by mixing 
of eu- and heterochromatin, the hallmark of NET formation [98], challenged the idea of an 
exclusively ‘passive’ neutrophil nucleus [92]. Additionally, NETosis contributes to pathogen 
defense and immune response in physiological as well as pathophysiological conditions. This 
was postulated to be “the second function of chromatin” [377]. With the findings presented 
in manuscript I, we add a ‘third’ until now undescribed function of chromatin. After 
initiation of chromatin decondensation at the point of no return, the swelling of the 
chromatin polymer appears to be the main driving force for nuclear and plasma membrane 
rupture. This observation paves the way for new concepts of how cells can use material 
properties to facilitate complex biological processes.  
4.2.1 Entropic swelling bursts the nuclear envelope  
Besides containing the genetic information of chromosomes, the cell nucleus is a very 
dynamic organelle. Its morphology can vary from cell type to cell type with pronounced 
associations with cell functions and gene expression. In addition, it is flexible, depending on 
the cell environment and cell activity [95]. From a biomechanical point of view, the nucleus 
can undergo several major changes as in migration and cell division [116, 378]. As already 
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pointed out, the neutrophil nucleus has to allow massive structural alterations to squeeze 
through the endothelium into the tissue. The description of NETosis adds several new 
requirements for its architecture. 
The neutrophil nucleus is not only characterized by its eponymous lobulated shape, but also 
by a unique composition of its envelope. These characteristics develop during granulopoiesis 
and comprise the lack in lamin A/C and proteins of the LINC complex, decreased lamin B 
levels as well as markedly increased LBR. These changes most likely contribute to the 
remarkable flexibility of neutrophils for instance during migration [94, 133]. Interestingly, 
the absence of lamin A/C does not only mediate overall flexibility but also causes a lack of 
lamin A/C-binding to chromatin [379] and makes the cell softer and less resistant as shown 
in migration studies [380]. Together with the decreased expression of the tethering LINC 
complex [119], it possibly allows the chromatin to redistribute more easily and faster as 
recently discussed by Manley et al. [94, 237, 381]. Additionally, the rapid re- and- 
decondensation of chromatin in neutrophils reported under hypotonic conditions supported 
this hypothesis [100]. As a consequence, the nuclear envelope is overall more fragile. This 
makes neutrophils evolutionarily prepared for profound reorganizations and most likely 
allows the fast chromatin remodeling observed in the first phase of NETosis (P1). 
Subsequently, it prepares the following chromatin decondensation in P2 (manuscript I, 
Fig. 1 and 2). It is likely that the nuclear envelope increases its “susceptibility to chromatin-
exerted pressure” [94]. Interestingly, murine neutrophils and HL-60 model cells contain more 
lamins and, at the same time, appear less fragile [99, 382]. It is therefore likely that these 
cells are less predisposed for chromatin remodeling as well as nuclear envelope rupture, 
which may lead to a delayed onset of P2. Indeed, stimulation of murine neutrophils yielded 
lower NET rates than human neutrophils, as repeatedly reported [383] and verified in 
manuscript II (Fig. 1 vs. Fig. 3). It would be interesting to study this phenomenon in more 
detail in our phase model to clarify whether NETosis in murine neutrophils shows a 
prolonged P1 and therefore reaches the point of no return later, or whether mice generally 
have lower NET rates for other reasons. 
In their review, Manley et al. also correlated the lack in lamin A/C with the short life-span of 
neutrophils, as the lack of lamin A/C renders the nucleus less protected and more prone to 
cell death [384] and DNA damage [385, 386]. This is of particular interest for aging 
neutrophils, which show an activated, pro-inflammatory phenotype [71, 73] including higher 
NET rates [387]. It is possible that DNA alterations can prime chromatin decondensation and 
facilitate the onset of chromatin swelling. In addition, NE from aging neutrophils can be 
released more easily from granules, cleave gasdermin D and induce lytic cell death by pore-
formation in membranes [388], a mechanism which was only recently implicated in NETosis. 
This could affect the integrity of membranes and thereby prime the cells for NETosis.  
In contrast, neutrophils from older hosts display impaired NETosis [76, 77]. Interestingly, 
alterations in lamin proteins were previously described for different cell types of aging hosts 
[389, 390]. Whether neutrophils also show these changes in lamin expression, such as 
increase in lamin A/C levels, and whether these alterations correlate with impaired NETosis 
due to aggravated envelope rupture, remains to be investigated.  
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In addition to its unique composition, the nuclear envelope can become modified further 
during NET formation, for instance by phosphorylation of the remaining lamin A/C [235]. 
Based on our phase model (manuscript I), it is expected that these modifications take place 
predominantly in the first and active phase of NETosis (P1) (manuscript I, Fig. 3). Whether 
this particular alteration has a functional implication in the subsequent envelope rupture or 
whether it is a by-stander product of the mitosis pathway is unclear. However, it is likely that 
the nuclear envelope undergoes even more profound changes than anticipated. For 
instance, it was postulated that the passive or active decrease/down-regulation of LBR, the 
most crucial tethering molecule in the neutrophil nuclear envelope, supports delobulation 
and decreases heterochromatin detachment from the nuclear membrane [94]. Similar 
mechanisms are likely to take place during P1. LBR decrease could mainly support chromatin 
remodeling and the onset of chromatin swelling. Nonetheless, this hypothesis requires 
further investigation especially in neutrophils from mice lacking LBR [391] or time-resolved 
observations of the nuclear envelope proteins correlated with the state of chromatin 
decondensation in human neutrophils.  
In two independent studies, Fuchs et al. and Amulic et al., postulated nuclear membrane 
dissolution during NETosis into vesicles [98, 235]. As already discussed in manuscript I, this 
process coincides with time-points of our P2, clearly after the start of chromatin 
decondensation. At which stage of NETosis the nuclear membrane actually starts to 
disintegrate was not further addressed in these two publications. In our study, we observed 
the rupture of the lamina (lamin B1) significantly earlier, exactly with the onset of P2 (t1) 
(manuscript I, Fig. 2). Together with our real-time observations, which show an impressive 
increase in chromatin area directly after t1, it is very likely that the generated entropic 
pressure of the swelling chromatin is sufficient to burst at least the nuclear lamina and 
literally ‘free’ the chromatin to swell further within the cytoplasm. Whether this corresponds 
with the burst of the nuclear membrane, or whether the membrane is already significantly 
weakened beforehand and starts to dissolve already within P1, however, is not clear. 
Potential mechanisms of membrane weakening include gasdermin D-induced pore 
formation [229, 230] and alterations of the supporting cytoskeleton [228]. Most likely, the 
membrane is prepared by specific modifications for rupture by the expanding chromatin. 
These considerations are even more important given that the release of ETs is not restricted 
to human neutrophils, but rather represents a highly conserved process among different 
species, cells and organisms. Therefore, the fluidity of chromatin within the neutrophil 
nucleus and the unique composition of its nuclear envelope might prime neutrophils, 
especially human neutrophils, to undergo NETosis. However, this is most likely not the only 
underlying mechanism. It is expected that cells either undergo a conserved program to 
prepare the nuclear envelope for rupture by swelling chromatin, or the entropic chromatin 
swelling itself, enabled by degradation and modification of DNA and histones, is sufficient to 
‘burst’ the nuclear envelope regardless of its predisposition. Further live-cell observations, 
however, are needed to correlate the state of chromatin remodeling in the first phase with 
the exact composition of the nuclear envelope. Likewise, studies on isolated nuclei from 
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different species could clarify how much pressure is generated by the swelling chromatin 
and whether this pressure suffices to burst the nuclear envelope of nuclei from all species.  
4.2.2 Modulation of chromatin swelling  
Each stimulus induces a specific time-course for NETosis depending on the underlying 
signaling cascade with its own onset for chromatin swelling [277]. Interestingly, the 
appearance of the released NET itself can also differ from stimulus to stimulus [277]. It is 
likely that the kind of chromatin modification in the first phase, which differs markedly 
between NOX-dependent and NOX-independent NETosis, is responsible for these variances. 
Thereby, the different enzymes contributing to chromatin decondensation can alter the 
polymer structure and therefore influence chromatin swelling in P2. Obviously, this will not 
hinder chromatin swelling itself, but it can provide an explanation for the slight variations 
observed in P2 duration in response to different stimuli (manuscript I, Supp. fig. 3).  
It is conceivable that general changes in extracellular conditions, such as fluid osmolarity, 
also modulate chromatin swelling properties. For instance, hyperosmolar stress can enhance 
NETosis [392]. How this is biophysically regulated, however, remains unexplored.  
Moreover, neutrophils are capable of actively stabilizing the swelling chromatin during NET 
formation, for instance by cross-linking of proteins through MPO-generated HOCl [393]. This 
observation also explains, at least in part, the ordered structure of the released NET and 
possibly allows the NET to stay intact during release. It may also facilitate the directed attack 
on pathogens. The question remains, what effect such alterations can have on the generated 
pressure and swelling behavior of the polymer itself. This is especially interesting, given that 
modification of the chromatin polymer structure could, thereby, influence internal 
structures to modulate passive energy-independent processes. 
Bearing in mind that the proteome of NETs can change dramatically in response to different 
stimuli [245, 246], the question of whether newly generated enzymes can modify NETosis is 
also important. In this context, inhibition of translation and transcription do not influence 
NETosis in response to several stimuli tested in murine and human neutrophils [214, 394]. 
Thus, NETosis seems to proceed independently of newly synthesized proteins. However, 
with regard to the diverse NET-proteome, it is possible that neutrophils are still able to 
generate proteins in the first phase of NETosis. The high energy levels required for protein 
generation [395] could be an additional explanation for the massive decrease in ATP levels 
within the first 15-30 minutes of NET formation (manuscript I, Fig. 3).  
However, a conflicting study of Khan et al., clearly showed dependency on transcription 
particularly on the promoter melting step in response to PMA, Ionomycin and LPS [396]. To 
explain this observation, the authors came up with a model in which promoter melting 
carries out an aberrant function, the support of chromatin decondensation. They termed 
this process “transcriptional firing”. Interestingly, for all stimuli, the number of released 
NETs increased over time independently of promoter melting inhibition [396]. With regard 
to our phase classification, it is therefore possible that inhibition of “transcriptional firing” 
only delays NETosis. It either prolongs P1 and delays the point of no return or prolongs P2 
due to alterations of the polymer structure.  
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Besides promoter melting, other mechanisms, which are involved in gene regulation such as 
histone modifications [106], were reported to have aberrant functions in NETosis. For 
instance, PAD4 activity with subsequent histone citrullination was frequently implicated in 
chromatin decondensation during NETosis. Furthermore, inhibition of chromatin 
deacetylation [397] or methylation [398] have been associated with increased 
decondensation. These mechanisms are exciting, but require further biophysical 
investigations with a focus on the altered chromatin structure. It is evident that several cell 
functions can exert until now underestimated roles, which can result in dramatic cell 
alterations such as NETosis.  
4.2.3 Pressure of entropic chromatin swelling bursts plasma membranes 
Similar to the nuclear membrane, the plasma membrane also undergoes profound changes 
during NETosis (manuscript I). Even before chromatin decondensation, the cytoskeleton 
degrades, the membrane rounds up and the cell height increases (manuscript I, Fig. 2). After 
full decondensation, the plasma membrane ruptures at a point predetermined by chromatin 
position and membrane behavior (manuscript I, Fig. 6). The plasma membrane was thought 
to become permeabilized by gasdermin D-induced pores [230]. Nonetheless, from the 
results of Sollberger et al. it is not possible to ultimately answer the question whether these 
pores are located only in the plasma membrane, in all membranes or whether gasdermin D 
is even secondarily pushed to the plasma membrane by the swelling chromatin. However, in 
their study, Sollberger et al. pointed out that gasdermin D-cleavage and the resulting pores 
are required for PMA-induced NET formation. Interestingly and perfectly in line with our 
phase model, they observed that once the cell has reached the step of chromatin 
decondensation (point of no return), it always lyses after the same period of time [230]. 
We also observed the generation of small membrane vesicles during NETosis, which 
remained on the substrate surface after cell retraction during cell rounding. Thereby, the 
cells possibly reduce excess membrane and therefore facilitate the final membrane rupture 
(manuscript I, Fig. 2, Supp. fig. 4 and Supp. movies 1/2/8/9). Since we were also able to rule 
out that PMA-induced NETosis is dependent on adhesion (manuscript I, Supp. fig. 12), 
vesicle formation might not be required for NETosis. Furthermore, it has to be clarified 
whether these vesicles are also formed on physiological substrates. Nonetheless, reduction 
of excess membrane might facilitate NETosis and provide a reasonable explanation for the 
accelerated NETosis in aged neutrophils. However, this hypothesis requires further 
investigation, particularly in live-cell and in in vivo settings.  
In this context, it would be of considerable interest to investigate how changes in membrane 
lipid composition alter the time-course of NETosis, especially the duration of P2. For 
cholesterol, an implication in NET release was already documented. Interestingly, depletion 
of cholesterol clearly enhanced NETosis [399, 400]. 
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Figure 9: Model of NET formation and regulation. The active, first phase of NETosis depends on enzyme 
activity. Within this phase, NETosis can be inhibited or attenuated by several external factors as well as active 
biological signaling processes and enzymatic activity. Additionally, the cell reorganizes its membranes, rounds 
up and degrades the cytoskeleton. With the start of chromatin decondensation, NETosis reaches a point of no 
return. Thereafter, NETosis is driven by material properties, above all entropic chromatin swelling. The 
progression of this second phase can be modified by, for instance, membrane predisposition and chromatin 
polymer structure. Neubert et al. in preparation.  
In summary, all these alterations including cytoskeleton degradation, DNA modification, 
histone degradation, remodeling of the cell body as well as modification of nuclear and 
plasma membrane, indicate that neutrophils actively prepare themselves in the first energy-
dependent phase of NETosis for the passive entropic swelling of chromatin in the second 
phase. Therefore, the cell can actively remodel its cell body to make use of material 
properties of its interior. This observation expands the toolbox of cells by a very interesting 
feature, which is, bearing in mind the broad distribution of ET formation among various 
species, most likely not restricted to neutrophils or even to the process of ETosis. The 
transferability of this concept to other dramatic morphological changes in biology has to be 
investigated in further studies.  
4.3 Implementation of the NETosis phase model in therapies 
With increasing implications in pathological conditions, NETosis is also of growing interest as 
a pharmaceutical target. Thereby, researchers mostly rely on knockout mouse models and 
ex vivo stimulation assays with isolated neutrophils. In this context, the inhibition/deletion 
of key enzymes involved in NET signaling such as PAD4, NE, MPO or NADPH oxidase are 
unavoidable. These models are indispensable to understand the underlying signaling 
cascades. However, they have the widely known limitation to only partially reflect in vivo 
conditions in humans. Obviously, this is of interest for NET assays, bearing in mind the 
pronounced dependency of NETosis on external factors, different stimuli as well as on the 
neutrophil species (human vs. murine) (manuscript II, paragraph 4.1 and 4.2). Additionally, 
several enzymes implicated in NETosis have multiple functions. For instance, knockout of 
NADPH oxidase inhibits NETosis. The afflicted mice, however, can suffer from severe 
infections due to decreased overall immune defense [297]. 
With the phase model presented in manuscript I, we added another important factor, which 
has to be considered when exploring NET-related therapeutic approaches: NET formation is 
only partially regulated by enzymatic activity. Therefore, if cells already passed the point of 
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no return, the progression of NET formation cannot be stopped anymore. This observation 
restricts the window of pharmacological intervention by direct inhibition of NET-associated 
enzymes but highlights the importance of considering other strategies. However, it has to be 
considered that neutrophils occur at different stages of NET formation within the tissue. 
Therefore, a combination of ‘alternative’ strategies with active inhibition of NET-associated 
enzymes represents a very promising approach.  
Among these ‘alternative’ strategies, the clearance of NETs by DNase is perhaps the most 
widely used one. DNase treatment was tested in several in vitro and in vivo studies with 
good results, especially in chronic inflammation [227]. Interestingly, DNase treatment was 
already established as inhaled medication in cystic fibrosis therapy (Dornase 
alpha/Pulmozyme®, approval 1994) long before the formation of NETs was implicated in the 
pathogenesis of this disorder [246]. However, the treatment with DNase also holds risks and 
is not the ultimate solution for all NET-associated diseases [192]. As shown by Kolaczkowska 
et al., NETs are only incompletely cleared by DNase treatment and leave active enzymes 
behind, which can cause severe tissue damage. This observation has to be considered in NET 
therapy [256]. To decrease the damage by cytotoxic NET-proteins a different concept of 
clearance was proposed: the neutralization of these mostly cationic proteins. This strategy 
revealed good results in a model of sepsis. In this study, the non-anticoagulant form of 
heparin could neutralize cytotoxic histones and improve survival in mice [401]. A 
combination of protein neutralization with DNase treatment could be an interesting 
approach in tissue to address locally restricted NETosis and avoid further damage by reactive 
proteins.  
However, it would also be beneficial to directly interfere with the passive phase (P2) 
(manuscript I) and delay or inhibit NET release in pathological conditions. Here, the most 
reasonable concepts include the stabilization of the plasma membrane by, for instance, 
alteration of membrane lipid composition or cross-linking of the chromatin polymer within 
the cell to stop chromatin swelling. Both concepts would ‘freeze’ NET formation to some 
extent and possibly allow subsequent clearance by phagocytosis. Importantly, this could 
allow a silent clearance of NETotic cells in comparison to DNase treatment. Nonetheless, 
several questions remain before such concepts can be tested in vivo, among them, which 
substances specifically target neutrophils and intercalate into the membrane or penetrate 
through the membrane to the chromatin polymer. It also has to be clarified whether NETotic 
cells express specific ‘eat-me’-signals at the surface, which would induce subsequent 
phagocytosis even without membrane rupture. To give one example, the typical ‘eat-me’-
signal of apoptotic neutrophils, phosphatidylserine, is only visible for NETotic cells after 
membrane rupture [98].  
It is also conceivable to use the pronounced susceptibility of NETosis towards external 
factors for its intervention. For instance, accurate regulation of osmolarity, plasma protein 
concentration, temperature, ROS scavenging and pH could decrease NETosis [370, 392] (all 
manuscripts) and possibly improve the effect of specific inhibitors of NET-associated 
proteins in combined dosage forms. One straightforward target for such combinations is the 
 CHAPTER 4 - Discussion and outlook 
 Dissertation - Elsa Neubert 
 
 109 
superficial dysregulation of NETosis such as on the surface of the cornea as suggested in the 
therapy of ophthalmic diseases [392].  
The precise targeting of NETosis in tissues, however, appears to be far more complex. The 
increasing knowledge of different neutrophil phenotypes and recruitment pathways in 
specific tissues [14, 35, 402] also expands the options in NETosis targeting. Specific inhibition 
of neutrophil recruitment into the affected organ could contribute to a more precise 
intervention of NET-associated diseases compared to an overall inhibition of NETosis. In this 
context, it is important to investigate further whether NET formation is necessarily 
associated with attenuated migration, especially after the point of no return or whether 
neutrophils are still able to migrate even after successful activation. 
4.4 Relevance of light-induced NETosis in vivo  
As extensively discussed in manuscript III, in vitro ROS-mediated light-induced NETosis is a 
starting point to further investigate the role of neutrophils and NETosis in light-sensitive skin 
diseases. Therefore, NET formation has to be verified within the tissue of patients suffering 
from photodermatoses. Controlled irradiation of human skin with light of defined 
wavelengths and subsequent collection of skin sections would be most suitable to clarify the 
contribution of each modality. However, with regard to the exclusivity of these samples, 
precise dose-monitored irradiation in model mouse could mainly support our understanding 
of light-induced NETosis in vivo.  
Along with these studies, it is essential to clarify the involvement of PAD4 activity in light-
induced NET formation. This is of particular interest regarding the high antigen levels 
directed against citrullinated proteins in many autoimmune disorders. In the inhibitor 
studies of manuscript III, we observed decreased NET rates after pan-PAD inhibition with Cl-
amidine (Fig. 3). Based on these results, at least, a contribution of PAD enzymes to the 
observed chromatin decondensation is likely. However, further studies are required to 
investigate the exact role of PAD4 by specific inhibitor studies [403], with isolated 
neutrophils as well as verification of citrullinated proteins in skin sections and mouse 
models. For the latter, it is essential to differentiate between general improvement of 
symptoms, decrease in citrullinated proteins, and NET formation, as PAD inhibition does not 
selectively block NETosis. PAD4 also restricts general protein citrullination and contributes to 
the anti-inflammatory response. Additionally, all results obtained in mouse models have to 
be precisely verified and validated in human tissue, as the involvement of PAD4 in NET 
formation in different species is a matter of ongoing debate [214, 224, 403, 404].  
Neutrophils from patients with autoimmune disorders were also frequently reported to be 
primed for NETosis (discussion of manuscript III). Whether this also applies particularly for 
light-induced NETosis, can be clarified by controlled irradiation of neutrophils from patients 
in comparison to healthy controls. However, the questions remain whether neutrophil 
priming can reduce the threshold for NETosis in response to light and whether this effect is 
attributable to a particular neutrophil phenotype, for instance LDGs of patients with SLE. 
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The results of manuscript III also indicate that light-induced NET formation in our setup is 
mediated by extracellular ROS formation (Fig. 5). Since several light sensitive autoimmune 
disorders show a pronounced ROS imbalance (see also discussion of manuscript III), it would 
be interesting to study the possible correlation between these two. Therefore, the redox 
capacity within the skin has to be correlated with the individual NETosis rate after light 
irradiation, conceptually similar to a recent study from Inoue et al., which correlates redox 
imbalance in blood with NET-associated lung metastasis [405]. Subsequently, if a correlation 
between these two characteristics exists, the application of ROS scavengers in mice model 
could serve as a proof of principle to target light-induced NETosis. Importantly, a beneficial 
effect of ROS scavenging was already described in NETosis targeting in autoimmune diseases 
[37]. 
Apart from its relevance in disease progression, light-induced ROS generation with 
subsequent NET release could also be important in therapeutic settings (see discussion of 
manuscript III). Induction of cell death by ROS generation after excitation of blue light-
sensitive porphyrin- or flavin-based photosensitizers is involved in the photodynamic 
therapy (PDT) of basal cell carcinoma, Bowen’s disease and actinic keratosis (carcinoma in 
situ) and has been linked to bactericidal effects in bacterial keratitis or acne. Whether 
NETosis is involved in these settings has to be addressed in separate in vivo studies. 
However, based on our current understanding and the data presented in manuscript III, it 



















Parts of the introduction and discussion including figures are prepared for the submission to 
a peer-reviewed journal in form of a review on the driving forces in NET formation. 
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